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Abstract
Inductively coupled plasma mass spectrometry (ICP-MS) is a powerful tool for 
elemental analysis and has been used to find the composition of many materials in recent 
years. This thesis deals with the analytical utility of ICP-MS for the determination of 
endogenous levels of Li in serum
Factors such as the scanned mass range and the dwell time were found to significantly 
affect the instrument response. Under optimum conditions for Li the serum matrix was found 
to cause limited non-spectroscopic interferences. Elemental recombinations of the major 
electrolytes in the matrix did not affect Li determination. However, several biologically 
important elements e.g. Cr, V, and As were significantly affected by these interferences 
which limited the usability of the multi-element capabilities of the technique.
The feasibility of the analysis of dilute serum was investigated. The results showed 
that the high levels of proteins in serum caused a rapid deterioration of the magnitude and the 
stability of the signal. Therefore, a wet digestion technique using HNO3 was devised. The 
method proved to be accurate and precise not only for Li but also for B, Mg, Co, Cu, Zn, 
Se, Br, Rb and Cs. International standard reference materials (SRM) were used in order to 
test the accuracy of the overall procedures. Comparable results to the certified values were 
obtained for all the elements studied. In addition, this work provided the first data for Li and 
B in two SRMs, namely, NIST bovine serum and Versieck's second generation serum.
The levels of Li in the serum of healthy subjects were evaluated based on the analysis 
of 196 samples. The data showed that the reference value for Li in serum approximates to 0.9 
ng.ml *. To demonstrate the applicability of this work for biological studies, the levels of Li, 
B, Mg, Co, Cu, Zn, Se, Br, Rb and Cs were determined in the serum of patients with skin 
disorders. Several changes in trace element levels e.g. the elevation of Li in polymorphic light 
eruption were observed.
Overall, this study demonstrates the suitability of ICP-MS for routine multi-element 
analysis of several trace elements in serum. Although matrix dependent problems can be a 
limiting factor, ICP-MS is likely to become the instrument of choice for routine analysis of 
biological materials.
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Introduction
1.1 Trace Elements: An Overview
Of the 90 chemical elements that occur in the earth's crust or atmosphere, only 11 
(O, C, H, N, Ca, P, K, S, Na, Cl, and Mg) are present in large amounts in the bodies of 
warm-blooded animals. Of these, the first 4 account for 96% of the total mass of the 
organism, with the others making up about 3.6%. The remaining 70 odd elements occur in 
minute quantities and are referred to as trace elements.
The first publication on the health effects of a trace element dates back to 1852, when
Chatin, a french botanist, reported that the occurrence of Goitre in man was associated with
a deficiency in environmental iodine [Chatin 1852]. Since then, there has been an increasing 
realization of the importance of trace element chemistry in biological systems. This awareness 
has been stimulated by the rising concern of man's impact on his environment and its 
biological effect on him.
To date, 15 trace elements are defined as essential. According to Cotzias, to be 
classified as essential an element must meet the following criteria [Cotzias 1967]:
(A) It should be present in all healthy tissues of all healthy things.
(B) Its concentration in these tissues must be fairly constant.
(C) Its withdrawal from the body induces reproducibly the same physiological and
structural abnormalities regardless of the species studied.
(D) Its addition either reverses or prevents those abnormalities.
(E) The abnormalities induced by deficiency are always accompanied by pertinent, 
specific biochemical changes.
(F) The biochemical changes can be prevented or cured when the deficiency is prevented 
or cured.
The elements fulfilling these requirements are As, Co, Cr, Cu, F, Fe, I, Mn, Mo, Ni, 
Se, Si, Sn, V, and Zn. Table 1.1 lists the chronology of discovery of essentiality of these 
elements.
In addition to the essential elements, there are several others which are always found 
in body tissues but for which no proof of essentiality has been established. These elements 
are often referred to as non-essential, e.g. Li, B, Ge, Sr.
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Table 1.1 Discovery of trace element essentiality for animals [Abou-Shakxa 1987, Havrancroft 1990]
Element year Investigator Some functions and deficiency aspects
Fe
I
Cu
Mn
Zn
Co
Mo
Se
Cr
Sn
Ni
Si
As
(17th century)
1852 Chatin 
1928 Hart
1931 Kemmerer
1934 Todd
1935 Underwood
1953 De Renzo
1957 Schwarz 
1959 Schwarz
1970 Schwarz
1970 Nielsen
1971 Schwarz
1972 Schwarz
1972 Schwarz 
1975 Nielsen
Involved in oxygen and electron transport. Deficiency results in 
anaemia. Excess is dangerous in haemochromatosis 
Constituent of thyroid hormones. Deficiency results in goitre and 
depression of thyroid function. Excess leads to thyrotoxicosis. 
Linked to oxidative enzymes, interacts with iron. Essential for 
cross linking of elastin. Deficiency results in anaemia and changes 
in ossification.
Participates in mucopolysaccharide metabolism and is connected 
with superoxide dismutase. Excess results in neurological 
disorders.
Constituent of over 100 enzymes. Deficiency leads to growth 
depression, sexual immaturity, skin lesions, etc.
Part of vitamin B-12 whose functions include synthesis o f  DNA; 
production of red blood cells; etc. Deficiency of Co is unknown 
but vitamin 6-12 deficiency causes pernicious anaemia.
Essential for the prevention of dental caries, Fe metabolism, uric 
acid excretion and maintenance of normal sexual function in male. 
Deficiency leads to irritability, irregular heart beat, lack of uric 
acid production, and coma. Excess intake causes gout and 
increased copper excretion.
Component of glutathione peroxidase, preserves normal liver 
function, and act as an anti-inflammatory agent. Deficiency induces 
Keshan disease and white muscle disease. Excess leads to lassitude, 
skin depigmentation and hair loss.
Functions as the glucose tolerance factor which stimulates insulin. 
Deficiency is associated with impaired glucose tolerance and a 
suspected link with heart disease. Excess can cause eczema and 
cancer.
Essential for the growth of animals. Functions believed to reside 
in stimulating the transcription of RNA and DNA, and protein 
synthesis. Excess causes anaemia and growth retardation. 
Functions include an antagonistic action to adrenaline; intensifying 
the action of insulin; and stabilizing RNA and DNA in tissues. 
Deficiency impairs Fe absorption leading to anaemia. Excess 
exposure causes eczema and cancer.
Functions in growth, fat metabolism, and blood production. 
Deficiency causes reduction in red blood cell production; upset Fe 
metabolism; and lack of growth of bones, teeth and cartilage. 
Excess leads to kidney failure; reduces the desire for food; and 
may be related to nmnic depression.
Appears to confer strength and stability to bones and teeth; it acts 
as an anti-cariogenic agent in the teeth of children. Deficiency 
causes anaemia, infertility, stunted growth, and osteoporosis. 
Excess leads to mottling of the teeth, depression of appetite, osteo­
sclerosis.
important for the strength and elasticity of the gristle. Deficiency 
leads to abnormalities in bones. Excess can cause eczema and 
cancer.
Believed to be essential for the growth of animals. Deficiency 
effects are unknown. Excess can be fatal.
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Some elements, e.g. Cd, Hg, and Pb, are prominently classified as toxic. This is 
because of their detrimental effects even at low levels. It should be noted, however, that all 
trace elements are potentially toxic when their levels exceed the limits of safe exposure. These 
limits vary widely from one element to another.
1.2 Analytical Considerations In Trace Element Studies
The analytical techniques used in trace element studies must be adequate for the 
intended purpose. In searching for a suitable technique the main characteristics that must be 
considered are: selectivity, sensitivity, accuracy and precision. Other properties which can 
be advantageous include: wide dynamic range, ease of operation, multi-element capabilities, 
speed of analysis, and cost effectiveness.
Selectivity'. This is a description of the ability of a technique to respond to a desired element 
and not to another. It is usually quantified as the ratio of the response obtained for the 
undesired constituent (interferrent) to that for the element of interest.
Sensitivity: This is a measure of the capability of the technique to discriminate between 
samples containing different amounts of the analyte. It is defined as the ratio of the change 
in the instrument response with a corresponding change in the stimulus. Quantitatively, the 
sensitivity is often determined as the concentration of the analyte required to cause a given 
instrument response e.g. 1 % absorption in the case of atomic absorption spectrometry (AAS).
Precision: The degree of mutual agreement of independent measurements under the same 
conditions. It is concerned with the spread of the data. Precision is usually calculated as the 
relative standard deviation of the results.
Accuracy: The degree of agreement of a measured value with the true or expected value of 
the concentration of concern. An indicator of the degree of accuracy is the confidence levels 
within which the measured value and the expected one are not significantly different, based 
on a two tailed Student's t-test.
Dynamic range: The range between the lower and upper limit of concentration for which 
incremental additions produce constant increments of response.
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Another parameter that is often quoted when evaluating the performance of analytical 
methods is the detection limit (DL). This is the smallest amount of the element that can be 
measured with a stated level of confidence. DL is usually calculated as the concentration of 
the element needed to produce a signal equal to 3 times the standard deviation of the blank.
The rapid development of analytical methodology during the past two decades has 
created powerful tools for trace element research. However, successful application of these 
tools in the analysis of biological matrices requires clear understanding of their related merits 
and limitations. In this section, a review of the basic theory as well as the analytical 
capabilities of the most popular techniques available to date, will be presented. Furthermore, 
the reported DL for these techniques are summarized at the end of this section in Table 1.2.
1.2.1 Atomic Spectrometry
Absorption or emission of electromagnetic radiation by atoms is accompanied by 
transition in energy levels of the outer-shell electrons. Since the differences between energy 
levels vary between elements, each will exhibit its own characteristic spectrum of atomic 
absorption or emission. The characteristic photon (absorbed or emitted) possesses a specific 
energy (wavelength). Thus, quantitative information on the levels of a certain element can be 
obtained from the amount of absorption or emission at that specific wavelength.
1.2.1.1 Flame atomic absorption spectrometry (FAAS)
This technique involves aspiration of the sample solution into a flame whose high 
temperature converts the analyte ions into free atoms in the vapour state. The flame is placed 
just below the optical path of radiation emitted at precisely the correct wavelength for 
absorption by the analyte atoms in the vapour. This emission is produced by a hollow cathode 
lamp or an electrodeless discharge lamp which contains the analyte element. The amount of 
radiation absorbed by the sample is measured with a photomultiplier tube after passing 
through a monochromator. Since usually only the test element can absorb this radiation, the 
method is very selective [Hei^e 1989].
The technique is simple, relatively free from matrix effects, and cheap. However, the 
evaluated DL are usually at the sub /tg.ml ' levels, which makes FAAS suitable for the 
analysis of only a few trace elements in biological samples e.g. Fe, Cu, Zn. Furthermore, at
-5-
present FAAS is not commonly used for simultaneous multi-element determination. Some 
developments in this area are, however, being undertaken piandy 1988].
1.2.1.2 Electrothermal atomic absorption spectrometry (ETAAS)
The principles of ETAAS are relatively simple. An electrically heated graphite tube, 
rod, furnace, or cuvette is placed in the optical path of an atomic absorption system instead 
of the flame burner used in FAAS. During operation 5 to SO jul of the sample are injected into 
the tube, which is then heated in three stages: (a) 'dry' (110 "C) to remove water and acid 
vapour, (b) 'char' (350 - 1200 ®C) to remove organic and more volatile compounds,and (c) 
'atomize' (2000 -3000 "C) to vaporise and atomize the analytes of interest.
The advantages of ETAAS include a high degree of selectivity, good sensitivity (sub 
ng.ml '), small sample volume or mass requirement, applicability to a large number of 
elements, and relatively low running costs. The technique suffers, however, from a limited 
linear dynamic range (about 2 orders of magnitude), slightly poorer precision (of the order 
of 2 to 5%) and longer measurement times than for FAAS. Although, background absorption 
from sample matrix components can be a problem, corrections based on the use of double 
beam systems or the Zeeman background corrector are usually adequate if carefully applied 
[Slavin 1988].
1.2.1.3 Flame atomic emission spectrometry (FAES)
FAES is based on the electromagnetic emissions from atoms in the excited state. 
Similar to FAAS, a flame is the source of atomization and excitation.
The technique is highly selective and offers multi-element capabilities together with 
a sensitivity around 10 ng.ml ' for many elements. It has a wide dynamic range (4 orders of 
magnitude), but suffers from serious matrix effects. Due to its relatively poor sensitivity 
FAES cannot be used for the determination of endogenous levels of many trace elements in 
biological samples e.g. serum [Risby 1988].
1.2.1.4 Inductively coupled plasma atomic emission spectrometry (ICP-AES)
The use of a plasma instead of the normal flame as an excitation source provides an 
improved sensitivity (sub ng.ml ') for most elements. This is because the high temperature in 
the plasma ensures that a higher proportion of the atoms in the fireball are in the excited state
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and alleviates chemical interferences. However, this high temperature, excites most elements 
to emit complex spectra. This in turn, leads to overlap between analytical lines and causes 
spectral problems. Finally, ICP-AES is a relatively expensive technique which may be the 
reason for its limited use in analytical laboratories [Wolnik 1988].
1.2.2 Inorganic Mass Spectrometry
Inorganic mass spectrometry involves the separation of gaseous ions according to their 
mass-charge ratio m/z. The sample may be ionized in a variety of ways, depending on its 
physical state and the information desired. The main technique of ionization used for the 
analysis of biological materials is spark source. This technique is based on the generation of 
an electrical spark between two closely spaced electrodes of the material to be analysed. This 
spark produces a high frequency discharge between the electrodes which results in the erosion 
and the subsequent ionisation of a portion of the electrodes material. These ions are then 
drawn into the mass spectrometer via a set of ion lenses.
Spark source mass spectrometry (SSMS) is a multi-element technique with a high 
sensitivity (sub ng.ml ' levels) for most elements. However, it suffers from the following 
drawbacks :-
(A) Non conducting biological materials have to be dissolved if they are not already in
a liquid form, then heated to dryness, and converted into conducting electrodes by 
mixing the residue with graphite powders. Such processes are tedious, time 
consuming, and prone to high levels of contamination.
(B) Spectral interferences from the large number of inorganic elements present at
relatively high concentrations in the pre-concentrated ash (Na, P, S, K, Ca) can be 
a problem. This is mainly due to the formation of polyatomic or doubly charged 
species.
(C) A high capital cost which is due to the need for a double focusing mass analyzer in
order to handle the relatively large energetic spread of the ions formed.
(D) Long analysis time as 5 to 7 days are usually needed for sparking and data processing 
[Morrison 1979].
The potential of SSMS in terms of accuracy and precision can be enhanced further 
by using the isotope dilution method. This is a definitive method which eliminates the need 
for external calibration and internal standardisation. It is based on the addition of a spike
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isotope of the element of interest to the sample and prior knowledge of the isotope ratio of 
the element in the sample. This method is applicable only to elements which have at least two 
stable (or one stable and one long lived radioactive) isotopes, and which are available in 
artificially altered isotopic composition [Fasset 1989].
1.2,3 Neutron Activation Analysis (NAA)
With NAA, the samples are irradiated in a nuclear reactor with a beam of 
predominantly thermal neutrons. As a result of the neutron bombardment, various elements 
in the samples are converted to radioactive isotopes. These isotopes decay by emitting 
characteristic y and fi radiations. Using a y spectrometer, the characteristic y radiation is 
detected and counted. By comparing the signal against that of a standard irradiated and 
counted under the same conditions as the sample, quantitative analysis can be made.
Instrumental neutron activation analysis (INAA) is the basic form of NAA. It involves 
the direct measurement of induced radioactivity after a suitable decay time. The technique is 
non-destructive and offers a multi-element capability together with relatively good levels of 
sensitivity (ng.ml ' levels). However, due to the chemical nature of biological matrices (rich 
in Na, S, P, Ca, K,...) several matrix interferences are usually observed. These can be 
grouped in two categories :-
(A) Gross background signals due to Compton, Bremsstrahlung and back-scattering.
These can all be thought of as increased noise level which reduces precision.
(B) Competing nuclear reactions which produce the same products, e.g. ’^Al(n;y)“Al and
*'P(n;o!)“Al.
Interferences in INAA can usually be corrected. However, this is often at the expense 
of precision. Other disadvantages of INAA include the long decay time for some elements 
(e.g. > 2 weeks for Fe, Co, Cs,...), and the high running costs.
In order to improve the sensitivity and precision of INAA for short lived elements, 
researchers often use radiochemical separation (RNAA). This technique is particularly useful 
for the analysis of biological materials. It enables the elimination of interfering matrix 
activities as well as quantitative isolation of a single element or of a group of elements. 
RNAA offers a sensitivity down to sub ng.ml ' levels for elements such as As, Cd, Cr, Mn,
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and V, together with minimum contamination risks. The separation procedures are however 
long winded and carry the potential of delivering to the analyst a high dose of radiation 
[Versieck 1988].
1.2.4 X-i*ay Spectrometry
When an atom is excited by removal of an electron from the inner shell an electron 
from the outer shell is usually transferred to fill the vacancy. This transfer is accompanied 
by the emission of a characteristic radiation which has an energy identical to the energetic 
difference between the two shells. Owing to its relatively high energy (wavelength) this 
radiation falls in the X-ray region. Quantitative determination is based on the proportionality 
between the intensity of the radiation at a characteristic energy and the number of atoms in 
the sample.
The excitation of the atoms, and subsequently the generation of X-rays can be 
performed with electromagnetic radiation or elementary particles. Any technique using X-rays 
as the exciting radiation is termed X-ray fluorescence (XRF) whereas techniques using 
elementary particles are referred to as particle induced X-ray emission (PIXE).
Advantages of X-ray spectrometry include non-destructivity, selectivity, applicability 
to all elements from Li to U, simultaneous multi-element capabilities, and good precision 
(" 5%). The technique is especially useful for the analysis of solid samples collected on 
filters, e.g. sediments and suspended solids, since very little or no sample preparation is 
needed. In contrast, the analysis of liquid specimens is often hampered by tedious sample 
preparation procedures. Furthermore, the sensitivity of XRF is relatively poor (/tg.ml ' levels) 
and inadequate for the analysis of several trace elements in biological materials. Recent 
advances with total reflection XRF (TXRF) and the use of synchrotron radiation as X-ray 
sources (SXRF) are promising an improvement in the DL of the technique down to sub ng.ml 
' levels for most elements [Janssens 1989; Jones 1989]. These methods, however, are still in 
the development stages.
PIXE, on the other hand, offers DL in the ng.ml ' region. However, although 
accurate, the technique is expensive, requires special expertise, and cannot be applied to the 
analysis of many trace elements in serum or blood samples.
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Table 1.2 Detection limits of various analytical techniques (ng.ml ')
Element FAAS‘ ETAAS' ICP-AES' SSMS’ INAA"' XRF*
Lithium 8 0.05 1.35 0.06 _ »
Boron 700 - 20 3 - -
Magnesium 0.3 0.004 0.12 0.2 * -
Aluminium 30 0.04 6 1 2 *
Titanium 50 1 0.75 " - 4
Vanadium 40 0.2 3 0.4 0.2 5
Chromium 5 0.01 3 0.5 2 5
Manganese 50 0.01 0.6 0.4 0.7 6.5
Iron 4 0.02 1.5 0.5 50 5
Cobalt 10 0.01 3 0.5 1 3
Zinc 2 0.01 1.5 2 100 4.5
Copper 2 0.02 1.35 2 2 3
Germanium 150 0.2 15 - - -
Arsenic 100 0.2 30 0.6 1 5
Selenium 130 0.2 90 2 5 -
Bromine - - - - 50 -
Rubidium 5 0.05 t\t - 10 1.5
Silver 2 1 30 - 3 -
Molybdenum 30 0.04 7.5 3 2 ÎÜ
Cadmium 2 0.003 1.5 7 5 Ift
Indium 50 - 0.05 45 - -
Tellurium 20 0.1 15 20 30 -
Caesium 5 0.05 - - 0.8 -
Barium 8 0.1 0.15 2 20 12
Lanthanum * - 1.5 - - 7.5
Cerium - 15 2 - - -
Tungsten * - 30 - - -
Gold 100 0.1 6 - 0.005 -
Mercury 280 1 30 7 0.8 -
Lead 3 0.05 30 3 500 3
Bismuth 40 0.1 30 2 - ih
Thorium 60 - 3 - - 9
Uranium * - 15 - 2 6
‘ Vanna 1987 
'  Peririn Elmer 1988
* Morrison 1979
* Sdka 1981 
' Waxd 1986
* : >  1 /ig.ml *
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1.3 Lithium au essential element?
Discovered in 1817 by J.A. Arfvedson, Li is the lightest of all solid elements (6.94 
amu) and has a wide and diverse distribution in nature. In 1841 Lipowitz reported that LiCO, 
is very efficient in dissolving uric acid [Lipowitz 1841]. Similar findings were also reported 
by Ure [Ure 1843]. Drawing upon these reports Garrod demonstrated the in vitro dissolution 
of uric acid deposits on cartilage by LiCO, [Garrod 1859]. He erroneously concluded that 
LiCOj could dissolve uric acid in vivo and thus is suitable for the treatment of Gout. Later, 
Garrod extended his view and reported that deposits of uric acid could also develop 
unpredictably in any tissue and thereby produce a wealth of disorders. He grouped these 
disorders under the descriptive phrase "uric acid diathesis", and recommended, as a part of 
the treatment, a daily intake of about 5 to 25 mmol of Li [Garrod 187Q.
In 1948, LiCl was introduced in the US as a NaCl salt substitute in low salt diet. 
However, before long cases of Li toxicity were reported in relation to this diet [Corcoran 
1949]. As a result, the Food and Drug Administration (FDA) rapidly withdrew these salt- 
substitute preparations from the market, labelling Li as toxic. Ironically, in the same year, 
on the other side of the globe, an Australian psychiatrist reported the successful use of Li in 
the treatment of mania [Cade 1949]. Several researchers soon confirmed the findings of Cade 
[Sdiou 1954; Hartigan 1963; Baastrup 1964]. In 1969, the FDA approved the labelling of 
LiCOa for the treatment of manic episodes of bipolar disorder (manic depression). Since then 
there has been a steady increase in basic and clinical research focusing on the clinical use and 
pharmacologic mechanisms of Li.
Although LiCOa is a safe drug when used knowledgeably, reversible side effects are 
seen on most patients on long-term treatment. These include polyuria ("70%), increased thirst 
("65%), hand tremor ("30%), weight gain ("20%), diarrhoea ("20%) and oedema of legs and 
face ("10%) [Amisden 1985]. Furthermore, levels of Li in serum should be carefully 
monitored during treatment. If they increase above 10 to 12 /ig.ml ', Li intoxication is 
expected. Such intoxication affects mainly the central nervous system (CNS) and kidneys. The 
characteristics of intoxication are muscular twitching increasing to epileptic seizures; slurred 
speech increasing to muteness; ataxia increasing to paralysis; tremor increasing to agitated 
state and cognitive bluntness; and sluggishness increasing to coma or death. The kidney 
effects include progressive acute renal failure with oliguria, but without demonstrable 
histopathological changes [Hansen 1978].
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The exact mechanisms by which Li exerts its beneficial, and indeed its possibly 
detrimental, effects are not wholly understood. It is thought that due to some chemical 
similarities between Li and other cations (e.g. Na"^ , Ca^ "^ , and Mg"^ )^, Li"^  may compete
with them regarding binding to regulator sites of enzyme molecules. This might in turn 
explain the effects of Li on various enzymes, e.g. its inhibition of adenylate cyclase [Fom 
1971] and phospho-fructukinase [Kajda 1973], as well as its increase in the activity of 
glycogen synthetase [Horn 1973]. Furthermore, it has been reported that Li"^  can partially 
substitute for Na  ^ or in the activation of transport adenyl-pyrophosphatases [Dick 1978].
Up until recently, Li has been generally assumed to be non-essential to life, quoting 
from a report from Cade: ''...mankind, or at least the non manic depressive members could 
live perfectly happily and efficiently in a lithium-free universe" [Cade 1975]. However, Patt 
et aly reported that rats fed on a relatively low Li diet (5-15 ng.g ‘) showed a reduction in 
fertility, as compared to Li supplemented rats (500 ng.g') [Patt 1978]. Using an even more 
deficient diet ("3 ng.g'), Burt reported that female rats on low Li diets required a longer 
period of gestation, and produced smaller litters. Furthermore, the survival rate of the litters 
was also depressed in Li deficiency [Burt 1982]. Surprisingly though, both studies on rats 
reported a preservation in the levels of Li in endocrine tissues (pituitary, adrenal, thyroid). 
Although these findings suggest a possible involvement of Li in neuro-endocrine functions, 
this evidence is not conclusive.
Similar studies of Li deficiency were conducted by Anke et al on goats. They 
reported that low Li diet impeded the growth of the animals, as well as the reproductive 
performance of their females [Anke 1981]. Furthermore, the same group reported later that 
the mortality of Li deficient mother goats during the first year was significantly lower than 
that of controls [Anke 1990].
The evidence from animal experiments discussed above suggests that there is a Li 
requirement for the two species studied. Due to substantial discrepancies among the analytical 
data no quantitative estimates could be made, not even in the form of a range of adequate 
intakes. Therefore, progress in the field of Li nutrition and metabolism will depend greatly 
on improvement in analytical methodology e.g. validation of procedures, and application to 
the analysis of biological matrices.
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1.4 Aims of this work
The objectives of this study were:
(A) to test the suitability of inductively coupled plasma mass spectrometry (ICP-MS) for
the analysis of Li in blood serum;
(B) to determine the reference levels of Li in serum, based on a large scale study
including 'healthy' subjects from various locations in the UK as well as a population 
from Finland;
(C) to investigate a possible relationship between the levels of Li in serum and the health
status of the subject, with a specific interest in some skin disorders;
(D) to pursue any possible synergistic or antagonistic relationship between Li and other
trace elements in serum, especially with the other first group elements Rb and Cs.
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2.1 Blood and Related Components
Human blood is a heterogeneous viscous fluid. It consists of a variety of cells (red 
blood cells, white blood cells, and platelets) suspended in a slightly yellow, watery solution 
of proteins and salts called plasma.
The ftmctions of blood which make it so vital to life may be described under 3 main 
headings: transport, maintenance of stable internal environment and body temperature 
(homeostasis), and defence against infection and uncontrolled haemorrhage.
Transport', one of the well known roles of the blood is the transport of oxygen from the lungs 
to all parts of the body and the transport of carbon dioxide back to the lungs to be expelled 
in the expired air. In addition, nutrients are transported from their production sites to the area 
where they are required. Waste products are transported by the blood either to the liver for 
further processing or directly to the kidneys for excretion. Finally, hormones are carried by 
the bloodstream from the endocrine glands to all parts of the body.
Homeostasis: blood is used to regulate body temperature in order to ensure optimal function 
of the enzymes which drive the chemical processes of the body. It also helps to maintain the 
acid-base balance of the body via its buffering properties. Finally, the blood ensures that 
various body tissues maintain the correct balance of water and salts within their cells, which 
is very important for the life of these cells.
Defence: blood provides a protection against infection by virtue of the antibodies it contains 
and by the phagocytic action of the white blood cells. In addition, in the case of injuries the 
blood flow ensures a continuing supply of platelets and blood clotting factors in order to form 
a clot that prevents blood loss.
Since they reflect most of the metabolic activities of the body, samples of blood or 
blood fractions are routinely used for the assessment of health status and are often subjected 
to various chemical, biochemical and physical tests.
When a blood specimen is withdrawn from the body, a clotting process is triggered 
due to the polymerization of fibrinogen to fibrin. The end product of this reaction is a 
precipitate of white and red blood cells entangled in fine strands of fibrin, and a watery
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solution called serum. Although the clotting process can be prevented by adding an 
anticoagulant to the specimen, there is always the risk of extraneous addition of certain trace 
elements from the anticoagulant in use. Hence serum is more commonly used, instead of 
whole blood, for elemental analysis. Note that the main difference between serum and plasma 
is that the former does not contain fibrinogen.
2.2 Composition and Physiological Role of Plasma (Serum)
Blood plasma is formed of about 90% water, 7% proteins, 2% relatively small 
organic compounds and 1% inorganic substances. The water in the plasma is derived mainly 
by absorption from the gastrointestinal tract with a small proportion obtained from cellular 
respiration.
The plasma proteins form a complex mixture with a variety of functions that include 
nutrition, control of body water, buffer capacity, transport of other substances, blood 
coagulation and immunological activities. There are three major types of plasma proteins 
namely:-
Albumins: Synthesized in the liver, they are the smallest plasma proteins and are mainly 
responsible for the maintenance and regulation of blood pressure, maintenance of water 
balance between blood and tissues, and regulation of blood volume.
Globulins: Depending on their ftmctions these proteins can be divided into three groups: ct 
and fi globulins, which combine loosely with other chemicals to carry them around in the 
blood, and y globulins, which are antibodies important for the body's immune system.
Fibrinogen: Produced by the liver, it is a key component in the process of blood coagulation.
The relatively small organic substances present in plasma consist of metabolites which 
are transported between the various organs of the body. In healthy individuals, the 
concentrations of most of these substances remain reasonably steady except for the ones which 
are absorbed from the food (glucose, amino-acids, fats, etc); these will therefore show 
transient increases in concentration following a meal.
Inorganic substances help to maintain osmotic pressure, normal pH, and the 
physiological balance between blood and tissues. They are usually present in the ionic form,
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either as simple salts or bound to plasma proteins. Although the term inorganic substances 
often relates to electrolytes such as Na, K, Cl, S, etc., trace elements are also included in this 
group.
2.3 Problems with Trace Element Analysis of Serum
Many investigations have been carried out on trace elements in blood serum to 
elucidate: (A) the influence of environment on constituents of the body; and (B) medical 
diagnosis of a disease status. A survey of the published data shows that widely divergent 
values were measured in different laboratories. Therefore, there is a mounting concern, that 
the elemental composition data generated by these studies, especially for ultra-trace (sub 
ng.ml ') levels, are inaccurate. This inaccuracy can be ascribed either to inadequate sample 
collection and preparation or to poor analysis.
The accuracy of any analytical technique is affected by intrinsic factors specific to the 
technique itself. Identification of these factors and their extent with regard to specific matrices 
can be a tedious job and necessitate a good understanding of the modes of operation, 
potential, and shortcomings of the instrument in use. Unfortunately, to-date, there is a 
tendency to use sophisticated commercial instruments in a 'black box' manner. This, together 
with the lack of international standard serum reference materials, which mimic the endogenous 
levels of trace elements in serum, play a major role in limiting the reproducibility of results 
obtained by various laboratories*.
The vital importance of adequate sampling was recognized a long time ago .. unless 
the complete history o f any sample is known with certainty, the analyst is well advised not to 
spend his time analysing it" (Thiers 1957]. In the case of serum, strenuous sample collection 
procedures are to be adopted in order to avoid extraneous element contamination. The origin 
of these contaminants may be cell debris, the collection and storage devices, the collection 
site, and many other environmental sources. With regard to the volume of blood collected, 
it has been reported that the first 20 ml are usually contaminated with cell debris, which 
raises the levels of Fe in serum by about 15% [Versieck 1986]. This contamination, which 
is not significant for most other trace elements, decline for Fe to about 2% when using the
* Recently, two such references were made commercially available: (A) the second generation 
serum [J Versieck, Ghent, Belgium]; and (B) NIST SRM 1598 bovine serum [NIST, 
Maryland, USA].
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second 20 ml. Collecting such large volumes of blood can, however, be a major source of 
discomfort for the patients and may impose a major constraint on large scale studies regarding 
certain diseases or age groups.
Blood collecting devices are potential sources of contamination. Several authors have 
found higher serum concentrations of Ni and Cr in blood collected with conventional steel 
needles than with polyethylene intravenous cannulae [Kumpulainen 1983; Sunderman 1984]. 
Such elevation is mainly due to an elution from Ni and Cr impurities in the stainless steel 
material of the needles. Other researchers, however, reported that identical results for the 
concentration of Ni and Cr in serum were obtained using siliconized steel needles and 
intravenous cannulae [Veillon 1984; Bro 1988]. Veillon et al related these observations to the 
possibility that the process of siliconizing imparts sufficient hydrophobicity to the needle to 
prevent serum contact with the metallic surface [Veillon 1984]. Another attempt to identify 
contamination due to the collection needles was carried out by Versieck et al. They irradiated 
steel needles, used them for in-vitro blood collection, and measured the levels of radioactive 
inorganic contaminants in the samples. These levels were found to be significantly high for 
Fe, Ni, Cr, Co and Mn [Versieck 1982]. However, the same authors, later admitted that 
"...the observed additions were very probably pushed up by irradiation damage to the needle 
during its activation in the reactor" [Versieck 1989]. Furthermore, Hudnik et al observed 
high levels of contamination with Mn from steel needles. The authors reported that this 
contamination is caused by impurities left on the surface of the needles after the 
manufacturing process and not by dissolution of surface layers of the metal [Hudnik 1984]. 
Although, needles of platinum-iridium or platinum-rhodium can be used as alternatives to steel 
needles, their cost and limited availability preclude their general use. Nowadays, 
polypropylene, polyethylene, and teflon intravenous catheters are thought to be the best 
available products for the collection of blood samples for trace element investigations. 
Siliconized steel needles provide the second best method of collection and if elements such 
as Fe, Mn, Ni, and Cr are not of interest for the investigator, then the majority of 
commercially available steel needles can be used.
Another potential source of contamination is the storage container. Throughout the 
1970s, there were reports regarding Zn contamination from various kinds of containers 
[Helman 1971; Hughes 1976; Nackowski 1977; Reimold 1978; Williams 1979; Lecomte 
1979]. Zinc, however, was not the only contaminant and a report by Moody and Lindstrom
“ 18-
examined the levels of impurities in various plastic materials and made recommendations for 
cleaning methods [Moody 1977]. Based on these studies, more stringent measures with regard 
to container production were adopted and most of the commercial suppliers, nowadays, 
provide specialised tubes that meet the requirement for trace element analysis.
Heydorn et al reported problems with the determination of Mn in blood serum due 
to contamination from airborne particulates (dust). Their results originally suffered from a 
large variability, which is not surprising since depending on the flow of the air in the 
laboratory some samples tend to be more contaminated than others. However, by keeping the 
sample containers shut all the time, the authors reported a reduction of the imprecision to 
about 10% of its original value [Heydom 1973]. The problem of contamination from airborne 
particulate is fully discussed by Zief and Mitchell. One of the conclusions from their work, 
is that a clean laboratory environment is essential to carry out trace and ultra-trace analysis. 
The design of such a laboratory environment is also described in the manuscript [Zief 1976].
Another factor that should be taken into consideration when collecting serum samples, 
is the length of time the blood is allowed to clot before separating the serum. In fact, during 
this period, the blood specimen undergoes various changes. These can be broadly classified 
as: (A) changes associated with gaseous exchanges; (B) alterations due to the continued 
metabolic reactions within the blood cells; (C) haemolysis or membrane permeability changes; 
and (D) changes due to dénaturation and loss of biological activities [Hawcroft 1987]. The 
most damaging between these changes, with regard to trace element analysis, are possibly 
those due to haemolysis. This is because of the large difference between the elemental 
composition of blood cells and serum. Dempster et al reported that a haemolysis which is just 
detectable to the naked eye accounts for an approximate 3 times increase in the Mn levels 
[Dempster 1988]. Nowadays, it is accepted that the best way to avoid detrimental changes is 
to centrifuge the samples within few hours [Versieck 1989]. Finally, it is worth mentioning 
that the physical characteristics of serum specimens can be affected by storage. When a 
sample that has been stored in a deep freeze is thawed, a watery layer is formed on the 
surface. If the sample is not well mixed before preparation or analysis, erratic results will be 
expected.
Based on the above mentioned remarks the following precautions should be adopted 
for a typical sample collection protocol :-
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(A) Samples are to be taken through intravenous cannulas (teflon, polypropylene,...).
(B) Non powdered gloves must be used (powder can be a source of contamination).
(C) Discard the first 10 ml of blood withdrawn, which might be used for routine 
biochemistry / haematology tests.
(D) Withdraw 30 ml of blood and transfer them to metal free centrifuge tubes.
(E) Leave to clot for 60 minutes.
(F) Centrifuge at 2500 rpm for 20 minutes.
(G) Transfer serum to metal free storage tubes.
(H) Place samples into air tight polypropylene bags, and store them at -20 °C.
2.4 Reference Levels of Trace Elements in Serum
Reference levels in serum (often inaccurately referred to as 'normal' values) are 
needed in order to identify true variations in elemental concentrations arising from 
physiological changes, pathological influences, and environmental and occupational exposures. 
However, data might differ depending on (A) the reference population and procedures adopted 
for selection; (B) the environmental and physiological conditions at the time of collection; (C) 
the technique and duration of specimen collection, transport, preparation, and storage; and
(D) the analytical method that was used with supporting data regarding its accuracy, 
precision, and quality control. Therefore, a compilation of recent reports (1986-1990) will be 
presented for each trace element. This compilation is a continuation of the authoritative work 
of Versieck and Cornelis [Versieck 1989] and will include whenever possible information 
about the analytical technique used, age, sex and geographical location.
Aluminium
To date, it is believed that typical levels of A1 in the serum of 'control' individuals 
are below 10 ng.ml '. The problems in determining such levels accurately originate mainly 
from the fact that A1 is very sensitive to external contamination. Sources of contaminants 
include air particulates, laboratory equipment and chemicals [Kostyniak 1983; Cornells 1984]. 
Furthermore, there is a lack of sensitive techniques capable of conducting accurate 
measurements at such low levels. Berlyne and Alder reviewed the literature data for serum 
Al. They concluded that the levels of A1 in serum cannot be measured accurately, and that 
at best semi-quantitative measurements can be conducted by electrothermal atomic absorption 
spectrometry (ETAAS) [Berlyne 1985]. Since then several reports on the development of 
methods for the analysis of Al in serum by ETAAS have been published. These methods seem
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to be accurate and capable of eliminating the early problems of semm matrix effects [Sanz- 
Medd 1987; Patriarca 1988; Gitelman 1989].
Table 2.1 Reported levels of Al in serum of healthy individuals
Author Mean ± SD 
(ng.ml')
Min Max n Method Age ±  SD % Country
(range) Females
Dijkmans 1987 
Hassanaly 1987 
Davidson 1988 
Roberts 1988 
Chappuis 1989
8.6 ± 2.12 
8.5 ±  3 
184 ±  52 
13.5 ±  5.1 
6.21
26
13
18
50
21
18
23
ETAAS
ETAAS
NAA
DCP-ES
ETAAS
44(20-85)
61 ± 9
44 Netbedauds
France
UK
UK
France
Table 2.1 shows clearly that a major analytical error is associated with neutron 
activation analysis (NAA). In fact, interference caused by reactions on P from fast neutrons, 
'^P(n;of)’^®Al, is the main source of problems. Although the use of Cd shielding can reduce 
such interferences, plenty of development is still needed in order to render this technique 
suitable for routine work. Another technique mentioned in Table 2.1 is direct current plasma 
emission spectrometry (DCP-ES). Roberts and Williams demonstrated that this technique is 
accurate, precise and can be used for routine analysis [Roberts 1988]. Different type of 
plasma emission spectrometers (ICP-AES) have also been found useful for the analysis of Al 
[Mauras 1985]. However, due to its inhibiting costs and greater susceptibility to matrix 
effects, plasma emission spectrometry is yet to be accepted as a real challenger to ETAAS.
Chromium
The determination of Cr in blood semm is a very tedious process. The analytical 
difficulties arise mainly from extraneous contamination and losses due to the volatilization of 
the element. Stainless steel needles and storage containers can be a major source of 
contaminants. Furthermore, many chemical reagents contain sufficient Cr to cause serious 
error. Once the problem of contamination has been overcome, finding a sensitive technique 
for undertaking the measurements can still be a challenging task.
During the first half of the past decade, levels of Cr varying between 6 and 32 ng.ml ' 
were reported [Kostadinov 1981; Minami 1984; Simonoff 1984]. However, increased recent 
awareness of the problems led to consistent results with values at the 0.1 ng.ml ' levels.
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Table 2.2 Reported levels of Cr in serum of healthy individuals
Author Mean ± SD 
(ng.ml*)
Min Max n Method Age ±  SD 
(range)
%
Females
Country
Ericson 1986 0.19 ± 0.07 16 ETAAS 50 USA
Offenbacher 1986 0.15 ± 0.02 0.12 0.18 6 ETAAS
Minoia 1988 0.16 ±  0.09 0.04 0.25 164 ETAAS Italy
Taylor 1988 <0.11 0.45 20 ETAAS UK
Sunderman 1989 0.06 ± 0.13 0.01 0.17 42 ETAAS (26-68) 50 USA
The most popular technique for the analysis of Cr is ETAAS. Originally, this 
technique suffered from inadequate background correction for Cr. This continued to be the 
case until the introduction of high intensity continuum sources and the Zeeman background 
correction systems [Veillon 1984; Sunderman 1984]. Taylor and Green, on the other hand, 
have recently reported that the use of totally pyrolytic graphite cuvettes eliminates the need 
for background correction. This was supported with experimental results, though no reasons 
were given for such an improvement [Taylor 1988]. Two other techniques have been 
described as useful for Cr determination, namely, stable isotope dilution-mass spectrometry 
[Veillon 1979] and Radiochemical NAA (RNAA) [V ^ieck 1978]. Both techniques are, 
however, time consuming and impractical for routine analysis.
The data reported by Sunderman et al (Table 2.2) are considerably lower than the rest 
of the results in the table. This difference cannot be attributed to material losses during 
analysis since the results reported by the various authors for bovine semm reference material 
were comparable. Therefore, whether the strict sample collection and preparation procedures 
adopted by Sunderman and his group have eliminated yet another source of contamination or 
whether the discrepancy is due to geographical differences is something to be investigated.
To date, there are no evidences suggesting differences in Cr levels between males and 
females. Furthermore, age does not seem to be affecting semm Cr, since the values reported 
by Offenbacher et al for 23 elderly subjects are in agreement with data obtained for 'control' 
adults (Table 2.2) [Offenbachs 1985].
Copper
As shown in Table 2.3 there is good agreement between most literature values 
reported for Cu. The mean level of Cu in semm being around 0.9 to 1.1 ^g.ml '. There are,
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however, some odd outliers. The data reported by Conlan et al is significantly higher than 
the rest of the results. Whether this observation reflects particularly elevated levels of Cu in 
the serum of elderly women or whether it is due to analysis errors is very difficult to 
determine. However, it might be beneficial if the same study was repeated including a further 
'control' group of younger women. Other results such as those reported by Grail et al, 
Shemberg et al, Cengiz et al, and Kok et al are slightly high. Such findings, however, should 
be tolerated, as one cannot expect the levels of trace elements in biological matrices to exhibit 
always statistically normal distributions around a set of firm numbers.
Sachdev et al reported low levels of Cu in indian infants (7.7 ± 1 . 6  months). Low 
serum copper in infants has previously been observed [Walraveas 1980]. However, Henkin 
et al reported that the levels of Cu in serum should reach the adult range within 3 to 4 months 
of life [H^ikm 1973]. Whether the discrepancy is due to a malnutrition status of the babies 
studied remains to be demonstrated. A slight, age related increase in serum copper 
concentration was observed in the male population by Lekahkul et al [Lekabkul 1987]. 
Similar increases in serum Cu has been reported by other investigators [Helgoland 1982; 
Schreurs 1982]. All these studies agree in that the trend was not perceived in the female 
population. A biological interpretation of these findings is beyond the scope of this work.
Table 2.3 reflects the popularity of flame atomic absorption spectrometry (FAAS) for 
the determination of serum copper. In fact, this technique is, nowadays, being routinely used 
in most clinical laboratories. Other techniques, such as NAA, particle induced X-ray emission 
(PIXE), and X-ray fluorescence (XRF), can be used to perform such analysis. However, they 
are too expensive to compete with the popularity of FAAS. Recently, Abe et al, described 
a relatively cheap colorimetric assay for Cu in serum. This technique has shown a high degree 
of sensitivity, a precision of < 3%, and freedom from matrix interferences. Good agreement 
was obtained when comparing the result of the assay witli FAAS [Abe 1989]. Thus 
colorimetry can be a usefiil substitute if the laboratory is not equipped with an FAAS system.
Manganese
Hitherto, reference levels of Mn in serum ("0.6 ng.ml ') was a long disputed topic. 
A critical revision of the published reports reveals that such a dispute can be eliminated if 
adequate precautions are undertaken. Mn is widely distributed in the environment. It is a
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Table 2.3 Reported levels of Cu in serum of healthy individuals
Author Mean ± SD
(jtig-nd‘)
Min Max n !Method Age ±  SD 
(range)
%
Females
Country
Grail 1986 1.25 ±  0.16 21 FAAS 39 (25-63) 100 UK
Beguin 1987 1.10 ±  0.02 100 PIXE Belgium
De V Heese 1987 1.06 ±  0.2 0.60 1.81 100 FAAS 18-23 100 SA*
1.06 ±  0.18 30 FAAS <40 100 UK
0.96 ± 0.19 24 FAAS 18-20 100 USA
Gerli 1987 1.00 ±  0.25 24 FAAS 64 Italy
Lekhakul 1987 1.12 ±  0.07 42 FAAS (10-20) 100 Thailand
0.83 ±  0.03 35 FAAS (10-20) 0 Thailand
1.11 ±  0.05 80 FAAS (21-30) 100 Thailand
0.91 ±  0.04 69 FAAS (21-30) 0 Thailand
1.13 ±  0.07 35 FAAS (31-40) 100 Thailand
1.13 ± 0.05 23 FAAS (31-40) 0 Thailand
1.17 ± 0.04 40 FAAS (41-50) 100 Thailand
1.17 ± 0.07 28 FAAS (41-50) 0 Thailand
1.16 ± 0.28 21 FAAS (51-60) 100 Thailand
1.04 ± 0.03 15 FAAS (51-60) 0 Thailand
1.16 ±  0.03 218 FAAS (18-60) 100 Thailand
1.04 ±  0.03 170 FAAS (18-60) 0 Thailand
1.11 ± 0.02 388 FAAS (18-60) 56 Thailand
Acarturk 1988 1.12 ±  0.02 30 AAS (35-70) 33 Turkey
Cengiz 1988 1.39 ±  0.21 16 FAAS 31 (18-55) 56 Turkey
Farrer 1988 1.01 ±  0.27 20 Israel
El Hawy 1988 0.91 ±  0.01 20 FAAS <40 0 Egypt
Kok 1988 1.25 ±  0.28 128 FAAS Neibedands
Narang 1988 1.08 ±  0.03 0.65 1.66 75 FAAS (16-65) India
Reyes 1988 0.94 ±  0.40 16 AAS 21.88 Chili
Shemberg 1988 1.33 ± 0.27 8 XRF 100 Israel
Shiue 1988 1.18 ± 0.16 10 FAAS (7-43) 30 Thailand
Abe 1989 0.66 ± 2.80 56 FAAS Japan
Diez 1989 1.00 ±  0.18 100 FAAS 58 ±  8 36 Spain
Dogan 1989 1.13 ± 0.03 33 FAAS 30 (16-61) 18 Turkey
Kapaki 1989 1.03 ± 0.14 28 FAAS Greece
Oster 1989 1.11 ±  0.34 0.63 1.35 64 FAAS 53 ±  8 FRG
Sachdev 1989 0.80 ±  0.09 20 FAAS < 1 40 India
El Tabbakh 1989 1.21 ±  0.23 0.96 1.72 10 FAAS 100 Egypt
Conlan 1990 1.65 ± 0.43 1.05 2.42 24 FAAS 79 (71-87) 79 UK
*SA =  South Africa
component of stainless steel (needles), occurs in airborne particulates, and is present in most 
plastics. Therefore, careful choice of sampling, storage and handling devices must be adopted. 
An evaluation of the levels of contamination from commercially available products have been 
carried out by Ericson et al [Ericson 1986]. Furthermore, sample collection and preparation 
must be carried out in a clean room environment in order to eliminate possible contamination 
[Parr 1985].
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As reported by Dempster et al, the elemental transfer from the Mn rich red blood 
cells to serum during haemolysis results in a significant elevation of serum Mn. Thus, 
haemolysis is another major source of contamination which may be responsible for the 
variation in reported literature values [Dempster 1988].
Table 2.4 Reported levels of Mn in serum of healthy individuals
Author * Mean ±  SD 
(ng.ml')
Min Max n Method Age ±  SD 
(range)
%
Females
Country
Ericson 1986 0.57 ±  0.18 16 ETAAS 50 USA
Lombeck 1986 0.64 ±  0.25 NAA (2-6) Belgium
Davidson 1988 4.89 ±  1.49 20 NAA 27 ±  8 65 UK
Freeland-
Graves 1988 0.95 ± 0.38 0.59 1.47 5 ETAAS 20(19-20) 0 USA
Hulanicki 1989 31.11 ±  7.07 5 ETAAS Poland
Greger 1990 1.00 ±  0.05 10 ETAAS 28 ±  3 0 USA
Table 2.4 shows that ETAAS is the most popular technique for carrying out Mn 
determinations. In fact, with ETAAS little sample preparation is needed (1:1 dilution with 
Triton X-100 or other matrix modifiers), though, background correction with either 
continuum source background correction systems or Zeeman correction is a necessity in order 
to overcome matrix effects [Baruthio 1988]. Other techniques used for the determination of 
Mn in serum include NAA and ICP-AES [Versieck 1980; Black 1981]. In both cases, 
however, costs and complex matrix modification procedures are the major inhibiting factors.
The data listed in Table 2.4 show that to-date, the majority of laboratories fail to 
provide accurate results. Both groups led by Freeland-Graves and Greger used stainless steel 
needles which are well known sources of contamination [Hudnik 1984]. Davidson and Ward, 
on the other hand, used tubes containing sodium heparin, for sample storage. Heparin has 
been reported to be high in Mn [DWv^ 1973]. Finally, the results reported by Hulanicki et 
al are listed only as an indicator of the severity of contamination which can be expected if 
uncontrolled sample collection procedures are used.
Table 2.4 shows no significant differences between the results obtained by Lombeck 
et aly for 'control' children, and those by Ericson et aly for adult laboratory personnel. 
Although not conclusive, such an observation gives the impression that serum Mn does not 
vary with age. Finally, Fernandez et aly Cotzias et al, Versieck et al, and Ericson et al all
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reported no significant differences between the Mn levels in the serum of males and females 
[Fernanda 1963; Cotzias 1966; Versieck 1980; Ericson 1986].
Nickel
The concentration of Ni in serum is very low and its determination is subject to 
serious contamination problems. Up until the pioneering work of Sunderman and his co­
workers [Sunderman 1984], the reference value for Ni in serum was thought to be in the 
range of 2 to 7 ng.ml ' [Vollkopf 1981]. The former group, however, imposed stringent 
sampling procedures based on the recommendations of the sub-committee on environmental 
and occupational toxicology of Ni [Brown 1981]. They also used a Zeeman background 
correction system which enabled them to improve significantly the detection limits for the 
technique they used, namely, ETAAS. Based on these refinements, the group reported, for 
a population of 39 subjects, a mean value + SD of 0.46 ±  0.26 ng.ml '. This result was soon 
supported by the findings of Wills et aly who analysed serum from 18 subjects and reported 
a value of 0.44 ±0 .18  ng.ml ' [Wills 1985].
Table 2.5 lists some of the most recent published data on Ni in serum. It is obvious 
that ETAAS is the method of choice for conducting such measurements. The data quoted by 
Hosokawa et al, seems to be too high to be accepted as accurate. This in turns poses a serious 
doubt over the suitability of FAAS, with its mod%t detection limits, for undertaking such a 
task. The data reported by Davidson and Ward is also very high. Actually, it has been 
reported that the limits of detection for Ni by NAA , arbitrarily defined as the amount of Ni 
that gives 30 net photopeak counts, is 7.3 ng* [Guinn 1980]. Such a value means that there 
is a need for either sample pre-concentration or the adoption of a long, time consuming, 
irradiation - counting protocol in order to be able to detect the true levels of Ni in serum.
As reported by Hopfer et al (Table 2.5) a clear difference could be seen between the 
Ni levels in USA and Canadian populations. The authors reported that this difference is 
directly related to the levels of Ni in tap water. These levels being 0.4 ± 0.2 in Hartford, 
Conneticut (where the USA samples were collected) and 109 ± 46 in Sadbury, Ontario 
(where the Canadian samples were collected). Apart from this observation, there is still no 
evidence regarding differences in serum Ni with either age or sex.
* For neutron flux 0 = 10'^  n, irradiation period tj = 5 hours, decay period t<, = 0, count 
period t, = 100 minutes, 40 cm’ Ge(Li) detector, sample to detector distance = 2 cm, "Ni.
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Table 2.5 Reported levels of Ni in serum of healthy individuals
Author Mean ±  SD 
(ng.ml')
Min Max n Method Age ±  SD 
(range)
%
Females
Country
Andersen 1986 0.65 ±  0.35 0.32 1.28 6 ETAAS Denmark
Hosokawa 1987 5.6 ± 0.8 30 FAAS Japan
Davidson 1988 2.2 ±  0.5 20 NAA 27 ±  8 65 UK
Hopfer 1989 0.2 ±  0.2 43 ETAAS 49 USA
0.6 ±  0.3 22 ETAAS 82 Canada
Sunderman 1989 0.2 ± 0.7 <0.05 1.0 42 ETAAS (26-68) 50 USA
Selenium
Reference levels of Se in serum normally range between 70 and 100 ng.ml *. 
However, it has been reported that these levels can be affected by the levels of Se in the soil. 
In fact, low serum Se has been observed in the population of Se deficient areas such as 
Finland and New Zealand (particularly the South Island) [West^marck 1977; Rea 1979]. 
Furthermore, the inhabitants of seleniferous areas such as South Dakota and Venezuela tend 
to have high serum Se [Howe 1979; Bratter 1984].
Table 2.6 shows that the levels of serum Se in the Finnish population have been 
restored to normal and that a steady increase in these levels have been observed over the past 
4 years [Mussalo-Rauhamaa 1987; Korpela 1989; Westermarck 1990]. This was due to a 
programme started in 1984 where selective amounts of Se were added to soil fertilizers.
Shenberg et al (Table 2.6) reported a relatively lower mean serum Se in female than 
in male Israelites. Such a difference between sexes has not been reported previously and was 
observed by neither Glattre et al nor Morisi et al. Furthermore, unlike the latter two 
studies, Shenberg and co-workers, did not report the use any standard reference material in 
order to certify the accuracy of their results.
Jacobson and Lockitch reported a progressive increase of serum Se with age up to 
maturity. This trend is in accord with the findings of most investigators and is accepted as 
a rule for healthy subjects [Verlinden 1983; Lombeck 1983].
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Table 2.6 Reported levels of Se in serum of healthy individuals
Author ]Mean ± SD 
(ng.ml')
Min Max n :Method Age ±  SD 
(range)
%
Females
Country
Beguin 1987 97 ±  40 98 PIXE Belgium
Gerli 1987 76 ±  19 67 XRF 36 Italy
Mussalo-
Rauhamaa 1987 79 ± 14 52 ETAAS 34(18-63) 65 Finland
Ringstad 1987 125 102 157 32 ETAAS (20-54) Norway
Sampson 1987 104 ±  21 21 ETAAS UK
Davidson 1988 126 ± 31 21 NAA 38 UK
Dawczynski 1988 76 ±  14 40 ETAAS GDR
Jacobson 1988 120 ± 12 99 143 20 ETAAS (1-5) Canada
132 ±  15 111 164 20 ETAAS (6-9) Canada
144 ±  20 102 205 57 ETAAS >  10 Canada
Philipov 1988 57 ±  14 294 ETAAS Bulgaria
Salonen 1988 85 ± 21 449 ETAAS 54 Finland
Shenberg 1988 130 ± 23 80 170 19 XRF (28-59) 0 Israel
114 ±  17 90 140 8 XRF (30-60) 100 Israel
Simonof 1988 80 ± 30 50 PIXE 43 ±  17 30 France
Glattre 1989 116 ±  16 129 ETAAS 72 Norway
120 ±  15 36 ETAAS 0 Norway
114 ± 16 93 ETAAS 100 Norway
Korpela 1989 85 ± 13 15 ETAAS 53(21-73) 53 Finland
Morisi 1989 93 ±  15 54 154 813 ETAAS (20-69) 0 Italy
91 ±  14 49 150 991 ETAAS (20-69) 100 Italy
91 ±  13 56 130 753 ETAAS (20-69) 0 Italy
91 ±  11 49 138 956 ETAAS (20-69) 100 Italy
89 ±  14 55 138 119 ETAAS (20-69) 0 Italy
89 ± 14 55 138 124 ETAAS (20-69) 100 Italy
91 ±  14 58 149 141 ETAAS (30-69) 0 Italy
89 ± 13 49 141 133 ETAAS (30-69) 100 Italy
87 ±  13 51 120 80 ETAAS (65-94) 0 Italy
93 ± 19 46 130 91 ETAAS (65-94) 0 Italy
82 ±  10 53 104 97 ETAAS (9-13) 0 Italy
78 ± 9 60 104 90 ETAAS (9-13) 100 Italy
83 ± 10 48 120 442 ETAAS (11-15) 0 Italy
83 ± 11 48 126 406 ETAAS (11-15) 100 Italy
82 ±  13 55 133 182 ETAAS (6-11) Italy
Oster 1989 75 ± 12 50 90 143 ETAAS 53 ± 8 FRG
Femandes-
Banares 1990 60 ±  35 92 ETAAS 34(16-71) 57 Spain
Westermarck 1990 121 21 ETAAS 36 Finland
Although Table 2.6 seems to imply that ETAAS is the most popular method used for 
the determination of Se in serum, a trial conducted by the International Union for Pure and 
Applied Chemistry (lUPAC) has shown that fluorometry (FLU), isotope dilution mass 
spectrometry (IDMS), NAA and XRF are very reliable techniques for conducting such 
measurements phnat 198Q. The trial reported that ETAAS and hydride generation atomic 
absorption spectrometry (HGAAS) are prone to systematic errors. The credibility of HGAAS
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was later restored after the identification of improper sample decomposition as the source of 
inaccuracy. An inter-laboratory trial by the Commission on Toxicology concluded that using 
an appropriate sample decomposition technique results in improved levels of accuracy and 
precision [Commission on Toxicology 1987]. With regard to ETAAS, application of the 
Zeeman-effect background correction and the use of various matrix modifiers such as 
palladium - ascorbic acid, platinum - nickel, and platinum - copper have enhanced the quality 
of Se measurements [Welz 1984; Saeed 1987; Knowles 1989].
Vanadium
The concentration of V in serum is very low. In the early eighties, Cornelis and co­
workers reported a mean value of 0.031 ng.ml * [Comdis 1981]. Such a value has not been 
accepted as an indication of the true levels of V in serum until recently [Versieck 1989]. This 
is mainly due to the lack of sensitive techniques capable of conducting accurate measurements 
at such low levels. Earlier investigations using ETAAS have concluded that there is a need 
for sample pre-concentration in order to conduct such measurements [Pyy 1984]. Recent 
attempts, using this technique, were successful in distinguishing between the serum V of 
healthy volunteers and that of hemodialyzed patients [Ishida 1989]; 60 % of the values for 
the former group were, however, below the detection limits (Table 2.7). Questionable data 
have also been produced, using ETAAS, over the past 10 years. Investigators reported levels 
of V in healthy volunteers ranging between 2.22 and 3.94 ng.ml * [Stroop 1982]. Clearly these 
levels are too high and most likely are due to ignored matrix effects.
The main technique used nowadays for measuring serum V is NAA. Table 2.7 lists 
results obtained by two different NAA methods, namely, instrumental (INAA) and 
radiochemical (RNAA). Using INAA both Campbell et al and Lavi and Alfassi, reported 
relatively high levels of V in the serum of control subjects. This is possibly due to sample 
contamination during the pretreatment stage; The former group used hydrated antimony 
pentoxide (HAP) separation whilst the latter used sample co-precipitation with Pb complexes. 
Radiochemical NAA offers a solution to sample contamination through post-irradiation 
chemical separation (possible material losses can be evaluated through the use of tracers e.g. 
"V). Two such separations have been described by Byrne and Costa and Cornelis et al [Byrne 
1978; Comdis 1980]. Using RNAA, Byrne and Kucera, determined the levels of V in the 
serum of 10 adults (Table 2.7) with an excellent accuracy, as determined with the use of the 
second generation serum reference material, and a precision of < 2 % [Byrne 1990].
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Table 2.7 Reported levels of V in serum of healthy individuals
Author Mean ±  SD 
(ng.ml')
Min Max n Method Age ±  SD 
(range)
%
Females
Country
Campbell 1988 4.03 ±  0.95 32 NAA 55 ±  14 69 UK
Lavi 1988 3.67 ±  1.57 1.3 6.05 10 NAA Israel
Ishida 1989 < 0.08 0.24 64 ETAAS Japan
Byrne 1990 0.07 ±  0.05 0.01 0.22 10 NAA 50 Belgium
Due to its low levels and the concomitant problems with its determination, very little 
is known about any possible variation in serum V with age, sex, or geographical location. An 
area of research which is most likely to be explored in this coming decade.
Tine
Reference levels for Zn in serum are thought to lie around 1.0 jug.ml *. A close 
examination of the data in Table 2.8 shows that the values reported by Lekahkul et al are 
abnormally high. Obviously, there must be a major analytical error associated with these 
results. It is most likely that this error is due to the gross contamination problem from the 
storage containers, discussed in section 2.3.
The data quoted by Friel et al show that there is no significant difference between the 
serum zinc levels of infants and adults [Friel 1988]. Although this is in line with the findings 
of Henkin et aly and Gibson and Dewolfe, the trend described by the latter groups is that the 
serum Zn concentration in the newborn is practically at the adult levels. It then falls during 
the period between 1 and 4 months, before returning to their expected levels [Henkin 1973; 
Gibson 1981]. It is not known yet whether this dip is due to physiological or nutritional 
factors.
Another interesting observation from Table 2.8, is the lower levels of serum Zn in 
Cuban elderly as compared with younger controls [Mahia Villas 1987]. This is not unexpected 
since a similar observation has previously been reported, and abnormal cell metabolism and 
deficient dietary intake have both been invoked to explain such a Zn decline [Sandstead 1982; 
Wilson 1985]. To date, the accepted trend with regard to the effect of age on serum Zn is that 
the Zn levels in serum remain constant up to a certain age (about 60 years) After which they 
show a tendency to decline [Y^sieck 1989].
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Table 2.8 Reported levels of Zn in serum of healthy individuals
Author Mean ±  SD 
Otg.ml')
Min Max n Method Age ±  SD 
(range)
%
Females
Country
Grail 1986 1.02 ±  0.34 21 FAAS 100 XJK
Mazzotta 1986 0.96 ±  0.05 40 FAAS (07-50) 30 Italy
Beguin 1987 1.10 ±  0.20 100 PIXE Belgium
De V Heese 1987 0.96 ±  0.13 0.71 1.29 100 FAAS (18-23) 100 SA
0.80 ± 0.12 30 FAAS < 40 100 UK
0.89 ± 0.10 24 FAAS (18-20) 100 USA
Dijkmans 1987 0.94 ±  0.17 18 FAAS 44(20-85) 44 Ndbedanch
Gerli 1987 0.73 ±  0.10 67 FAAS 36 Italy
Lekhakul 1987 2.16 ±  0.06 218 FAAS (18-60) 100 Thailand
2.33 ±  0.07 170 FAAS (18-60) 0 Thailand
2.41 ±  0.17 42 FAAS (10-20) 100 Thailand
2.79 ± 0.20 35 FAAS (10-20) 0 Thailand
2.38 ± 0.13 80 FAAS (21-30) 100 Thailand
2.38 ±  0.09 69 FAAS (21-30) 0 Thailand
2.27 ± 0.13 35 FAAS (31-40) 100 Thailand
2.66 ±  0.14 23 FAAS (31-40) 0 Thailand
1.66 ±  0.10 40 FAAS (41-50) 100 Thailand
1.79 ±  0.12 28 FAAS (41-50) 0 Thailand
2.15 ± 0.06 21 FAAS (51-60) 100 Thailand
2.33 ± 0.07 15 FAAS (51-60) 0 Thailand
Mahia Villas 1987 1.06 ±  0.23 0.63 1.61 27 FAAS (20-40) 0 Cuba
0.64 ±  0.31 0.16 1.71 29 FAAS (40-95) 0 Cuba
1.10 ±  0.37 0.36 1.90 30 FAAS (20-40) 100 Cuba
0.59 ±  0.18 0.16 0.94 29 FAAS (40-95) 100 Cuba
1.08 ±  0.31 0.36 1.90 57 FAAS (20-40) 53 Cuba
0.62 ±  0.26 0.16 1.71 58 FAAS (40-95) 50 Cuba
Miles 1987 0.88 ±  0.12 16 FAAS 35 ±  10 0 USA
0.83 ±  0.15 11 FAAS 32 ±  11 100 USA
0.99 ±  0.21 5 FAAS 14 ±  2 100 USA
0.99 ±  0.16 21 FAAS 11 ±  3 USA
Bakan 1988 1.05 ±  0.21 72 (36-81) 11 Turkey
Bakos 1988 0.88 ± 0.14 7 FAAS (28-76) 0 Iraq
0.73 ± 0.06 3 FAAS (28-76) 100 Iraq
Cengiz 1988 1.05 ±  0.10 0.90 1.28 16 FAAS 31(18-55) 56 Turkey
El Hawy 1988 0.82 ±  0.11 20 FAAS (10-50) 0 Egypt
Friel 1988 0.94 ±  0.33 13 FAAS 27 ±  1 w Canada
Kok 1988 0.74 ±  0.16 128 FAAS Nethodands
Mussalo-
Rauhamaa 1988 0.78 ±  0.12 FAAS Finland
Shemberg 1988 0.97 ± 0,15 27 XRF (28-60) 30 Israel
Shiue 1988 0.90 ± 0.12 10 FAAS (7-43) 30 Taiwan
Stafford 1988 0.83 ± 0.10 0.65 1.05 23 FAAS 82(69-94) UK
Swanson 1988 0.85 ± 0.01 0.64 1.13 53 FAAS 77(64-95) 70 Switedand
Diez 1989 0.73 ±  0.17 100 FAAS 58 ±  2 36 Spain
El Tabbakh 1989 0.65 ±  0.90 0.56 0.80 10 FAAS 26 ±  2 100 Egypt
Kapaki 1989 1.10 ±  0.19 28 ETAAS 46(16-73) 36 Greece
Oster 1989 0.93 ±  0.18 0.60 0.13 88 FAAS 53 ±  8 FRG
Neggers 1990 0.96 ±  0.20 0.42 1.50 112 FAAS 21(14-36) 100 USA
0.91 ±  0.18 0.42 1.68 364 FAAS 22(12-42) 100 USA
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The data presented by El Tabbakh et aly for the analysis of serum from pregnant 
women, agree with reports by Meadows et al and Breskin et al with regard to lower levels 
of serum Zn during pregnancy [Meadows 1981; Breskin 1983]. Apart from pregnancy, there 
is no significant difference, in the concentration of Zn in serum, between males and females.
The effects of geographical location on serum Zn need careful interpretation. De V 
Heese et al showed no significant differences between women from South Africa, UK, and 
USA [De V Heese 1987]. Kok et al reported a low mean serum Zn (0.74 /ig.ml *) for 128 
healthy subjects from the Netherlands [Kok 1988]. Djinkmans et al, however, obtained a 
mean values of 0.94 jwg.ml ' for 18 subjects from the same country [Djinkmans 1987]. 
Therefore, based on the information in Table 2.8, it is very difficult to interpret the low 
values reported by Mussalo-Rauhamaa et al and Bakos et al [Mussalo-Rauhamaa 1988; Bakos 
1988]. In fact, additional information regarding the nutritional habits of the subjects and the 
results for the reference material used for establishing the accuracy of the measurement must 
be presented before any conclusions can be drawn.
Finally, for reasons previously mentioned, FAAS is the main method used in clinical 
laboratories for the analysis of Zn in serum. Accominotti et al, on the other hand, described 
an accurate method for the determination of serum Zn by ETAAS. Although this technique 
is tedious and time consuming, it could be particularly useful if the volume of the sample that 
can be collected is very low [Accominotti 1988].
Other Elements
A  limited number of studies has been published regarding other trace elements. 
Therefore, a brief overview of the knowledge regarding these elements will be listed.
Arsenic: The levels of As in serum are subject to regional differences as well as short-term 
effects from dietary intake [Nielsra 1988]. Although the mean value for As is expected to be 
around 1 ng.ml ', the range of concentrations observed extend over one order of magnitude 
i.e. 0.088 - 5.488 ng.ml ‘ [Versieck 1985]. This spread may be the indication that a log­
normal frequency distribution of As in serum should be expected.
Boron: This element is very poorly documented in most biological matrices. In her attempt 
to determine reference levels of B in various body fluids and tissues by ICP-MS, Havercroft
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reported levels of B in serum ranging between 8 and 48 ng.ml ' (Havercroft 1989]. These data 
are in good agreement with the values reported by Iyengar (mean ± SD, 22 ± 5 ^g.kg '; 
NAA-MS) [Iyengar 1989]. However, the accuracy of these results are still in question since 
there are no certified reference materials, or inter-laboratories studies to evaluate the accuracy 
and suitability of various analytical techniques for B determination.
Cadmium: The cadmium content of human serum is believed to be around 0.1 ng.ml ' [lagner 
1981; Iyengar 1987]. However, most analytical techniques lack the sensitivity to provide 
accurate results at these levels. Castillo et al, recently reported that with ETAAS they could 
achieve a detection limit of 7.05 x 10'® ng (3.58 x 10  ^ng.ml ') with a linear range of 0.01 - 
0.08 ng.ml '. The data they reported for samples collected from 20 'control' subjects were, 
however, far too high (2.1 - 7.9 ng.ml ') [Castillo 1987].
Caesium: Cs levels in blood serum are in the range of 0.5 to 1.5 ng.ml ' [Kasparek 1979; 
Gumming 1983]. Serum Cs is usually determined by INAA. This is because of the long half- 
life of the '®^Cs isotope, which enables its determination, in a purely instrumental way, after 
the activity of most interfering elements has decayed to background levels. Kumar et al 
compared the Cs levels in biological samples from manic, depressed manic, and recovered 
manic patients as well as 'controls’. Although the results fell within the expected range, the 
paper contained no indications about sample collection, preparation, mode of analysis and the 
accuracy of the results [Kumar 1989].
Cobalt: Thiers and co-authors were the first to report the very low levels of Co in serum. 
They analysed 2 samples for which they obtained 0.064 and 0.085 ng.ml ' [Thiers 1955]. 
Using ETAAS, Sunderman et al reported a reference range for Co in serum between < 0.02 
and 0.25 ng.ml ', with a mean value ±  SD of 0.05 ±  0.01 ng.ml ' [Sunderman 1989]. These 
results are in accordance with the values quoted by Versieck et al using INAA [Versieck 
1978]. However, they are much lower than those reported by Cumming et al (0.30 ± 0.12, 
INAA) and Sampson (0.35 ± 0.15, ETAAS) [Gumming 1983; Sampson 1988].
Lead: The concentration of Pb in blood serum is less than 1 ng.ml ' [Nixon 1985]. The 
determination of this element is usually carried out by ETAAS, though IDMS can also be 
used. One of the major points that the analyst must take care of before attempting such
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measurements, is the sensitivity of Pb to contamination with laboratory air-particulates which 
are exceptionally rich in this element.
Molybdenum: The levels of Mo in plasma or serum are poorly documented. The element is 
very difficult to determine as it exists at very low levels (<  1 ng.ml '). Kasperek et al 
reported, based on the analysis of 7 samples by INAA, a mean ± SD of 0.59 ± 0.23 ng.ml ' 
[Kasperek 1979]. For a slightly larger population (16 samples), Ericson and co-authors 
reported, using ETAAS, a value of 0.8 ± 0.2 ng.ml'. The results from this study ranged 
between < 0.3 and 1.3 ng.ml ' [Ericson 1986]. Finally, it has been reported that Mo can be 
quantified in serum by cathode-ray polarography [Christian 1979]. The described sample 
preparation procedures were somewhat complex, which inhibited follow-on work to pursue 
the potentials of this method.
Rubidium: Reference values for Rb in serum are close to 200 ng.ml ' [Allain 1984]. Several 
techniques are well suited for the determination of Rb, namely, AES, AAS, NAA, and IDMS 
[Allain 1984; Hallis 1985; Belkastad 1984; Schulten 1983]. Good agreement between the 
results from these techniques is often observed.
2.5 The Determination of Lithium in Serum
Endogenous levels of Li in serum are very low. In 1969, Christian reported that these 
levels are about 10 ng.ml ', as determined by FAAS. The samples were simply 10 fold diluted 
with water. However, the results were mostly at or below the detection limits of the technique 
[Christian 1969]. Delves and co-workers, used sample pre-concentration before the FAAS 
determination was carried out. Lithium was selectively extracted in 0.5 ml of isobutyl methyl 
ketone. The enhancement effect of the organic solvent combined with the extraction and pre­
concentration of the element resulted in an average sensitivity increase of 7 times that 
obtained by direct determination of the aqueous solution. The authors reported for 70 whole 
blood samples a mean value ± SD of 3 ± 4 ng.ml ' [Delves 1971]. Unfortunately, the 
extraction procedures were complicated and time consuming. Therefore, no further efforts 
were made to apply this promising method for serum.
By 1970, the use of Li salts for tlie treatment of manic depressive psychosis was 
accepted internationally. Furthermore, monitoring Li levels in the serum during therapy was 
routinely carried out, using flame atomic emission spectrometry (FAES), in order to avoid
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Li intoxication [Pybus 1970]. Owing to the popularity of the technique, several workers 
attempted to determine the 'reference' levels of Li in serum by FAES, most of them, 
however, reported that these levels were below the detection limits [Grime 1974]. In order 
to overcome this problem, Grime and Vickers attempted a separation of the vaporization and 
atomization processes. They incorporated a tantalum filament with a conventional flame 
burner, the former was used for vaporizing the sample and the latter for atomizing the 
vapour. Using tiiis technique, the authors reported that the amount of Li in a pooled human 
serum sample was 8 ng.ml '. The main drawback of this method, however, was the need for 
a separate 'blank' determination. Thus a portion of each sample had to be re-analysed and the 
signal at a spectral line close to that of Li, e.g. 670 nm, was noted and subtracted from the 
signal originally obtained at 670.8 nm [Grime 1974]. Similar problems were also reported by 
Matusiewicz who used a discrete injection FAES system. Furthermore, Matusiewicz reported 
the need for artificial serum standards in order to correct for (A) emission enhancement 
caused by the major electrolytes in the sample and (B) the variability in the aspiration rate 
between serum and aqueous standards. Apart from these drawbacks the method seemed of 
adequate precision and accuracy, needed no sample pretreatment, and was capable of 
providing detection limits down to 1.5 ng.ml \  The analysis of 9 replicates of a serum pool 
sample resulted in a mean ± SD of 9 ± 0.5 ng.ml * [Matusiewicz 1982].
In 1980, Pickett and Hawkins published a report defending the suitability of FAES 
for conducting Li determinations at physiological levels. They stated that the technique 
provides a detection limit of 0.005 ng.ml ', freedom from matrix effects, and limited, easily 
overcome, enhancement effects caused by the presence of electrolytes [Pickett 1980]. Such 
potentials have not been reported by other researchers. In fact the main problem with FAES 
is its poor DL and as described earlier, most researchers, believing that the levels of Li are 
above these DL, attempted to overcome this problem by minimising sample dilution. All that 
was measured, however, was most probably a non-corrected enhancement of the blank.
In a recent report, Castillo and co-workers, 'digested' two serum samples and 
analysed them using an FAES system with an air-acetylene burner. They reported a detection 
limit of 0.12 ng.ml ' and the results for their samples were 0.5 and 1 ng.ml ' respectively 
[Castillo 1987]. Although the authors reported the presence of signal interference from the 
Cl and K ions, they did not mention how they overcame this problem. Furthermore, there was 
no mention of the background correction problem usually associated with this type of
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analysis, neither was there an explanation for the use of an air-acetylene flame instead of the 
nitrous oxide-acetylene flame which is proven to be more suitable since it reduces the levels 
of interference [Matusiewicz 1982].
The analysis of Li in blood serum by ETAAS was attempted in the mid 1970's. 
Stafford and Saharovici, analysed samples fiom patients undergoing Li therapy. They reported 
that at these levels a 25 fold dilution with distilled water provides an accurate, and matrix 
interferences free determination. Their conclusions being based on the good agreement 
between the measured and the known concentration of a serum control (Dade Monitrol II) 
material [Stafford 1974]. Using the same technique, however, Ehrlich and Diamond observed 
a matrix interference which is caused by the high levels of Cl in the samples. They claimed 
that the presence of Cl ions reduced the dissociation of salts, and hence the amount of free 
Li vaporized. This effect was overcome according to the authors, by the addition of NH4NO3 
which removes the Cl at the ashing stage as NH4CI [Ehrlidi 1978]. Similar findings were also 
observed by Trapp who reported the presence of another non-identified interference but which 
can be eliminated by the addition of KH1PO4 [Trapp 1985].
Moynier and co-workers, studied the problems encountered during Li determination 
by ETAAS. They reported that a 1:5 dilution with 0.1% triton X-100 is sufficient to correct 
for the interference caused by the alkali metals (K, Na, Rb, Cs), though they were not sure 
whether it did correct for interferences from other elements e.g. Cl, Zeeman background 
correction did not seem to be effective for the correction of spectral interferences, though 
using a red filter seemed advantageous. In their original study, the authors reported a DL of 
2 ng.ml ', and their results for endogenous levels of Li varied between < 2 and 17 ng.ml ' 
with 26% of the results being below the detection limit. In the later study, using a fast heating 
atomizer, enabled the group to reduce the losses during the ashing stages thus enhancing the 
DL down to 0.5 ng.ml '. Under these conditions the results for Li in 23 healthy subjects 
ranged between 0.5 and 17.1 ng.ml ' [Bourret 1985; Moynier 1987].
Shen et al, reported that the advantages observed by Trapp when adding KH2PO4 to 
the samples were due to the formation of thermostable LiP04 which raised the maximum 
permissible chairing temperature for Li, thus reducing possible inter-element interferences. 
Furthermore, the authors reported that the improvement in DL observed when using fast 
heating atomizers was due to a partial reduction in the formation of LijCj during the charring
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period. Being more difficult to atomize than other Li species, the presence of LijCj results in 
a decrease in the absorption signal as well as a tailing of the peak. Experimenting with 
various tube coatings, Shen and his co-workers concluded that using tantalum carbide coated 
graphite tubes eliminates the Li^Q problem. However, there was still a need for matrix 
modification in order to eliminate NaCl interferences. Ammonium nitrate proved to be very 
useful in this case. Finally the authors analysed the serum of 7 healthy subjects. The mean 
result was 2.8 ng.ml ‘ with a range of 1.2 - 7,3 ng.ml ' [Shen 1988].
In summary, serum Li determination by ETAAS is subject to three major problems: 
the formation of volatile LiCl species which causes material losses during the ashing 
procedures; the formation of Li^Q; and the possible signal enhancement from the presence 
of other alkali metals in the sample. Although several authors have attempted to solve these 
problems, it is not clear yet whether they were 100% successftil, especially since the accuracy 
of their results has not been validated.
Another technique used for the analysis of Li in serum is mass spectrometry (MS). 
Lehmann and co-workers, used a field disorption (FD) source for ionising the samples. The 
technique is very specific and free from spectral interferences. However, the authors did not 
investigate whether there are some matrix interferences which may originate from the 
ionisation process. By analysing 5 samples the group reported a range of values between 6 
and 17 ng.ml ' [Lehmann 1978]. Fleishman et al, used an elaborate sample pretreatment 
method which included, ashing, salt co-precipitation, and paper chromatography, before 
analysis by MS. In order to account for any possible losses during preparation the authors 
used isotopic dilution. In this method, it is not the amount of the element but the ratio of its 
isotopes, achieved when the initial sample is mixed with an isotopic tracer, that is determined 
in the final preparation. The data presented in this report were a mean plasma concentration 
of 0.56 ng.ml ' with a range of 0.33 - 1.60 ng.ml '. These values were considerably lower 
than all the other data available at the time. The authors stated that this may be due to 
regional differences in the diet of the population, though it may be possible that some of the 
high levels reported are a consequence of methodological errors [Fleishman 1980].
Finally, Clarke et al, described a method based on a mass spectrometric assay of %  
from decay of tritium produced by thermal neutron reaction on "Li, "Li(n;a)*H. Although the 
technique is susceptible to interferences, e.g. 'H(n;y)^H and the decay of environmental
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tritium, these are negligible in the case of biological materials. The accuracy of the technique 
was checked by comparison of the obtained results for several standard reference materials 
against their certified values. The authors reported the analysis of one plasma sample for 
which they obtained 0.53 ng.g ', and twelve whole blood samples where the mean ±  SD was 
0.58 ±  0.06 ng.g '. The main drawback of this technique is, however, the need for a decay 
period of 1 year before the samples are cool enough for mass spectrometric analysis [Clarke 
1987].
Table 2.9 Reported levels of Li in serum of healthy 
individuals (ng.ml *)
Author Method n Mean (range)
Christian 1969 FAAS 10
Delves 1971 FAAS 70 3
Grime 1974 FAES 1 8
Lehmann 1978 FDMS 5 (6-17)
Fleishman 1981 IDMS (0.33-1.6)
Matusiewicz 1982 FAES 1 8
Bourret 1985 ETAAS 23 (<2-17)
Castillo 1987 FAES 2 (0.5-1)
Clarke 1987 NA-MS 1 0.53
Moynier 1987 ETAAS 23 (0.5-17)
Shen 1988 ETAAS 7 2.8
In summary, the analysis of reference levels of Li in blood serum (Table 2.9) is made 
difficult by the lack of accurate and sensitive techniques. Although IDMS is capable of 
satisfying the analytical requirements, difficult sample preparation procedures together with 
a long analysis time meant that the technique could not be used for routine analysis. The 
suitability of ICP-MS for undertaking these measurements has not yet been investigated. It 
is hoped that this project will provide the decisive answers with regard to this area of 
research.
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Inductively Coupled Plasma Mass Spec&omêtéry
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3.1 Historical Background
Inductively coupled plasma mass spectrometry (ICP-MS) is an instrumental technique 
for elemental and isotopic analysis which synergetically combines the capabilities of an argon 
plasma, for atomizing and ionizing injected samples, with the sensitivity and selectivity of a 
mass spectrometer. The development of ICP-MS grew out of the work of Gray [Gray 1974; 
1975a; 1975b] who demonstrated that by coupling a direct current plasma (DCP) with a mass 
spectrometer, excellent detection limits could be obtained (<  1 ng/ml) and isotope ratio 
determination, with a precision of about 0.5 %, could be achieved.
Although laying the foundation for plasma source mass spectrometry, the DCP was 
rapidly found to be of limited analytical use. This was mainly due to a low ion yield for 
elements with ionization energies higher than 8.5 eV, and severe inter-element effects caused 
primarily by elements with low ionization energies [Gray 1978]. As a result, two groups of 
scientists embarked on studies investigating the suitability of alternative plasmas. The first 
group, based at the Ames laboratories, Iowa, worked with an inductively coupled plasma 
(ICP), whilst the second, based at the University of Toronto, tested the performance of a 
microwave induced plasma (MIP).
Despite the fact that the MIP demonstrated a high sensitivity for most elements, the 
Toronto group found that this plasma was susceptible to severe matrix effects [Douglas 1981]. 
Indeed, as with the DCP, the gas temperature was too low to dissociate the nitrogen monoxide 
species, which in turn suppressed the Ionization of any element with higher ionization energy 
than its own (9.2 eV).
The Ames group, on the other hand, managed, in collaboration with Gray, to obtain 
favourable results from their ICP-MS system and produced, in 1980, the first ICP-MS 
publication [Houk 1980]. From that paper, it was clear that ICP-MS has a tremendous 
potential, promising low detection limits, limited interference effects, and a long linear 
dynamic range extending over 4 orders of magnitude.
Interest in ICP-MS increased dramatically when Sciex™ demonstrated their Elan 
instrument in the 1983 Pittsburgh conference. This was shortly followed by the release of the 
VG Isotopes version PlasmaQuad™. Today, an increasing number of commercial instruments
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are being used in analytical laboratories and a much wider understanding of the potential and 
the analytical characteristics of this method are being established.
3,2 Instrument Overview
Figure 3.1 is a schematic diagram of the main components in commercially available 
ICP-MS instruments. Samples, presented as aqueous solutions, are nebulized and introduced, 
via a stream of argon gas, into the ICP in the form of an aerosol (A). The argon plasma heats 
the aerosol to approximately 7000 K (B) where the dissolved solids are atomized and ionized. 
A portion of the ions is allowed to flow into a high vacuum chamber of the mass spectrometer 
via a sampling interface (C) and enters the ion optics (D), where it is collected and focused 
into a quadrupole mass spectrometer (E). The ions finally exit to an electron multiplier 
detector (F) mounted off axis to reduce photon noise from the plasma.
Based upon the above description, ICP-MS systems could be divided into six main 
units, namely, the sample introduction unit, the ICP, the plasma sampling interface, the ion 
focusing unit, the quadrupole mass filter, and the ion detection and data handling systems. 
Each of these components plays a major role in maintaining the overall superior performance 
of ICP-MS as an analytical tool, and still is subject to intensive research in order to overcome 
some of the analytical problems associated with the technique. It is, therefore, imperative that 
each of these units must be studied in detail in order to achieve a full understanding of 
ICP-MS.
3.2.1 Sample introduction
The conventional sample introduction system supplied with all commercial ICP-MS 
instruments consist of a peristaltic pump, a nebuliser and a spray chamber. Aqueous solutions 
are sucked into the nebuliser via the peristaltic pump. Most of the sample leaving the 
nebuliser is carried to the plasma by a stream of argon gas in the form of droplets. However, 
large droplets tend not to be carried very far and fall-out of the gas stream onto the walls of 
the spray chamber.
Some nebulisers can be used without a peristaltic pump in the solution input line. 
These nebulisers work due to the natural suction action created by the flow of a gas jet across 
the tip of the sample tube. In such cases, however, the rate of delivery can be affected by 
viscosity differences between sample and standard or by the depth of solution in the sampling
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Figure 3.1 A schematic of an ICP-MS system, (A) sample introduction unit, (B) inductively coupled 
plasma, (C) differentially pumped interface, (D) ion optics, (E) quadrupole rod set, (F) channeltron 
multiplier detector.
Figure 3.2 The plasma torch, (A) inlet for aerosol carrier gas, (B) inlet for auxiliary argon gas, (C) 
inlet for coolant argon gas, (D) plasma load coil, (E) plasma fire ball.
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container. It is, therefore, necessary that solution delivery is controlled by a pump, supplying 
a constant uptake rate to the nebuliser, in order to achieve long term stability.
The majority of nebulisers used are pneumatic ones because of their simplicity of 
construction. Several types of these nebulisers are commercially available, the most common 
ones being the cross flow Jarrel-Ash, the Meinhard concentric and the V-Groove (de Gal an). 
The basic operating principle is the same for all three types, the stream of sample solution 
being disrupted by the high velocity gas flow to produce an aerosol. Whilst the first two types 
are commonly used for routine analysis, the De Gal an nebuliser is particularly useful for the 
introduction of corrosive solutions or solutions with a high dissolved solids content [Williams 
1989].
The role of a spray chamber is to prevent large droplets (greater than 10 fim in 
diameter) from entering the ion source [Gustavsson 1984]. In the case of ICP-MS, this is 
necessary in order to: provide an even loading of the plasma; reduce condensed-phase 
vaporization interferences i.e. signal suppression or enhancement due to the differences in the 
rate of release of metal atoms in the plasma which is determined by the chemical form or 
physical environment in which the analyte atom is present [Smith 1984]; and prevent high 
solvent loading of the ICP which may result in a significant reduction of its excitation 
properties [Boumans 1982; Boom 1982]. As reported by Dale and Buchanan several types of 
spray chambers, can be successfully used in plasma nébulisation systems [Dale 1986]. The 
type used originally in commercial instruments was the Scott double pass cylinder normally 
made from borosilicate glass, with other materials such as PTFE being commercially available 
for the analysis of corrosive solutions. However, recent investigations have shown that the 
temperature of the spray chamber is positively related to the amount of solvent-loading of the 
plasma which, in turn, increased significantly the magnitude of inter-element interferences, 
and reduced the stability of the signal [Hutton 1987; Paul 1989]. To date, most spray 
chambers are water cooled and kept at a temperature around 13 “C.
Although much in use, conventional pneumatic nébulisation suffers from a poor 
nébulisation efficiency of about 1-2% [Browner 1984]. Consequently, numerous attempts have 
been made to develop alternative nebulisers capable of providing improved efficiency e.g. 
ultrasonic nebulisers, and frit nebulisers. Furthermore, several workers have investigated 
different sample introduction techniques, including electrothermal vaporisation (ETV), direct
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sample insertion (DSI), laser ablation (LA), arc nébulisation (AN), and flow injection analysis 
(FIA).
Ultrasonic nebuliser systems can produce aerosols with smaller, more uniform particle 
size distributions than pneumatic nebulisers. These more easily transportable particles will 
result in an improved nébulisation efficiency of about 10-20 % {Issaq 1977]. Another 
advantage of ultrasonic nébulisation resides in the fact that the formation of the aerosol is 
electrically driven and, therefore, not dependent on the carrier gas flow. Thus, the nebuliser 
gas flow rate and the aspiration rate can be optimised independently [Olson 1977]. However, 
ultrasonic nebulisers are more complex and expensive than their pneumatic counterparts. 
Furthermore, because the washout time is somewhat longer, the analytical throughput rate is 
20-30 % less. Another disadvantage of ultrasonic nébulisation is that due to the high 
nébulisation efficiency, the aerosol cools the axial channel of the ICP to such an extent that 
the analytical performance of the plasma is degraded [Boumans 1975]. Although, Fassel and 
Bear have reported that this problem with high loading of the plasma can be overcome by the 
addition of a desolvation system for generating dehydrated aerosol prior to injection into the 
ICP [Fassel 1986]. However, this desolvation process suffers from transport interference 
effects due to differences in the sample and standard matrices. Relatively few laboratories 
routinely use ultrasonic nebulisers, and as quoted by De Gal an "the ultrasonic nebulizer has 
probably generated more frustrated scientists than any other piece o f atomic spectrometric 
equipment" [De Galan 1986].
Glass frit nebulisers have several attractive features, namely: simple to make and 
operate; not prone to clogging due to samples with a high solids content; a high nébulisation 
efficiency (up to 94 %); and a low sample consumption rate (as low as 2/xl). However, as 
described by Layman and Lichte, the long memory effects, the loss of solute by surface 
adsorption and the trace contamination of the samples from the pyrex material are major 
problems associated with such nébulisation systems [Layman 1982].
Over the past seven years researchers have shown that electrothermal devices could 
be successfully used as an alternative means of sample introduction for ICP-MS [Gray 1983; 
Gray 1986b; Date 1987; Park 1987; Grégoire 1988]. To date, most commercial ICP-MS 
systems provide an ETV apparatus as an optional sample introduction device. The main 
advantages of ETV over conventional nébulisation are, the low volume of solution required
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(~10 /xl), ease of analysis of organic materials, reduced oxides and hydroxides interferences, 
reduced effects of high salts, and the possibility of matrix modification in order to reduce 
potential isobaric non-spectral interferences [Hall 1988; Tsulcaliara 1990b]. One of the main 
considerations that should be undertaken when using ETV-ICP-MS is the inhibition of the 
transport of materials between the vaporiser and the plasma. This could be due to the 
formation of nonvolatile carbides on the furnace walls and the loss of very volatile materials 
on the walls of the tubing. This inhibition can be reduced by the addition of volatilising gases, 
such as if eons, to the argon carrier stream [Kirkbright 1979]. Disadvantages of ETV-ICP-MS 
include poor sample throughput rate, contamination from the tungsten wire impurities, and 
the need for faster data acquisition systems in order to collect isotope or multi-element 
information [Shai 1990].
The DSI system described by Boomer et al [Boomer 1986] shares most of the above 
listed advantages of ETV i.e. low sample volume requirement, greatly reduced oxides and 
hydroxides formation; and improved detection limits. Furthermore, the DSI device is simpler 
in design and cheaper than its ETV counterpart. It is also less susceptible to the transport 
problems experienced by ETV-ICP-MS. However, the analysis of samples with high salt 
contents can be a problem in DSI-ICP-MS. This is because, some of the vapours, released 
from ashing the samples in the plasma, reach the interface and cause the clogging of the 
orifice. In addition, the use of tungsten in the insertion loop imposes several limiting factors, 
namely, precluding the determination of highly non volatile elements, those elements isobaric 
with WO^ and W02^ and those elements which exist as impurities in the wire itself {e.g. Fe, 
Ni and Mo) [Hall 1988].
The advantages of using LA-ICP-MS for the analysis of solid samples include little 
or no sample preparation; application to almost all materials; high spatial resolution, low 
polyatomic and oxides interferences; and good detection limits [Arrowsmitfa 1987]. The 
original work by Gray using a ruby laser as a means of sample introduction for an ICP-MS 
system pinpointed problems related to the high arrival rate of the sample to the plasma, the 
short duration of the burst, and the sample deposition on the interface [Gray 1985a]. These 
problems were overcome by the use of Nd:YAG lasers with high repetition rates (10-20 Hz) 
and mass analyzers capable of scanning at rates up to 10 scans per second [Gray 1988]. 
Nowadays, several LA-ICP-MS systems aie commercially available. Although suffering from 
poor reproducibility and limitations arising from the problem of standardisation, the
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advantages of these systems are very much dependent on the matrix analysed and the elements 
of interest [Durrant 1989a]. Finally, in a recent presentation, Houk et al claimed that 
improvement in the precision of LA-ICP-MS was achieved by attaching a microphone to the 
sample cell and using the acoustic waves generated during ablation for the normalisation of 
the analyte signal [Houk 1990].
The suitability of arc nébulisation (AN) for sample introduction into ICP-MS has been 
extensively investigated by Jiang and Houk [Jiang 1986; Jiang 1987]. As with ETV and other 
'dry' introduction methods, the use of AN greatly reduces interferences due to polyatomic 
ions, oxides and hydroxides interferences. Coupled with minimum sample preparation and 
memory effects, this technique seems very promising. Its main disadvantages are, however, 
its restriction to samples that are electrical conductors, and tlie relatively poor sensitivity 
which may be due to the high rate of introduction of matrix elements into the plasma.
Flow injection analysis has been successfully applied as an alternative method of 
sample introduction by several workers, namely, Thompson and Houk, Dean et al, and 
Hutton and Eaton [Tliompson 1986; Dean 1988; Hutton 1988]. The advantages of FIA-ICP- 
MS are: the ability of analysing samples with high salt content, viscosity, and acid strength 
without blockage or distortion of the sampling interface; small sample volumes; and rapid 
analysis time. A recent report by Vickers et al, contradicted the earlier finding of Dean and 
co-workers with regard to the relatively poor precision of FIA, quoting "... the precision of 
the FIA approach is much better: approximately twice that o f CFA (continuous flow analysis) 
as determined in this investigation..." [Vickers 1989]. As such, FIA-ICP-MS seems to have 
a great potential and may become in the future the method of choice for the analysis of liquid 
samples.
In addition to the three sample introduction techniques available commercially 
(pneumatic nébulisation, ETV and LA) a new system has been launched by VG Elemental, 
which consists of a hydride generator fitted with a tubular membrane gas liquid separator. 
This system is particularly useful for the analysis of As and Se in samples with a high salt 
content [ Janghorbani 1989; VG Elemental 1990].
In summary, sample introduction is an active research area where much work is 
currently being undertaken in order to enhance the performance and the capabilities of
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ICP-MS. To date, tlie characteristics of several methods are being investigated [Jarvis 1989; 
Tsukahaiii 1990a; Hirata 1990], whilst others which have proven to be successful with ICP 
atomic emission spectrometry are yet to be applied to ICP-MS [Kanpster 1987; Isoyama 
1990a,b; Ivaldi 1990; Peng 1990].
3.2.2 The Inductively Coupled Plasma
The ICP is an argon plasma maintained by the interaction of a radio frequency (RF) 
field and ionised argon gas. The plasma is formed by a tangential stream of argon (auxiliary 
gas) flowing between two quartz tubes, as shown in Figure 3.2. Radio frequency power is 
applied through the water cooled coil, and an oscillating magnetic field is formed. The plasma 
is made conductive by exposing it to an electrical discharge which creates seed electrons and 
ions. Inside the induced magnetic field, the charged particles are accelerated in a closed 
annular path. These particles then transfer energy to the neutral species by collision and 
further ionisation takes place. The process occurs instantaneously and the plasma expands to 
its full dimensions. Meanwhile, another stream of argon (coolant gas), flowing between the 
two outermost tubes, cools the inside walls and centres the plasma radially in the tube. A 
combination of skin effect and gas flow geometry establishes the toroidal form of the plasma 
fireball. Finally, an aerosol of the sample to be analysed is injected along the axis of the 
toroid via a laminar flow of argon (the carrier gas).
Figure 3.3 shows a schematic diagram of a typical ICP together with a temperature 
profile based upon the work of Fassel [Fassel 1977], and an indication of the various 
identifiable regions as proposed by Koirtyohann et al [Koirtyohann 1980]. In the preheating 
zone (A) the temperature is high enough to desolvate, volatilise and dissociate the sample and 
the solvent vapour introduced with it. As they reach the initial radiation zone (B) the various 
species start to get atomised, and by the time they are in the normal analytical zone (D) these 
species are atomised and ionised, leading to a high population of singly charged ions. This 
normal analytical zone is the region from which the ions are sampled in ICP-MS [Gray 
1986a].
Based on the assumption that the ICP is in a thermal equilibrium, the degree of 
ionisation of the atoms of an element in the normal analytical zone of the ICP (M"^ /M“), can 
be calculated from the Saha Equation [Boumans 1966];
Ml .  e-is/CT (3.1)
Where n. is the electron density, m. is the mass of the electron, K is the Boltzmann's 
constant, T is the effective temperature of the ion, h is the Plank's constant, and Q" are 
the partition coefficients of the ion and neutral atom, and IE is the ionisation energy of the 
element. The efficiency of ionisation for most elements has been calculated, based on equation 
(3.1) by Houk [Houk 1986]. The results of these calculations are listed in Figure 3.4. 
However, there are considerable evidences that the plasma is not in a thermodynamic 
equilibrium and that the degrees of ionisation observed experimentally are generally higher 
than the values predicted by equation (3.1) [Houk 1981]. Therefore, the data listed in Figure 
3.4 should be used as rough estimates of the expected relative signals during analysis. When 
more accurate values of the ionisation efficiency are needed, it is customary to use the ratio 
of the signal of the element of interest to that of a fully ionized element of a close m/z value, 
corrected for isotopic abundance and mass discrimination [Olivares 1988; Gray 1989].
Generally, most of the elements with ionisation energies below that of Ar (15.75 eV), 
the main gaseous component of the plasma, are efficiently ionised in the ICP (> 90%). In 
fact, even many metalloids and non metals with high ionisation energy such as As, Se, and 
S yield a significant number of singly charged positive ions. The only elements which are not 
normally detected are He, F, and Ne. This is because these elements have higher ionisation 
energies than Ar.
Although the ICP is a very efficient ionisation source, the conditions in the plasma 
are such that relatively few doubly charged ions are formed. The values in parenthesis in 
Figure 3.4 shows that only Ba and some rare earth elements could produce a high proportion 
of doubly charged ions (between 10 and 20%). However, as reported by Gray, much lower 
levels of these ions are usually seen due to a rapid recombination of doubly charged ions 
during the extraction process [Gray 1989].
Due to the high population of Ar"^  ions in the plasma, even the presence of a fully 
ionised analyte at concentrations up to 1 % w/v in a solution will not produce enough ions 
to affect significantly the total ion density of the ICP [Houk 1988; Gray 1989]. This in part
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Figure 3.3 The plasma fireball, (A) preheating zone; 7000 - 8000 K, (B) initial radiation zone; ”8000 
K, (C) induction region; ” 10000 K, (D) normal analytical zone ”6000 K.
Rt>
100
Ce Pi Nd Pm Sm Eu Gd Tb Dy Hu El Tm Yb Lu
9Q 13 90(101 99* 97 0 ) 100* 93(7) 99* 100* 9 9* 91(3) 92 B)
Th
100
Pa U Np Pu Am Cm 01 E« Fm Kid No Lw
Figure 3.4 Calculated values for degree of ionisation for and at T*» =  7500 K, n, =  1 x 10" 
cm .^ Elements marked by asterisks yield significant but partition functions were not available.
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explains the great immunity of the ICP to inter-element interactions or interferences 
encountered with other ion sources [Fassel 1978; Blades 1981].
The main disadvantage of ICP as an ion source is the fact that most of the processes 
taking place in the plasma are yet to be fully understood. Thus, scientists argue that 
fundamental investigations are still needed in order to improve and expand the analytical 
utility of the technique [Vickers 1990].
3,2.3 The Interface.
In all mass spectrometers, ions are physically separated by some combination of 
electrostatic and/or magnetic fields in a vacuum environment. The vacuum is needed to ensure 
that the accelerated ions do not collide with residual gas molecules and become deflected from 
their intended paths.
Because the ICP requires a total gas flow rate around 15 l.min ', direct introduction 
of the total ion beam into the mass spectrometer is impractical. The method used to reduce 
the high gas load is to interface the two instruments through differential pumping.
Figures 3.5 and 3.6 show schematics of the interface used in commercial instruments. 
The plasma flows around the tip of a water cooled metal cone called the sampler (A). This 
cone has an orifice of 1 to 1.5 mm diameter drilled into its tip. Most of the gas flowing 
through this orifice is evacuated via a pump that maintains the pressure at around 1 Torr (C). 
Behind the sampler there is another cone, the skimmer (B). The distance between the sampler 
and the skimmer's orifices is usually about 6 to 6.5 mm. The gas flows through the 
skimmer's orifice, usually about 1 to 1.5 mm in diameter, and on into the second vacuum 
chamber kept at around 10'* Torr (K).
The sampling interface system initially used in both the Ames laboratories (Houk et 
al) and the University of Surrey (Gray and Date) consisted of a single cone with an aperture 
of smaller diameter 0.5 to 0.7 mm, and a vacuum pump taking the pressure behind the cone 
down to around 10  ^Torr. This setting was based on the experience of the latter group with 
DC plasmas. However, due to the higher temperature in the ICP, the use of such a small 
orifice led to the formation of a boundary layer (a layer of cooler gas) over the extraction 
aperture. Sampling through the boundary layer proved to have two major disadvantages.
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Firstly, the lower temperature in that region provided a suitable environment for the 
formation of ion molecules, thus causing high levels of interferences. Secondly, when real 
samples with moderate levels of salts were analysed, the condensation of salts readily plugged 
the pinhole sized orifice [Date 1981; Gray 1981].
Using a larger orifice, 1 to 2 mm in diameter, reduced dramatically the boundary 
layer effects. However, as the diameter exceeded 1.2 mm a large photon background was 
observed. This was mainly due to a secondary discharge formed in the gas entering the 
plasma [Date 1983]. Subsequently, the interface originally used by Douglas and French for 
the MIP studies [Douglas 1981] was tested and favourable results were obtained. This 
interface is the one currently used in commercial instruments and was described earlier.
The main advantage of using the cone and skimmer assembly was originally thought 
to be the reduction in the rate of pressure variation along the axis of the aperture of the cone 
which significantly depresses the secondary discharge [Gray 1983]. However, it was later 
shown that although the use of such an assembly reduced the photon background, it did not 
eliminate the secondary discharge. In fact, the origin of the discharge is not due to 
electro/gas-dynamic effects but rather to an arcing between the plasma discharge and the 
sampler [Douglas 1986a]. A lot of research is still being carried out on the behaviour of the 
plasma at the interface. The properties of free jet expansion have been applied in order to 
theoretically depict this behaviour and to identify and optimise the parameters involved 
[Douglas 1988a]. Furthermore, lim et al used atomic emission and atomic fluorescence 
spectrometry in order to describe some of the phenomena which occur during the extraction 
process [Lim 1989]. The results of both studies could be summarised by the following 
recommendations:
(A) The skimmer-sampler distance should be optimised in order to reduce the background 
gas flow into the mass spectrometer. Under normal operating conditions this optimum 
is around 6.7 mm.
(B) The edges of the skimmer should be kept sharp to prevent the formation of a shock 
wave at its tip. This will, however, mean that the tip will be easily overheated and 
degraded; thus reducing the life span of the skimmer.
(C) The orifice of the skimmer should not be too large (over 1.5 mm), otherwise oxides 
formed in the boundary layer inside the sampling orifice can be drawn through.
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Figure 3.5 The interface and ion optics for a VG Isotopes PlasmaQuad system, (A) sampler, (B) 
skimmer, (C) rotary pump, (D) extractor, (E) collector, (F) photon stop, (G) ion lens 1, (H) ion lens 
2, (I) diffusion pump, (J) differential aperture, (K) ion lens 3, (L) ion lens 4, (M) mass filter, (N) 
quadrupole mass analyzer, (O) channeltron detector.
«
Figure 3.6 The interface and ion optics for a Sciex Elan system, (A) sampler, (B) skimmer, (C) rotary 
pump, (D) photon stop 1, (E) Einzel lens, (F) Bessel box, (G) photon stop 2, (H) mass filter, (I) cryo- 
pump, (J) quadrupole mass analyzer, (K) channeltron detector.
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In summary, the ion sampling interface plays a crucial role in ICP-MS. It is supposed 
to provides a mean of extracting the ions from the ICP in a stable, reproducible manner, with 
as little cooling or perturbation of the plasma as possible. Over the past ten years considerable 
progress has been made in this area. This has depended on, at least, an empirical 
understanding of fundamental physical phenomena occurring during ion extraction, an area 
where much more progress is still needed.
3.2.4 Ion Focusing
As the ion beam flows through the skimmer, it enters a region where the pressure is 
reduced to the point that the flow becomes random. In order to ensure that as many ions as 
possible reach the mass spectrometer, the beam is focused and transmitted by an assembly of 
electrostatic ion lenses. The design of the ion lens system used in the various commercial 
prototypes is dictated by the differential pumping assembly adopted by the manufacturer.
Figure 3.5 shows the arrangement of the lens elements in the VG instruments. The 
negative voltage applied on the extractor (D) attracts the positive ions in the region behind 
the tip of the skimmer cone and directs them towards the collector (E). Negatively charged 
species are repelled and together with neutral atoms and molecules diffuse away from the 
system axis towards the intermediate stage diffusion pump (I). After passing through the 
extractor the ions are entrained by the collector electrode. An on-axis 'metal stop' is mounted 
on the collector to prevent photons and energetic neutral species generated by the plasma from 
reaching the detector (F). These species may contribute significantly to the background signal 
(Long 1986]. Ions appearing around the photon stop are focused through the differential 
pumping aperture (J) by two consecutive lenses (G) and (H). As the ions pass through this 
aperture, separating the second from the third vacuum chambers, they tend to diverge from 
their path due to the difference in pressure. The final lens elements (K) and (L) serve to 
refocus these ions into the entrance aperture of the quadrupole.
Figure 3.6 shows a schematic of the ion optics incorporated in the Sciex systems. 
They consist of a metal stop (D), a triple cylinder Einzel lens (E) and a Bessel box (F). The 
stop is installed at the base of the skimmer to shadow the entrance of the bessel box, thus 
preventing salt deposition on its stop. The Einzel lens system focuses and entrains the positive 
ions from around the stop into the bessel box. This box is an efficient optical device with
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high ion transmission. The box is fitted with a central 'metal stop' to uniformly reduce the 
background signal over the whole mass range.
Optimizing the ion optics can improve dramatically the performance of ICP-MS 
[Kawaguchi 1988]. It has been claimed recently, by a new ICP-MS systems manufacturer that 
improved ion optics have led to better sensitivity with an almost uniform response across the 
mass range of the elements [Turner 1990]. Furthermore, it was put forward that the 
dependence of the matrix effects on the mass of the major elements in the sample as well as 
the ICP operating conditions, may be due to changes in the total ion current passing through 
the skimmer aperture. These changes, caused by the high levels of salt in the sample, may 
alter the focal properties of the ion optics and hence the analyte ion signals [Gillson 1988].
3.2.5 The Quadrupole Mass Analyzer
The quadrupole mass analyzer is based on the principle introduced by Paul and 
Steinwedel [Paul 1953]. Its basic concept is to provide a periodic and axially symmetrical 
radio frequency field which will transmit a selected mass group and cause ions of improper 
mass to deflect away from the axis.
The electric field is formed by a set of four electrically conducting, cylindrical rods 
arranged so that their longitudinal axes define a parallelepiped. The rods are all operated at 
the same absolute potential but with adjacent rod potentials having opposite polarity. Figure 
3.7. The applied potential has a dc component U and a radio frequency component, V,coswt, 
which for the ideal hyperbolic case, gives a potential field, V(x,y):
V(x^) ° (U+Vjcosiùt) (3.2)
where x and y are the distances from the z axis and 2r„ is the distance between opposite rods. 
The electric field components E. and E, are thus:
dV X
^  -(l/+P;,cos«r) — (3.3)
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Consequently, the accelerations experienced by a charged particle, m/e, moving along 
the z axis will be given by:
Ê Î. .  E — ' (3.5)dfi ’ m
Î 1  -  E i .  (3.6)dû-
A mathematical manipulation of this set of equations lead to the most famous set 
known as the Mathieu equations. The general solution of these equations shows that for a 
given U/V„ and w, a specific range of m/e values remains in stable oscillation as the ions 
travel down the analyzer. For values outside this range, the ions are unstable and will exhibit 
oscillations with increasing amplitude until they finally strike the electrodes. An entire 
spectrum can, therefore, be produced by either varying w at constant voltages or more 
conveniently by varying both the r.f and d.c voltages while keeping both U/V„ and w 
constant.
There are several reasons for using quadrupoles as the mass spectrometers of choice 
in ICP-MS: (A) they are relatively cheap and compact; (B) they are more tolerant of high 
operating pressures and spreads in ion energy than most other analyzers; and (C) they can be 
scanned rapidly at rates up to 3000 mass units per second. Furthermore, in terms of 
performance, the quadrupole analyzers transmit a large fraction of the injected ion beam, and 
their resolution, although relatively poor, is usually sufficient to separate peaks from elements 
with adjacent mass numbers, which is suitable for most analytical purposes.
Another measure of the performance of mass analyzers is their abundance sensitivity. 
This is a resolution parameter which describes the degree to which the tail of a mass peak 
contributes to the adjacent masses. With current quadrupole technology results of about l:lCf 
for the low mass side and 1:10’ for the high mass side have been reported [Douglas 1985]. 
The abundance sensitivity, as well as the resolution and percentage of transmitted ions of the 
quadrupole are strongly influence by the ion energy. Ions must have a low enough energy in 
order to experience sufficient RF cycles for those with unstable trajectories to actually strike
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Figure 3.7 Quadrupole geometry and rod connections
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- 56-
the rods. The ion energy distribution is relatively independent of the ion mass. It is, however, 
a function of the difference in DC potential between the plasma, source of ions, and the rod 
system. Since the potential of the plasma depends upon the ICP torch and load coil geometry, 
nebuliser gas flow, and other factors not under direct user control, all commercial ICP-MS 
systems provide a pole bias facility, which is used for adjusting the mean DC levels for the 
rods. This enables the difference in potential between the plasma and the rods to be set to 
give optimum ion energy.
3.2.6 Data Acquisition
Mass resolved ions leaving the mass spectrometer are generally detected by an off-axis 
channeltron electron multiplier (CEM). Although several other types of detectors have been 
tried ^uss 1987;Huang 1987;TuroM- 1990], qualities such as robustness, tolerance of gas 
pressures up to 10 * torr, reasonably long life, low natural background count rates, relatively 
high electrical gain, and fast response make the CEM the most commonly used detecting 
device.
The standard CEM consists of a curved tube with a resistive coating of typically 10® Q 
down its whole length. The tube flares at the input end to form a funnel. A positive ion 
striking the funnel causes the ejection of one or more secondary electrons from the surface, 
which are accelerated down the tube. Collisions with the walls release further electrons and 
as the gain for this process in generally greater than unity a cascade builds up exponentially. 
Towards the bottom of the tube the space charge of electrons that builds up during the cascade 
becomes sufficient to inhibit further multiplication. This effect ensures that all output pulses 
are of the same size, about 10’ to 10® electrons. The cloud of electrons leaving the CEM is 
collected by the collector electrode. This is used to produce an analogue signal that is fed into 
an amplifier. The signal from the amplifier is compared with a reference level, sent from the 
ICP-MS control unit, via a discriminator in order to reject electronic and RF noise. Signals 
from the ion detector are counted into memory channels and subsequently transferred to the 
data storage system, i.e. the computer, by a multi-channel scaler (MCS).
The data collection in an ICP-MS can be carried out either in a full scan mode or in 
a peak hopping mode. In the former, the channel addresses of the MCS are swept in 
synchrony with the sweeps of the mass analyzer such that each peak occupies the same group 
of channels in successive sweeps. This mode provides information about the whole range of
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elements. However, in this mode, one cannot readily skip mass regions which are not of 
interest and the same acquisition time is spent on minor and major peaks. In the second mode, 
the analyzer is stepped across the peaks of interest. The advantages of this approach are the 
possibility of collecting data for the masses of interest only, and to spend more of the data 
collection time on the less abundant isotopes. The main disadvantage of this mode is that a 
larger fraction of the sampling time may be spent in settling time at the end of each jump 
before data acquisition can begin [Russ 1989].
3.3 Analytical Performance
3.3.1 Detection Limits
The detection limits (DL) of a particular technique are determined by the noise and 
the sensitivity of the technique to the specific element. It has been recommended that they 
should be defined as the concentration of the element of interest giving a signal equal to 3 
times the standard deviation of the background, i.e. different from the background signal at 
98% confidence level PUPAC 1978]. Although the DL calculated using operating conditions 
optimised for individual elements are generally better than those calculated with the 
instrument optimised for a fiill mass range coverage, the latter are often used because they 
reflect not only the power of detection of ICP-MS but also its multi-element capabilities.
Even the earliest reported DL showed the potential of ICP-MS. Since then, however, 
a major improvement in terms of enhancing the performance of the technique has been 
achieved. Table 3.1 lists the DL for ICP-MS reported in 1983, together with results from the 
PlasmaQuad™ (VG Elemental, Cheshire, UK) and the recently produced Elan™ (Sciex, 
Toronto, Canada). Data from other analytical techniques are also included for comparison. 
This table shows that the detection limits attained by ICP-MS are superior to those attained 
by other multi-element techniques and surpass or rival those of graphite furnace atomic 
absorption spectrometry, currently one of the most sensitive methods available.
3.3.2 Linear Dynamic Range
The linear dynamic range (LDR) is the part of the calibration curve in which the 
instrument response is a linear function of the concentration of the element of interest. It is 
a common practice to report the LDR in terms of its extent in orders of magnitude. This 
together with the DL provides an estimate of the working range for the instrument.
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Table 3.1 Detection limits of ICP-MS for selected elements (ng.ml *)
Element ICP-MS* ICP-MS* ICP-MS* ETAAS* ICP-AES* INAA'* XRF*'
Lithium 4.5 0.29 0.1 0.05 1.35
Boron 1.5 3.78 0.1 20 3 - -
Magnesium 0.75 0.94 0.1 0.004 0.12 * -
Aluminium 0.9 0.97 0.1 0.04 6 2 *
Titanium 0.45 2.43 0.06 1 0.75 - 4
Vanadium 0.6 0.16 0.03 0.2 3 0.2 5
Chromium 0.3 0.11 0.02 0.01 3 2 5
Manganese 1.2 0.29 0.04 0.01 0.6 0.7 6.5
Iron - 1.62 1 0.02 1.5 50 5
Cobalt 0.75 0.38 0.02 0.01 3 1 3
Zinc 4.5 0.59 0.08 0.01 1.5 100 4.5
Copper - 0.23 0.03 0.02 1.35 2 3
Germanium 1.5 - 0.08 0.2 15 - -
Arsenic 10.5 2.84 0.05 0.2 30 1 5
Selenium 22.5 0.28 0.5 0.2 90 5 -
Bromine - - 1 - - 50 -
Rubidium 0.45 0.36 0.02 0.05 * 10 1.5
Silver 0.3 0.32 0.03 1 30 3 -
Molybdenum - 0.7 0.08 0.04 7.5 2 *
Cadmium 0.75 0.57 0.02 0.003 1.5 5 *
Indium 0.15 - 0.02 0.05 45 - -
Tellurium 0.75 3.06 0.04 0.1 75 30 -
Caesium 0.15 - 0.02 0.05 - 0.8 -
Barium 0.45 3.21 0.02 0.1 0.15 20 12
Lanthanum 0.3 0.09 0.01 - 1.5 - 7.5
Cerium 0.3 - 0.01 - 15 - -
Tungsten 0.75 0.11 0.06 - 30 - -
Gold 0.3 0.11 0.1 0.1 6 0,005 -
Mercury 0.6 0.23 0.3 1 30 0.8 -
Lead 0.45 0.3 0.02 0.05 30 500 3
Bismuth 0.3 0.11 0.04 0.1 30 - *
Thorium 0.3 0.04 0.02 - - - 9
Uranium 0.6 0.02 0.01 - 15 2 6
1- Date 1983
2- Williams 1989
3- Peridn Elmer 1988
4- Stika 1981
5- Ward 1986
* =  > 1 /fg.ml*
- =  not reported
The original work on ICP-MS showed a LDR of 3 orders of magnitude for Cr, Co, 
and Cu [Date 1981; Houk 1981]. With the improved interface, the LDR was later enhanced 
to 4 orders of magnitude [Douglas 1983]. To-date, there are reports on a LDR of about 6 
decades [Houk 1988] which may be extended to 8 [Gray 1989]. However, with count rates 
higher than 10* counts sec', the channeltron electron multiplier suffers severe deviation from
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linearity due to dead time and sag effects [Russ 1989]. Accordingly, a wide LDR could only 
be obtained if correction for these factors is applied and the detector is used at lower gain, 
in a mean current mode [Knoll 1979]. Such mode of operation is, nevertheless, not 
recommended since it shortens dramatically the life time of the detector. Therefore, for all 
analytical purposes and depending on the background signal for the element of interest, an 
LDR of around 4 orders of magnitude should be expected.
3.3.3 Spectral Interferences
Spectral interferences in ICP-MS are caused by an overlapping of signals deriving 
from various sources. The main reason for the presence of such interferences is the relatively 
poor resolving power of quadrupole mass spectrometers; thus peaks which fall within I amu 
from each other cannot be separated. Depending on the origin of these peaks, spectral 
interferences can be classified into isobaric, polyatomic, and doubly charged.
Isobaric interferences are due to an overlap between isotopes of neighbouring 
elements, e.g. “Fe and “Ni, and can be deduced from an isotopic table of the elements. 
Normally, it is possible to correct for this type of interference by measuring an 'interference- 
free' isotope of the overlapping element and, based on its signal level and the natural 
abundancy of the various isotopes of interest, a value can be calculated to be subtracted from 
the signal at the mass of the sought-for element. Although, this correction is not always 
suitable, especially if the element of interest exists at much lower levels than the interfering 
one {e.g. ““Ca and °^Ar), it is often possible to use interference-free isotopes. However, in 
some cases this might be at the expense of sensitivity. Generally, isotopic interferences do not 
pose a major problem in real sample analysis, and they are accepted as an inherent part of 
ICP-MS.
Polyatomic interferences are due to singly charged species which fall within 1 amu, 
in mass, from the elements of interest, e.g. ”cr®0 and ”Cr. The origin of these species may 
be due either to the analytes in the sample forming oxide ions (MO"^ ), or to the major 
components of the plasma gas and matrix species forming molecular ions.
In the early ICP-MS work, the origin of oxide ions was traced back to reactions and 
recombinations in the boundary layer [Date 1984]. However, it was later reported that these 
processes do not account for all the oxide ions observed and that a few percent of
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undissociated MO^ may be present in the plasma whilst the residual oxides are formed most 
likely in the sampling process, either by the cooling of the plasma at the edge of the sampler 
or by rapid ion molecule reactions in the supersonic expansion [Douglas 1986b]. Problems 
arising from oxide interferences are numerous, the most obvious ones being the falsely high 
results for the overlapped elements, and the reduction in the sensitivity for the oxidised ones. 
McLeod et al, for example, reported that the formation of Cr, Ni,Ti, Co, Zr, and Mo oxides 
overlapping with As, Se, As, Ag, Cd, and Te respectively, severely limited the analysis of 
these elements in Ni based alloys [McLeod 198Q.
In order to overcome these problems the effects of the ICP-MS operating conditions 
on the intensity of the MO"^  species, relative to the M  ^signal, have been studied extensively. 
The first breakthrough in reducing the oxide levels came with the replacement of the pin hole 
interface with the sampler and skimmer assembly [Gray 1985b]. This was mainly due to a 
reduction in the boundary layer effects observed with the former system. Using the new 
assembly and a Sciex Elan 250 ICP-MS instrument, Vaughan and Horlick studied the effects 
of the TCP power, nebuliser flow rate and sampling depth on the ratio MO /^M"  ^ [Vaughan
1986]. By comparing Ba  ^and BaO  ^ signals, their results showed that at a constant power the 
ratio BaO^/Ba^ increased non-linearly as the flow rate increased. This observation was 
attributed to the cooling effect the nebuliser gas has on the plasma, the attribution was 
justified by an observed decrease in the BaO^/Ba^ ratio at constant flow rates with increased 
ICP power. No proper evaluation of the effects of sampling depth could be carried out in that 
study due to the shift of the maximum response with the increase in sampling depth to greater 
nebuliser flow rates than used by the authors.
A similar study was carried out on a VG isotopes PlasmaQuad by Long and Brown 
[Long 1986]. The results of this study were in good agreement with the findings of Vaughan 
and Horlick. However, since more elements were studied, the behaviour of Pb, Cs, and Sm 
was found to be slightly different than that of Ba. In fact, the ratio of the oxides to the singly 
charged ions fell to a minimum before increasing non-linearly with the nebuliser flow rate. 
No reasons for this difference are provided by the authors and it could not be attributed to 
the formation of doubly charged ions since Sm has a close second ionisation energy to Ba 
(11.07 and 10.00 eV respectively), nor could it be associated to the strength of the oxide bond 
since the Sm-0 bond is stronger than that of Ba-0 (6.42 and 5.84 eV respectively).
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The second breakthrough came with the introduction of controlled temperature spray 
chambers which indirectly helped in cutting down the oxide levels by reducing the water load 
of the plasma [Hutton 1987]. As reported by Williams, the use of a water cooled spray 
chamber has led to an improvement of about 20% in the MO^/M* ratio for several rare eaith 
elements [Williams 1989]. Based on these studies, the state-of-the-art knowledge regarding 
oxide ions is that this type of interference can be minimised by using a water cooled spray 
chamber, a high ICP power, e.g. 1.5 KW, and a low nebuliser flow rate, 0.7-0.9 1/min.
Depending on the major components of the sample introduced, several ion-molecule 
interactions take place between these components and the Ar in the plasma to form the so- 
called background or chemical interferences. For example if an organic material dissolved in 
1% HCl is analysed, the following species will be observed: CIH^, CIO^, ClOH^, CIO/, 
ClOjH", ClCr, ArCr, CH% CC+, C 0 \  COH% CO/, CO,H", A rC \ A rA r\ and CCF. It 
is, however, more difficult to determine their probability and intensity since they vary 
depending on the operating conditions. These species are formed during the sampling process 
and although using a proper matrix-matched blank can alleviate some of their problems, they 
can be a major limitation in the analysis of ultra trace levels. A listing of the background 
spectral features of distilled water and various strong acids have been tabulated by Tan and 
Horlick [Tan 1986]. Nitric acid provided much simpler spectra than HCl, HCIO4, or H^ SO^ . 
This is mainly due to the higher ionisation energy of N. Therefore, if the sample to be 
analysed has to be present in a slightly acidic aqueous medium, the use of HNO, can 
dramatically abate the problems of chemical interferences. Further attempts to bring down the 
effects of these interferences were based on either sample matrix modification [Palmier! 1986; 
Lyon 1988b; Plantz 1989] or the addition of a molecular gas to the nebuliser stream [Hywel 
Evans 1989]. Although, these attempts were successfiil in solving some particular problems, 
they fell short from providing a general solution. This is particularly true due to the 
disadvantages of contamination associated with matrix modification, and the cooling effects 
exhibited by the addition of other gases to the plasma, which effectively reduce the potentials 
of ICP-MS.
For a large number of elements, the singly charged elemental ion (M^) is by no means 
the only analyte species generated in the ICP. In fact, elements with second ionisation 
energies lower than 15.75 eV tend to form doubly charged elemental ions (M^ "^ ) during their 
short period of residence in the plasma. Due to their double charge, M^"^  ions are observed
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at half the mass of their ion counterparts. Therefore, when analysing samples containing 
substantial amounts of such elements, spectral interferences on isotopes of half the mass of 
the element of interest, e.g. interference on “Ga"^  from are expected. Once again, it
is difficult to determine the probability and intensity of these interferences since they vary 
depending on the operating conditions. Notably, the behaviour of doubly charged ions has 
been reported to vary depending on the type of plasma RF load coil used. On the Sciex Elan 
instruments, where a centre tapped load coil is used, the ratio decreases as the
aerosol flow increases (Horlick 1985, Douglas 1989]. However, on the VG Isotopes 
PlasmaQuad as well as most research instruments, where a standard load coil or load coils 
grounded at the torch mouth are used, increasing the aerosol gas flow rate induces an increase 
in abundances [Long 1986; Gray 1987a; Gray 1987b; Tsukahara 1990b]. The main 
difference between the two systems is the formation, with standard torches, of a secondary 
discharge caused by a high voltage in the plasma relative to the sampler. Grounding the load 
coil at the centre, greatly reduces the plasma potential and eliminates the secondary arcing 
[Douglas 1986a]. Therefore, it can be concluded that the reason for the difference in 
behaviour of h f  ^  ions may be due to the fact that the secondary discharge which increases 
with the increase of plasma loading, plays an important role in the generation of these ions. 
This conclusion is justified by comparing the results of Long with those of Gray [Long 1986; 
Gray 1987b]. The former used a standard load coil whilst the latter obtained lower 
species using a load coil grounded at the torch mouth, on otherwise identical instruments 
(grounding one end of the load coil reduces the secondary discharge). Furthermore, it has 
been reported that the levels of ions decrease with the increase in the aperture size of the 
sampler (another well known effect of increasing the aperture size is to lessen the secondary 
discharge) [Williams 1989]. Finally, it is worth noting that doubly charges interferences 
behave in a similar manner to polyatomic interferences with regard to variations in the plasma 
power and the temperature of the spray chamber [Vau^ian 1986; Gray 1987b].
3.3.4 Non-Spectroscoplc Interferences
Non-spectroscopic interferences are those in which the variations in the intensity of 
the signal for a certain analyte cannot be accounted for by any recognisable spectral overlap. 
They are normally observed in ICP-MS when the matrix of the sample contains high levels 
of concomitant elements, thus they are often referred to as matrix interferences or effects. At 
present, matrix effects are confusing and vaguely understood.
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Sampling through the boundary layer, Gray and Date reported that by varying the Na 
concentrations between 200 and 1000 fjig.mV', 3 to 30% suppressions in the signal for 10 
/tg.ml * Co and Bi, were observed. Furthermore, the signal for “Co was subject to greater 
suppression than that for ”®Bi [Gray 1983]. Using the sampler and skimmer assembly, 
Douglas et al reported that 1000 /ig.ml ‘ A1 and phosphate has no effect on the signal from 
2 /ig.ml ’ Ca solutions [Douglas 1983]. However, the same author observed in a later study 
that the presence of 1000 /ig.ml ’ of Na led to a 10% decrease in the signal for 10 /ig.ml ’ Cu 
and Zn, and estimated that total dissolved solids (TDS) of 0.1 % might be run without matrix 
effects [Douglas 1985]. This was in agreement with tlie findings of McLeod et al where 1 % 
TDS in a Ni based matrix caused signal suppression of Ag, Sn, Sb, Tl, Pb and Bi which was 
not observed when the samples were diluted to the level of 0.1% TDS [Mcleod 1986]. 
Longerich et al, on the other hand, found that as minimum as 0.025% TDS in an Ag matrix 
can cause up to 50% suppression on 10 ng.ml ’ Co, Ni, Cu, Zn, As, and Bi [Longerich
1987]. Finally, Brotherton et al reported that 10% suppression occurred for Co, In, Ba, and 
Pb in 0.01 M synthetic ocean water solutions. Diluting the samples to 0.001 M, on the other 
hand, led to a slight increase in the signals for Co, Y, and Ba [Brotherton 1989].
Several studies have been carried out in order to identify the origin(s) of these 
interferences and/or to describe their behaviour over a wide range of operating conditions 
[Olivares 1986; Grégoire 1987a; Kawaguchi 1987; Tan 1987; Crain 1988; Gillson 1988; 
Brotherton 1989; Kim 1990; Wang 1990]. From these studies the following trends have 
emerged:
(A) the heavier the matrix element, the more severe are the matrix effects observed.
(B) Light analytes are more seriously affected than heavier ones.
(C) Elements with low ionisation potentials exhibit more effects than elements with
relatively high ionisation potentials.
(D) Matrix effects are more severe at high nebuliser flow rates.
(E) Increasing the sampling depth reduces matrix-effects.
(F) Increasing the plasma power reduces matrix-effects.
It is accepted that there are several mechanisms responsible for these effects and that 
each mechanism may predominate only under certain experimental conditions. Olivares and 
Houk, attempted to explain their results theoretically by evaluating the increase in the 
electron density of the ICP, due to the introduction of high levels of salts, and its effect on
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suppressing the ionisation of the analyte [Olivares 1986]. Although the observed trend 
matched the theory, that is easily ionisable elements affect the signal more than elements with 
high ionisation potential, the degrees of suppression for Co, with the various salts, were 
always higher than the ones calculated theoretically; thus suggesting the presence of other 
effects. A second theory was put forward by Grégoire [Grégoire 1987b]. This theory 
'ambipolar diffusion' suggests that increased electron density from the ionised concomitant 
element causes an increase in the diffusion velocity of the ions in the ICP. This will result 
in a decrease in the number of ions in the central channel of the plasma which can be 
observed as a signal suppression [Boumans 1976]. A theoretical evaluation of the effect of 
concomitant mass on signal suppression for Li, based on this theory, was presented by the 
author. Although, the observed trend matched that obtained experimentally, it did not predict 
the correct slope, thus suggesting the presence of other effects which become more important 
as the mass of the concomitant element increases. Such an effect might be the one suggested 
by Gillson et al who demonstrated that ion transmission through the skinuner is affected by 
space charge interactions (Colombie repulsion) with the light elements being pushed away 
from the central axis whilst the heavier ones are being transmitted more efficiently [Gillson
1988].
Crain et al reported that changing the size of the skimmer orifice changes dramatically 
the behaviour of non-spectroscopic interferences [Crain 1988]. The large skimmer aperture 
diameter reduced signal suppression. However, the extent of suppression was greater for 
analytes with high ionisation energies, and did not vary much between various matrix 
elements with similar ionisation potential but with substantial differences in mass. This can 
be explained by the fact that increasing the skimmer aperture diameter intensifies the jet flow 
across the nebuliser such that space charge effects become minimal. Wang et al attempted to 
overcome suppression effects by tuning the ion lenses in the presence of the matrix ions 
[Wang 1990]. For a Co matrix, very little difference in recoveries was observed, whilst with 
a Pb matrix the suppression was considerably reduced. These results would be expected if 
space charge effects were the predominant but not the only mechanism causing non- 
spectroscopic suppression.
Beauchemin et al observed signal enhancement for several test analytes in the presence 
of high levels of Na, K, Cs, Mg, or Ca [Beauchemin 1987a]. However, Grégoire reported 
that this enhancement, or so-called sensitization effect, was not due to a contamination in the
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solution transport system nor was it due to some change in the nature of the plasma. Instead 
it might be due to the chemistry of the ions entering the interface or to some changes in the 
characteristics of the ion lens system [Grégoire 1987a]. Since these effects were observed only 
by users of a Sciex ICP-MS it might be that their origin is in the ion lens system adopted by 
Sciex, which is very different from that used in other ICP-MS instruments.
Finally, high levels of salts can produce physical non-spectroscopic effects by 
interfering with normal nebuliser function either by changing the sample viscosity, causing 
aerosol ionic redistribution [Blades 1981], or by deposition and volatilisation of the excess 
analytes on the walls of the spray chamber. Furthermore, such interferences can be caused 
by the formation of an oxide salt of the concomitant element, which deposits on the sampler 
and subsequently plugs its orifice [Beauchanin 1987a; Douglas 1988b]. However, Gray 
reported that with up 0.1 % TDS little trouble is experienced with salt deposition on the 
sampler aperture [Gray 1989].
3.3.5 Influence of Operating Conditions
Variations of ion signals as a function of the operating parameters of commercial ICP- 
MS systems have been reviewed by Horlick et al, and Vaughan et al, for the Sciex 
instrument, and Long and Brown, and Gray and Williams, for the VG instrument [Horlick 
1985; Vaughan 1987; Long 1986; Gray 1987b]. Both systems showed similar behaviour, and 
although there are many variables that affect the final signal (coolant, auxiliary, and aerosol 
flow rate, plasma power, sampling depth, ion-lens voltages, rod voltages,...), all four studies 
agree that the key parameters are aerosol flow rate, ICP power, and sampling depth. A typical 
plot of ion signal as a fonction of aerosol gas flow rate at a constant power and sampling 
depth is shown in Figure 3.8. It is evident from this plot that the aerosol flow rate must be 
carefully chosen and controlled. Furthermore, depending on the matrix analysed and the 
elements of interest one should be careful in his choice of aerosol flow rate since, as 
described earlier on, the magnitude of polyatomic, doubly charged and non-spectroscopic 
interferences also varies with this parameter. Working at high plasma powers does improve 
the signal intensity and depending on the system in use a power between 1.3 and 1.5 kW 
normally provides the optimum performance. A sampling depth of around 15 nun is a 
reasonable choice. Increasing the depth does not provide any advantages and signal intensity 
is sacrificed. Decreasing it, on the other hand, does shorten the sampler's life-time
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dramatically. Finally, it is recommended that the operator does, on a daily basis, tune the ion- 
lens potentials in order to obtain an optimum response.
3.3.6 Precision and Accuracy
Sources of instabilities in ICP-MS lie at different points between the nebuliser and the 
detector. Fluctuations in gas flow, nébulisation efficiencies, plasma tuning, the physical 
characteristics of the sampling interface, and the tuning electronics in the mass analyzer do 
contribute, together with count statistics, in limiting the reproducibility of any set of 
measurements. A combination of some or all of these factors is manifested in an instrumental 
drift in the signal of the ICP-MS when operated over long periods. Correction for this drift 
can be carried out either via internal standardisation or the analysis of synthetic solutions 
(sensitivity standards). Both methods have proved to be useful but at the same time have their 
specific drawbacks. Internal standards have to be of similar ionisation energy, and 
neighbouring in mass, to the elements of interest. Furthermore, they should not exist at a 
detectable levels in the original sample [Thompson 1987]. Clearly, it is not always feasible 
to meet these requirements during the analysis of 'real' samples. On the other hand, by using 
sensitivity standards one assumes that the drift varies linearly between each two consecutive 
standards; which is not always true. The choice between the two methods depends upon the 
nature of the sample to be analysed and the performance of the machine itself.
As ICP-MS has become more popular several authors have evaluated the precision 
of the technique with regard to various matrices. The precision is normally reported as the 
relative standard deviation (RSD) of multiple runs of the sample of interest. Jarvis and 
Williams obtained, using multi-element mode of analysis, a precision better than 5% for 
several elements in a geological reference material analysed three times [Jarvis 1989]. This 
precision deteriorated to 17% as the concentration approached the detection limits of the 
instrument. Table 3.2 lists the percent RSD for some elements at the 50 and 1000 ng.ml ' 
level in solution. These data show that the precision varies with the element of interest (mass 
and ionisation energy) as well as the concentration of the element in solution. Improvements 
in the relationship between concentration and precision can be obtained by pre-concentration 
procedures [McLaren 1985], the use of alternative introduction techniques such as ETV, 
GFN, or UN [Serfass 1986], or the use of different modes of analysis such as isotopic studies 
[Dean 1987; Janghorbani 1988]. Isotopic studies, however, are currently the most effective
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techniques available for improving the precision. They are capable of routinely producing
results with 0.1 to 1.0 % RSD [Russ 1987; Delves 1988; Ting 1988; Van Heuzen 1989]
Table 3.2 Signal precision for selected elements at SO and 1000 ng.ml ' 
levels in solution
Element Mass % RSD* 
50 ng.ml *
% RSD* 
1000 ng.ml *
Lithium 7 5 .
Beryllium 9 4 1.52
Boron 11 5 -
Magnesium 24 - 0.71
Aluminium 27 2 -
Scandium 45 - 0.83
Chromium 52 7 -
Manganese 55 5 -
Cobalt 59 3 1.08
Copper 63 2 -
Zinc 66 5 -
Arsenic 75 - 0.88
Selenium 78 6 -
Strontium 88 4 -
Molybdenum 95 3 -
Rhodium 103 - 1.08
Barium 138 2 -
Mercury 202 2 -
Thallium 205 4 -
Lead 208 3 -
Data evaluated based on 10 runs.
1 Taylor 1989
2 Meddings 1989 
- not reported
Over the past 10 years several certified standard reference materials (SRM) have been 
analysed by ICP-MS. Comparing the reported results with the certified values, reveals that 
if appropriate sample preparation procedures were adopted, and the analyst took time to 
identify and correct for possible matrix dependent interferences, very good accuracy could 
be expected. McLaren et al, Taylor and Howard, Beauchemin et al, and Ward and Walker 
reported accurate results for the analysis of water reference materials (NRCC CASS-1; NIST 
SRM 1643a, SRM 1643b, and NRCC SLRS-1) [McLaren 1985; Beaudiemin 1987b; Taylor 
1988; Ward 1989a]. Marine SRMs have been analysed by McLaren et al and Ridout et al 
(NRCC BCSS-1 and TORT-1 respectively), the former group reporting that due to matrix 
interferences standard addition techniques provided much better accuracy than external 
calibration [McLaren 1987; Ridout 1988]. Analysis of geological reference materials have also
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been reported (SY-3, GSP-1, NIM-G; BCR-1, SY-2, NUN-1; AVG-1, G-2, JB-1, JG-1, 
MESS-1, MRG-1, NBS-688, NIM-G, NIM-L, NIM-N; NIM-S, SY-2, W-1) [Date 1985; 
Longerich 1987; Jarvis 1989]. All three groups obtained good accuracy, using different 
methods of sample preparation. Notably, the method described by Jarvis and Williams 
involved minimum sample treatment and was based around slurry nébulisation where the 
samples are introduced into the ICP as a suspension of finely ground particles. Finally, the 
accuracy of ICP-MS for the analysis of biological materials has been verified by the analysis 
of biological SRMs such as IAEA H4, NIST SRM 1577, 1571, tomato leaves, pine needles, 
5277, and NRC DORM-1, DOLT-1 [Beauch^nin 1988; Eaton 1988; Abou-Shakra 1989; 
Durrant 1989b; Thompson 1989; Ward 1989b; Frid 1990] The results were plausible, though 
most of these authors agreed on the difficulty of measuring elements such as V, Cr and As 
due to spectroscopic interferences (section 3.3.3).
3.4 Analysis of Blood Serum by ICP-MS
Recent reviews on the simultaneous multi-element analysis of blood serum by ICP-MS 
have been reported by Templeton et a/ and Vanhoe et al [Tmnpl^n 1989; Vanhoe 1989]. 
The former group attempted to analyze 31 elements in rat serum, namely, Li, Be, B, Mg, Al, 
Ca, P, V, Cr, Mn, Fe, Co, Ni, Cu, Zn, As, Rb, Sr, Mo, Ag, Cd, Sn, Sb, Cs, Ba, Pd, Pt, 
Hg, Tl, Pb, and Bi. Although the authors suggested that sample handling should be kept 
minimum, serum samples were wet digested with HNO,. No explanation was given for 
adopting such procedure, nor was any reference made regarding the grade and the purity of 
the acid. Furthermore, the instrumental parameters were optimised such that different groups 
of elements were analysed under different conditions, thus each sample was analysed five 
times in order to determine all the elements of interest. Data for V, Cr, and As were not 
reported due to the expected polyatomic interferences (**C1'®0 on ’^V, "°Ar"C on “Cr, and 
^Ari^Cl on "As). Similarly, data for Ni were not cited due to the use of Ni cones and 
skimmers. Lithium, Ag, Cd, Sn, Pt, Tl, Ba, Hg, and Bi were reported to exist at levels below 
the detection limits of the instrument. Finally, the data obtained for some of the elements (Co, 
Mn, Al) were higher than the levels expected in human serum. The levels of these elements 
in human serum are actually at or below the detection limits quoted in this work (Chapter II, 
section 2.4). In summary, although only a limited number of elements could be analysed 
simultaneously, the results for essential elements were not satisfactory. In the other study, the 
authors reported that it is possible to determine Fe, Co, Cu, Zn, Rb, Mo, and Cs, simply by 
diluting the samples five times with 0.14 M HNO, (purified by sub-boiling distillation), then
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adding 100 ng.ml ' of In (final concentration) to the samples as an internal standard to correct 
for signal suppression, and finally by using a 'matrix matched' blank to correct for possible 
polyatomic interferences on Fe, Co, Cu and Zn. Although the last assumption lacks any 
scientific support, the authors reported very accurate results for the analysis of the second 
generation serum standard reference material [Versieck 1988]. This may be due to the fact 
that the matrix matched blank consisted of exactly the same levels of analytes existing in the 
reference material, and as such, whether this correction is valid for 'real' samples remains to 
be confirmed. In addition, it is surprising that the authors quoted results for Co as low as 
0.24 ± 0.05 ng.ml ' (equivalent to 0.048 ±  0.01 ng.ml ' in the analysed solution) whilst 
reporting that the blank signal for Co was 0.08 ±  0.02 ng.ml '. Finally, there was no mention 
of the effect of introducing non-digested serum on the long term stability of the instrument, 
which is an important factor if such a method is to be adopted for routine analysis.
Other studies regarding the analysis of serum by ICP-MS are centred around specific 
elements. Lyon et al, attempted to eliminate the Cl interference by co-precipitating chloride 
with silver [Lyon 1988a] and by desalting the serum via gel filtration [Lyon 1988b]. The 
authors reported that although these techniques were successful in reducing the Cl problems, 
low recoveries were obtained for elements such as Cu and Zn which seriously limits the 
multi-element capabilities of the technique.
In summary, the applicability of ICP-MS for the analysis of blood serum is still to 
be demonstrated. Signal suppression, polyatomic interferences and other problems that might 
be related to the serum matrix need to be evaluated before the technique can be used for 
routine analysis.
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4.1 Chemicals and Laboratory Ware
Double distilled deionised water used throughout was obtained from an ELGASTAT 
UHQ (Buckinghamshire, UK) water purification system at a resistivity of 18 MO/cm. 
Inorganic standard stock solutions were purchased from BDH Chemicals (Hampshire, UK). 
Nitric acid, sodium chloride and sodium nitrate were all Aristar grade also from BDH 
chemicals. L-cysteine was bought from Sigma Chemicals (Dorset, UK).
Metal free polypropylene containers were acquired from Elkay Laboratory Products 
(Hampshire, UK). The pipettes used in this study were Gilson Pipetman™ (FIOOO and P200) 
and EDP-2™ automatic pipette available from Anachem Ltd (Bedfordshire, UK), The tips 
used with these pipettes were Rainin™ tips purchased from the same supplier. Finally, the 
blood collection tubes were obtained from Sterilin Ltd (Middlesex, UK).
4.2 Instrumentation and Operating Conditions
The inductively coupled plasma mass spectrometer used in this work was a PQII 
instrument, VG Elemental (Cheshire, UK). Sample introduction was carried out by using a 
Jar ell Ash cross flow nebuliser (Michigan, USA), operated in conjunction with a single-pass 
water cooled spray chamber. The torch was of the Fassel type, with a demountable injector 
tube of 1.5 mm internal diameter.
4.2.1 Operating Conditions
The sensitivity of analyte ions in ICP-MS depends on various operating conditions 
of the system, namely: the plasma power, carrier gas flow rate, sampling depth (cone to load 
coil distance) and the water content of the carrier gas flow and aerosol. Although the optimum 
conditions are different for each element, compromised conditions recommended by Gray and 
Williams [Gray 1987b] were adopted throughout the study. A summary of these conditions 
is listed in Table 4.1. In addition, the ion optics of the mass spectrometer were tuned using 
a synthetic solution containing 100 ng.ml ' Be, Co, Ce and Bi so that an optimised maximum 
response was obtained for all four elements.
4.2.2 Data Acquisition
Using the software package provided by VG Elemental, the raw data (without any 
blank correction) was transmitted to an AT 286 personal computer (PC), which was hard
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Table 4.1 ICP-MS operating conditions
Plasma power 1300 W
Reflected power < l o w
Coolant argon flow 14 l.min*
Auxiliary argon flow 0.5 l.min*
Carrier argon flow 0.75 l.min*
Uptake rate (cross flow nebuliser) 1.1 ml.min*
Spray chamber temperature 0 - 2 °C
Load coil - cone spacing 10 mm
Sampling cone diameter 1.0 mm
Skimmer cone diameter 0.7 mm
Sweeps 240
Dwell time 320 //sec
Channels 2048
Mass region 5 - 240 amu
wired to the ICP-MS instrument. The data was then processed using programs written in 
FORTRAN 77, First, the blank subtracted intensities of the analytes were calculated either 
with drift correction or with internal standardization. Depending on which method of 
calculation was used, the intensities of the analytes were divided by either the corresponding 
sensitivity standard (calculated based on the assumption that the drift between two consecutive 
standards is linear) or internal standard intensities before the blank subtraction was actually 
done. These net intensities were then transformed into concentrations by normalizing to the 
intensities of the multi-element standard. The following equation summarizes the whole 
calculation procedures for a particular analyte:-
5  S.D F a X C , x ( - f  -
C -  -------------   J î------ (4.1)
where
C. = Concentration of sample 'a'
DF, = Dilution factor of sample 'a'
C, = Concentration of the multi-element standard
S. Raw intensity for sample 'a'
Sj, = Raw intensity for sensitivity or internal standard for 'a'
Srt, = Raw intensity for sample/reagent blank 'rb'
Sirt = Raw intensity for sensitivity or internal standard for 'rb'
S, = Raw intensity for multi-element standard 'ms'
Sj. = Raw intensity for sensitivity or internal standard for 'ms'
Sj. = Raw intensity for standard blank 'b'
Sa, = Raw intensity for sensitivity or internal standard for 'b'
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For further details and complete listings of the calculation programs the reader is 
referred to Appendix 1.
4.3 Detection Limits
The detection limit (DL) of an instrument for a particular analyte is the minimum 
amount of this analyte that can be statistically distinguished from a 'blank'. In 1978 the 
lUPAC recommended that DL must be calculated as 3 times the standard deviation (SD) of 
the 'blank' [lUPAC 1978]. In mathematical terms, assuming that is the standard deviation 
of n readings of the blank and the equation of the calibration curve of the instrument is:-
S a X C + b (4«2)
where, S is the magnitude of the signal, a is the gradient, C is the concentration, and b is the 
intercept. The detection limit is then expressed as:-
DL 3 X ^  (4.3)a
If S, is the signal/response of the instrument for an analyte of concentration C„ equation (4.3) 
becomes :-
C3 X cr. X — ^  (4.4)S - b
Examination of equation (4.4) shows that an improvement in the detection limits can be 
obtained by increasing the response of the instrument, reducing the signal for the blank and 
reducing the fluctuation of this signal.
4.3.1 Experiment 1
In order to calculate the detection limits of the ICP-MS for elements in synthetic 
standards, ten integrations of double distilled deionised water followed by four integrations 
of a multi-element standard solution containing 100 ng.ml ' (Li, B, Mg, Al, V, Cr, Mn, Fe, 
Co, Cu, Zn, As, Se, Br, Rb, Mo, Cd, Cs, Hg and Pb) were obtained.
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Table 4.2 Detection limits in synthetic standards (ng.ml *)
Element Exp.l Exp.2 Element Exp.l Exp.2
Li 0.2 0.07 Zn 0.44 0.07
B 1.0 0.30 As 0.35 0.09
Mg 1.3 0.40 Se 6.28 0.96
Al 0.15 0.05 Br 3.30 1.10
V 0.09 0.03 Rb 0.11 0.03
Cr 0.11 0.04 Mo 1.22 0.36
Mn 0.09 0.05 Cd 0.37 0.11
Fe 12.4 4.8 Cs 0.09 0.02
Co 0.09 0.03 Hg 0.53
Cu 0.35 O.iO Pb 0.02
Exp.l =  
Exp.2 =
Long scan mode (5-240 amu) 
Short scan mode (5-140 amu)
Table 4.2 lists the results of this first experiment. These results demonstrate clearly 
the superior sensitivity of ICP-MS compared to other major analytical techniques (NAA, 
AAS, etc.). However, even with such high levels of sensitivity, a 2 to 3 fold dilution of a 
serum sample significantly reduces the precision of the measurements as the Li levels 
approach the detection limits of the instrument.
As discussed earlier in this section, the detection limits can be improved by increasing 
the instrument response for the analyte and reducing the fluctuation and the signal of the 
blank. The only parameters in Table 4.1 that have not been optimised are the dwell time and 
the mass region. Therefore, in the first instance, any possible relationship between the dwell 
time and the stability and magnitude of the blank signal was investigated. This was followed 
by an evaluation of the possible benefits of a large cut in the scanned mass range and the 
tuning of the ion lenses for Be, Co and Ce only.
4.3.2 Effects of Varying the Dwell Time
Ten double distilled deionised water samples were analysed under various dwell time 
conditions. Table 4.3 shows tlie mean and the standard deviation of the readings. It is clear 
that as the dwell time decreased more stability was achieved. This is mainly due to the fact 
that, at higher dwell times, there is a greater probability of picking up noise signals from the 
rf-generator or the rest of the electronics in the instrument itself. Therefore, for the remainder 
of this work a dwell time of 320 //sec was used.
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Table 4.3 Effect of dwell time on the blank signal (counts, sec *)
Dwell time* *Li “Rb *“ Cs
1280 242 ±  19.9 27 ±  3.3 26 ±  1.4
640 64 ± 5.0 16 ±  3.3 12 ±  1.9
320 10 ± 0.8 1 ±  0.5 1 ±  0.5
180 9 ± 0.8 2 ±  0.5 1 ± 0.5
 ^mean ±  standard deviation of 10 readings 
* /tsec
4.3.3 Effects of Varying the Scanned Mass Range
The same experimental procedures were followed as in experiment 1 with a decreased 
scan range of 5 to 140 amu. The results in Table 4.2 show a great enhancement of the DL. 
which allows the analysis of blood serum for most of the listed elements to be carried out 
with an acceptable precision (<10 %).
The main reason for this enhancement is that ICP-MS tends to be less sensitive for 
elements at the very low or very high mass extremes of the spectrum (Figure 4.1). Therefore, 
a major loss of sensitivity, mainly in the 50 to 140 amu region, is to be expected when trying 
to optimise the signal for both mass extremes (experiment 1). However, the loss of signal is 
dramatically reduced when optimising for only one end of the mass scale.
As a final investigation the instrument was tuned only for Be and the same steps as 
in experiment 1 were carried out scanning only over the mass range of 5 to 13 amu. The 
results showed an unrivalled DL of 0.006 ng.ml *, which reflects the great potential of the 
ICP-MS for undertaking ultra trace analysis, even when used in its mono-elemental mode.
4.4 Matrix Effects
Interferences derived from the matrix of interest limit the precision and accuracy of 
most analytical techniques. In particular, for the analysis of blood serum by ICP-MS, a 
number of polyatomic interferences originate from the combination of the major electrolytes 
in the matrix (Na, K, C, Cl, O) either with each other or with the Ar in the carrier gas. 
Another source of interference, discussed already in Chapter III, is the possible signal 
enhancement or suppression due to the high content of salts in the serum.
-76-
R e la tive  in te n s ity100
80
40
20
200 250100 150
M a ss  (amu)
Figure 4.1 Typical ICP-MS response curve
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Figure 4.2 Magnitude of the Cl interference on V and As
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4.4.1 Polyatomic Interferences
Although the composition of the gas sample extracted from the plasma at the interface 
is frozen within 1 fiSQc of leaving the plasma temperature, fast ion molecule reactions can 
occur, during this period, between the species of higher concentrations in the analyte matrix 
and the elements of the plasma gas such as argon, hydrogen and oxygen. The end product of 
these reactions is the formation of interfering polyatomic ions resulting in what is generally 
known as polyatomic interferences. A more detailed description of these interferences is found 
in Chapter III. However, in order to evaluate their extent, with regard to the serum matrix 
(rich in Cl, Na, K, C and Ca), five simulated serum solutions were prepared. The reagents 
used for this preparation were aristar grade NaCl and NaNOj, 1000 /yg.ml * Ca and K in 
HNO3 standard solutions, and L-Cysteine 'CH%(SH).CH(NHz).COOH". Table 4.4 lists the 
elemental content of all five solutions. Each solution was spiked with 100 ng.ml ' Be and In 
as internal standards before analysis by ICP-MS. The interference was then identified from 
possible elemental contamination in the solutions, by comparing the isotopic ratios of the 
elements.
4.4.1.1 Polyatomic Inteiferences from CP Species
The levels of Cl in human blood serum vary between 2940 and 4120 //g.ml ' Pyengar 
1978]. Chlorine ions were found to combine with O and Ar, hence, the formation of "Cf'O, 
”C1*'’0 , ’*Cl‘“Ar and "C rA r species which interfere with ‘^V, "Cr, "As and ”Se respectively. 
Figure 4.2 and Figure 4.3 show the variations in the apparent concentrations of V, Cr, As, 
and Se with the Cl content of the sample. Although the ratios of the signals of "V/"Cr (3.12) 
and "As/"Se (3.13) are very close to the natural "C1/”C1 isotopic ratio (3.13), it is due to 
the small isotopic abundancies of "Cr and "Se (9.5% and 7.5% respectively) that the apparent 
concentrations of these isotopes are much higher than "V and "As.
Comparing these concentrations to the ’normal’ levels of V, Cr, and As in blood 
serum ( “0.1; “0.1; '1  ng.ml '), it can be clearly observed that, for mass 51,53 and 75, the 
signals from the Cl interference are 10 to 100 times higher than the ones from the elements 
themselves. Therefore, unless the Cl in the sample is eliminated or dramatically reduced, the 
mathematical model described by Williams [Williams 1989] to correct for such interference 
is not sufficiently accurate. Furthermore, since the magnitude of the interference increases 
with the Cl content of the sample, it is very difficult to perform an accurate matrix matched
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blank correction. As a result, since "V is 99.75% and "As is 100% abundant, the two 
elements cannot be measured under the run conditions adopted in this study.
Table 4.4 Simulated serum matrices, major analyte concentrations (/ig.ml ')
Na Cl S K Ca
matrix a 4535 7000 2000 300 150
matrix b 3500 4500 1400 220 110
matrix c 3200 3600 1200 194 97
matrix d 3000 2500 1000 170 85
matrix e 1500 1000 500 100 50
In the case of "Se, the signal from ”Cl"Ar is comparable to the one from the 'true' 
Se in serum. However, since Se has got several isotopes (76, 77, 78, and 82), it may be 
possible to overcome this problem by utilising other isotopes.
4.4.1.2 Polyatomic Interferences from S* Species
The S levels in blood serum range between 1120 and 1270 /ug.ml ' Pyengar 1978]. 
The main polyatomic species involving S are "S'*0, ®*S‘"0, ”S"S, and "S*S which interfere 
with ^ (^Ti,Ca), ”Ti, “Zn and “Zn respectively. Figures 4.4 and 4.5 present the variations in 
the apparent concentrations of Ti and Zn isotopes as a function of the S content of the 
samples. Furthermore, whilst no SAr species were observed. Figure 4.6 shows the effect of 
a "S'®0'H interference on ^Ti.
Since the S species interfere only with “'•'‘'’ "Ti and “ “Zn, the easiest way to overcome 
the S interferences is to use other 'clean' isotopes of those elements e.g. “’Ti and “Zn. 
Besides, in the case of Zn, the magnitude of the ”S*“S signal is c.a. 500 times lower than the 
normal levels of Zn in serum. This interference is, therefore, non significant as its effect on 
the accuracy of the measurements will be less than 0.5%.
4.4.1.3 Polyatomic Interferences from K* Species
Figure 4.7 illustrates the extent of the interference on "Mn. This may result 
in an apparant concentration which is 2 to 3 times higher than the 'true' levels of Mn in blood 
serum. One way to overcome this problem is to calibrate the signal against matrix- 
matched blanks with various levels of K at the beginning of each run procedure and subtract, 
according to the K levels in the sample, the expected interference from the "Mn signal. 
However, due to the huge peak of Ar at mass unit 40, there is a large tail-back effect which
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prevents any accurate integration of the neighbouring peaks at masses 39 and 41. Since the 
only isotopes of K are "K and '"K, no determination of the K signal could be carried out 
accurately, thus, the idea of calibrating a K signal against that of is not feasible.
4.4.1 A  Polyatomic Interferences from other Ions
The carbon ions from the L-cysteine in the sample can combine with the Ar in the 
carrier gas to form a “C"Ar species which will overlap with the major isotope of Cr at mass 
52. This interference, illustrated in Figure 4.8, makes the direct determination of Cr in blood 
serum highly inaccurate. It is, therefore, imperative that some sort of sample pretreatment is 
to be carried out if the Cr levels of serum are to be measured. Unexpectedly, no Na or Ca 
species could be observed in this experiment. This is in direct contradiction with a recent 
report by Lyon et al [Lyon 1990] which describes the effects of a “Na"“Ar interference on 
"Cu. The main reason for this discrepancy may be due to the fact that the magnitude of 
polyatomic interferences is very much instrument dependent, and whilst Lyon et al used the 
old ICP-MS "PlasmaQuad" this experiment was carried out on the newer version "PQII". An 
alternative reason might be that these measurements were not conducted under sensitive 
enough conditions to be able to detect this interference (Lyon et al carried out isotope ratio 
studies on copper and were looking at < ± 0.5% accuracy and precision, compared with ± 
5% for this study). Finally, the same experiment was repeated but this time containing various 
levels of Mg and Br (1, 5, 10 and 20 ^g.ml '). No significant polyatomic effect was seen for 
both elements.
4.4.2 Signal Suppression (Enhancement)
Details on the effects of high levels of salts on the signal deterioration (or 
enhancement) have been reviewed in Chapter III. Since blood serum is basically a NaCl 
matrix, the effects of 0.1 M of NaCl on the signal of several test analytes (Li, B, Mg, Al, Cr, 
Mn, Fe, Co, Cu, Zn, Se, Br, Rb, Mo, Cd, and Cs) is evaluated.
Two test solutions containing 5 ng.ml ' of Li, Al, Cr, Mn, Co, Ge, Mo, Cd, and Cs; 
620 ng.ml ' of B, Fe, Cu, Zn, Se, and Rb; 9 ^g.ml ' Mg and Br, were prepared in double 
distilled deionised water and 0.1 M NaCl respectively. The magnitude of the respective 
elements was used to approximate a three fold dilution of those reported in the scientific 
literature for serum. However, for elements which are known to exist in serum at levels 
below 1 ng.ml ', a concentration of 5 ng.ml ' was used in order to avoid the poor precision
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observed when approaching the detection limits of the instrument. Finally, both solutions 
were spiked with 100 ng.ml * Be and In as internal standards.
Figure 4.9 shows that, at 95% confidence limits ( ± 1.96 SD), the NaCl in the matrix 
does not affect significantly the signal of most elements. The only exceptions being A1 and 
Cr. In the case of Cr this discrepancy was traced back to C impurities in the NaCl which 
masked the “Cr via the ^Ar"C polyatomic interference described in the previous section. In 
the case of Al, the results obtained were highly inaccurate and imprecise for both NaCl and 
water solutions, 24.95 ± 3.18 (12.75% RSD) and 34.83 ± 4.52 (12.98% RSD) respectively. 
The source of this problem is obscure and could not be related to any polyatomic interference 
(section 4.4.1). Furthermore, the fact that there was an approximately 13% imprecision on 
different readings from the same sample is difficult to explain.
4.5 Analysis of Blood Serum
As it was established in the previous section, a simple three fold dilution of a serum 
sample is enough for the levels of salts in the matrix to become insignificant, in terms of their 
effects on the magnitude and the stability of the signal. Therefore, the idea of simply diluting 
the samples before analysis was very attractive, especially as it meant minimal sample 
preparation thereby limiting the possible sources of contamination, and increasing the sample 
throughput.
In order to assess the applicability of this idea, frozen serum samples were left to 
thaw at room temperature and then pooled and shaken together to ensure homogeneity. The 
final pooled volume was c.a. 120 ml. Three 20 ml aliquots were taken from this pool, 0.6 
ml of 3 /tg.ml ' Li, Be and In solution was added to the first, 1 ml to the second and 2 ml to 
the third and diluted with 1% HNO, up to 60, 100 and 200 ml respectively. Each of these 
samples was then run ten times with three minutes wash-out between runs.
The injection of 3 fold diluted serum resulted in a rapid deterioration of the signal 
followed by instrument shutdown after running 3 to 4 samples only. This phenomenon was 
reproducible, and solely due to the rapid blockage of the injector tube as a result of the high 
levels of proteins in the samples.
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Figure 4.10 shows the magnitude of the Li signal as a function of sample throughput 
for the 5 fold diluted serum. The values represent the ratio of the signal for a specific sample, 
to the signal of the first sample analysed. The main possible reason behind the deterioration 
of the signal may be the gradual formation of a clot in the injector tube which in time may 
cause a shut down of the instrument. When internal standard correction was applied the signal 
was adjusted to within ten percent. However, such precision is not satisfactory especially 
when the levels encountered in non-spiked serum are 10 to 50 fold lower.
In the case of 10 fold dilution, matrix effects were negligible and an accuracy of 
<10% was obtained. In addition. Figure 4.11 clearly shows that for the determination of Li, 
it is more appropriate to use Be as an internal standard instead of In. One possible explanation 
of this observation is that due to the mass bias of the instrument, an internal standard with 
neighbouring mass number may be more useful than one with a similar ionisation energy. 
This is particularly true since the levels of electrolytes in solution were found not to exhibit 
significant ionisation suppression of high ionisation energy elements.
Subsequently, 2 ml of the serum pool was spiked with 0.2 ml of 3 jttg.ml * Be internal 
standard, diluted up to 20 ml and analysed under the multi-element mode. The results for Li 
were just above the DL and as expected highly non reproducible; the mean and standard 
deviation of six readings were 0.9 ± 0.3 ng.ml*. Based upon the signal enhancement 
encountered when switching from long scan range to a short one, such precision may be 
greatly enhanced by using short scan mode. The main disadvantage in this case is the inability 
of performing multi-element analysis. Therefore, it was decided to investigate whether sample 
digestion may help to improve the precision of the measurements without loosing the multi­
element capabilities of ICP-MS.
The errors associated with the analysis of any matrix may largely be governed by 
what happens at the preparation stage. It is, therefore, important to choose a digestion method 
that involves a minimum amount of sample pretreatment, provided that it is capable of 
delivering results of acceptable accuracy and reliability. Two such methods are dry ashing and 
wet ashing with hot oxidising mineral acids.
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4.5.1 Dry Ashing
This is perhaps the commonest technique for ashing biological samples, that is 
burning off the organic part of the sample and leaving the inorganic residue as an ash for 
subsequent analysis. The procedures are very simple, the sample is placed in a crucible and 
heated for a fixed length of time in a muffle ftirnace at 500 to 550 °C.
The main advantages of this technique are its simplicity and its freedom from 
contamination since no other reagents are involved. However, several obvious drawbacks are 
also associated with dry ashing, namely
(A) Any elements that can be converted into a volatile form are wholly or partially lost. This 
is particularly true for non metals which are readily oxidised to volatile products. 
Furthermore, some elements are more prone to loss by volatilisation if certain other 
species are present in the matrix. Chloride ions, for example, in the serum can react with 
lead to produce the volatile PbCL.
(B) Another source of error is the possible reaction between the sample and the crucible 
material. For instance if this is porcelain or silica products, reactions such as fusion may 
occur and analytes can be absorbed into tlie crucible walls.
(C) The differences in the temperature within the digestion vessel, could lead to incomplete 
ashing of the sample. This will result in small amounts of carbon residues which may not 
readily dissolve in a mineral acid.
Bearing in mind the above mentioned problems it was decided to leave the dry ashing method 
as a last resort and to start by looking at wet digestion.
4.5.2 Wet Digestion
Wet digestion is based upon heating the sample in the presence of a concentrated 
oxidising mineral acid or mixture of acids. If the acids are sufficiently oxidising and the 
sample is heated strongly enough for a sufficient length of time, then it should be possible to 
oxidise most samples completely leaving various elements present in tlie acid solution in 
simple inorganic forms suitable for analysis. Wet digestion is particularly useful for the
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determination of trace elements because by and large these are converted into simple non 
volatile inorganic cations which remain in the acidic medium.
The three most commonly used strong oxidising mineral acids are HNO„ H2SO4 and 
HCIO4. Since nitrogen has a much higher ionisation energy than sulphur or chlorine, it is 
more suitable to use HNO3 for the digestion in order to reduce possible ICP-MS bound 
polyatomic interferences during analysis.
Figure 4.12 is a schematic diagram of the digestion procedures adopted. A 1 ml aliquot 
of each sample was transferred into 15 ml, metal free polypropylene containers. Next, 0.75 
ml of nitric acid and 0.1 ml of 3 /tg.ml ' solution of Be and In were added. Twelve hours 
later, the samples were placed in a water bath (100 °C) and allowed to boil for five hours. 
After cooling, the samples were made up to 3 ml with double distilled deionised water. Before 
this digestion method could be implemented it was tested for its elemental recovery, precision 
and accuracy.
4.5.2.1 Elemental Recovery
In order to ensure that there is no elemental gain or loss through adsorption or 
contamination during the course of the digestion, the following procedures were carried out. 
Five solutions containing various levels of elements were prepared. The elemental 
composition of these solutions is listed in Table 4.5. Three aliquots of each solution were 
digested, whilst another three were three fold diluted with deionised water. With solution five 
used as a matrix matched blank, all thirty samples were analysed and the percentage recovery 
R for each element, as well as the standard deviation (SD) were calculated according to 
equations (4.5) and (4.6) respectively.
M,.  100 X —1 (4.5)
^2
SD^ R X y + q 2^ (4 6)
Where:
M, = Mean concentration for the three digested samples. 
Mj = Mean concentration for the three diluted samples.
= Relative standard deviation for the digested samples. 
= Relative standard deviation for the diluted samples.
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Table 4.6 shows the results for eighteen elements. Clearly a good recovery was obtained 
for Li, B, Mg, Fe, Co, Cu, Zn, Se, Br, Rb and Cs. It was noticeable, however, that in the 
case of Li and Co, there was a substantial signal deterioration as the levels in the samples 
approached the detection limits of the instrument. Consequently, there was a fall in the 
precision of the measurement which resulted in the apparent poor recovery levels for solutions 
1 and 2.
Although for Mg the data showed no apparent problem, the signal for "Mg was so large 
that for solution 4 it exceeded the dynamic range of the instrument. Considering that the 
normal levels of Mg in blood serum are about twice the levels in solution 4, it is, therefore, 
more appropriate to use the smaller isotopes of Mg in any fixture calculations.
Table 4.5 Elemental composition of the recovery test solutions
Elements Solution 1 Solution 2 Solution 3 Solution 4
Li, Al, V, Cr, Mn
Co, As, Mo, Cd, Cs (ng.ml ‘) 0.25 0.50 1.00 5.00
B, Fe, Cu, Zn, Se, Rb (ng.ml ') 33 66 132 660
Mg, Br (Acg.ml ‘) 0.45 0.90 1.80 9.0
NaCl (mg.ml ') 5.84 5.84 5.84 5.84
L-Cysteine (mg.ml ') 3.78 3.78 3.78 3.78
In the case of Se, the major isotope “Se (49.6%) cannot be used for any ICP-MS 
analysis due to its overlapping with the ^Ar^Ar dimer. Furthermore, the poor results for the 
less abundant isotopes "Se (9.0%) and ”Se(7.6%) are mainly due to polyatomic interferences 
by “Ar^Ar and ®^crAr respectively. As shown in Table 4.6 the only isotopes that can be used 
successfiilly are "Se and ®Se. However, one should bear in mind that at mass 82 there is a 
contribution to the signal from ”Kr (natural abundancy = 11.6%) which can be corrected for 
by subtracting the signal at mass 83 generated by “Kr(natural abundancy -  11.5%). Such 
correction is effective only in matrices where the levels of Kr are very low compared to those 
of Se; fortunately blood serum is one of these matrices.
For the elements suffering from polyatomic interferences, namely, V, Cr, and As, the 
data for solutions 1, 2 and 3 were below the detection limits of the instrument. This was
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Table 4,6 Percentage recovery for various test solutions*
Isotope Solution 1 Solution 2 Solution 3 Solution 4
*Li 137.33 ± 45.76 87.33 ± 15.52 109.67 ± 4.78 102.40 ± 6.75lOfi 99.20 ± 11.27 101.67 ± 1.38 111.91 ± 3.17 109.84 ± 2.35“B 102.32 ± 2.63 98.15 ± 3.18 105.98 ± 1.14 108.51 ± 3.26"Mg 102.22 ± 0.00 102.96 ± 4.48 100.70 ± 2.37 99.00 ± 1.59"Mg 100.00 ± 0.00 97.78 ± 2.40 97.37 ± 2.23 97.85 ± 2.49"*A1 N .D N .D N .D 110.93 ± 16.335 1 y N .D N .D N .D 44.29 ± 16.32“ Cr N .D N .D N .D 52.79 ± 4.96^Fe 140.52 ± 27.64 102.40 ± 22.98 115.06 ± 12.35 101.21 ± 1.86"Mn 66.51 ± 32.55 112.26 ± 23,36 99.28 ± 17.01 92.38 ± 7.29*Fe 104.45 ± 9.15 99.42 ± 2.91 103.37 ± 3.15 91.50 ± 3.48"Fe 105.14 ± 4.69 89.12 ± 1.80 97.90 ± 7.09 96.35 ± 4.62"Co 144.00 ± 15.25 126.33 ± 13.22 90.23 ± 15.57 104.53 ± 2.59“ Cu 98.13 ± 2.33 93.17 ± 2.10 98.22 ± 0.88 102.58 ± 7.66“Cu 104.15 ± 2.67 98.21 ± 6.18 105.62 ± 0.76 105.98 ± 0.50“Zn 92.90 ± 3.00 94.02 ± 1.42 98.46 ± 3.55 98.93 ± 2.06“Zn 91.16 ± 4.57 92.66 ± 4.58 97.03 ± 3.67 98.00 ± 1.59"As N .D N .D N .D 43.67 ± 7.79"Se 52.56 ± 8.13 43.31 ± 4.18 41.68 ± 0.53 40.43 ± 0.59**Se 142.34 ± 21.62 106.66 ± 7.96 114.65 ± 7.42 115.52 ± 0.70"Se 109.94 ± 5.49 102.35 ± 7.74 98.46 ± 4.84 94.47 ± 3.87"Br 100.44 ± 1.26 99.11 ± 1.66 97.68 ± 4.14 100.47 ± 0.20®'Br 100.44 ± 1.26 95.11 ± 1.66 95.16 ± 3.43 99.33 ± 0.93
" » S e 99.31 ± 2.37 98.99 ± 8.41 98.83 ± 6.25 100.62 ± 2.39“Rb 95.12 ± 3.07 90.98 ± 2.19 97.58 ± 1.75 97.10 ± 0.19“Mo N .D N .D 8.73 ± 1.16 10.92 ± 2.30“Mo N .D N .D 6.96 ± 0.48 12.19 ± 1.92“Mo N .D N .D 8.35 ± 2.07 8.47 ± 0.84‘“Cd N .D N .D 141.76 ±117.15 105.56 ± 12.22”^Cd N .D 124.43 ± 41.46 127.66 ± 41.65 93.24 ± 9.21“"Cd N .D 90.74 ± 33.31 90.00 ±  28.05 93.72 ± 9.28‘"Cs 93.33 ± 6.80 101.33 ± 8.99 100.33 ± 6.94 100.10 ± 4.90
* Percentage recovery ±  standard deviation 
N.D not determined
mainly due to the apparent high levels of blank signal caused by the presence of Cl and C. 
Furthermore, the recovery values obtained for solution four were very poor. A possible 
reason for such results may be the large fluctuation in the signal from the interfering 
polyatomic ions, combined together with the fact that the magnitude of the interfering signal 
is much higher than that of the element of interest.
After dilution, the concentrations of Mo and Cd in solutions 1 and 2 became lower 
than the detection limits of ICP-MS for the two elements. Therefore, no recovery values could
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be calculated for these solutions. In the case of solution 3, the concentrations were at or just 
above the detection limits of the instrument. This is manifested in a very poor recovery and 
precision. A good recovery however, was obtained for Cd in solution 4. Unfortunately, this 
was not the case for Mo. The very poor result was mainly due to erroneously high levels of 
Mo in the dilute solutions. The source of these errors is not known, and could not be 
attributed to Br polyatomic interference (section 4.3.3).
In the case of Mn, it was surprising to observe the presence of a high blank indicating 
a significant K contamination of the sample. As expected, the effect of the interference 
correction ^lank subtraction) was to produce a very poor accuracy and precision for the low 
concentration solutions. Respectable results were only obtained for Mn levels equal to or 
higher than 1 ng.ml '.
Finally, the problem associated with the analysis of Al mentioned in section 4.3.1 was 
also faced in this experiment. Although the results for solution 4 were acceptable, the levels 
measured in both digested and diluted solutions were 100 fold higher than expected.
4.5.2.2 Precision
The precision of the digestion method was determined through the analysis of 10 
digested samples from the serum pool mentioned in section 4.5. The F-test was used to 
determine whether the observed variance of the results was significantly larger than the 
expected variance derived from equation (4.1). Actually, equation (4.1) can be rewritten as:-
C. -  ,  X &  X C, (4.7)
as
where
and
a .  -  ^  ^  (4-8)
S. Sha^s “ - r  -  /  (4.9)
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From equation (4.7) the relative standard deviation of the concentration, can be derived 
according to the following equation:-
where:
= relative standard deviation of the dilution factor.
= relative standard deviation of the corrected signal of the sample 'S^'. 
cr„ = relative standard deviation of the corrected signal of the standard 'S„'. 
= relative standard deviation of tlie concentration of the standard.
Since the dilution factor DF is given by the ratio of the original volume of the sample 
used for digestion to the final volume after dilution, the relative standard deviation of DF ( O  
is:-
G../ -  0 ^  (4.11)rtif
where
= the relative standard deviation of the original volume 
=  the relative standard deviation of the final volume
The error on the original volume of the sample is associated with pipetting. 
Throughout this work the same 1 ml pipette was used for transferring serum samples. In 
order to calibrate this pipette for serum, 10 samples of the serum pool were transferred and 
weighed separately. The mean and standard deviation of the 10 measurements were 1.0237 
±  0.0016 g, resulting in = 0.0016. The error on the final volume was calculated by 
filling 10 pre-weighed digestion tubes up to the 3 ml mark with water and re-weighing them. 
The mean and standard deviation were 2.9858 ±  0.0363 g, with = 0.0122. Therefore, 
using equation (4.11) cr^ , was calculated to be 0.0123. Similarly, the error on the 
concentration of the standard is due to dilution. The original volume being 1 ml, calibrating 
the pipette for distilled water led to a mean ±  standard deviation of 0.9948 ±  0.0019 g, thus 
— 0.0019. The 1 ml standard solution was then 100 fold diluted in a 100 ml 
polypropylene beaker. The error on the final volume was calculated by filling 6 pre-weighed 
beakers with distilled water and reweighing them; the mean ±  standard deviation was 
99.4874 ± 0.0629 g, thus = 0.0006. The final solution was further diluted 100 fold and 
hence was calculated according to equation (4.12) to be equal to 0.0030.
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° r c s  “A X (oL + 0 % )
In order to calculate <7„„ it was assumed that:-
^  (4 .13)t^a
and
“ - f  (4.14)i^rb
Equation (4.8) can, Üierefore be written as:-
s»  -  s .. -  (4 .15)
and can be expressed as:-
fO m  _ ! — (4.16)
where
ff„ = the standard deviation of 'S„'
= the standard deviation of 'S^'
Based upon equations (4.13) and (4.14) a„ and can be calculated accordingly:-
+ " I
and
eib
where:-
ff„ = relative standard deviation of 'S.'.
= relative standard deviation of 'Si,'. 
= relative standard deviation of 'S^'. 
= relative standard deviation of 'S*'. 
ff* = relative standard deviation of 'Sw,'.
Assuming that the data fits in a gaussian distribution, the error on a signal S is equal 
to the square root of S. Equations (4.17) and (4.18) can, therefore, be re-written as:-
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J -  + J_. (4.19)
and
'erf» “  ^crb ^ - L  + J -  (4.20)5ft i^rt>
Equations (4.19) and (4.20) show that a„ and not only vary from one isotope to 
another but also depend mainly on the instrument response for the isotope of interest. Thus, 
the value of for a particular isotope can be calculated by replacing and by their
corresponding values in equation (4.16). The same reasoning used to calculate can also
be applied for the calculation of
(4.21)
where
S„ .  A  (4.22)
and
5^ -  ^  (4.23)Su,
Knowing a^y and the total precision error for an isotope x, can be 
calculated according to equation (4.10).
From Table 4.7 it follows that for all the elements determined, the reproducibility of 
the analysis is not significantly affected by sample digestion. It is noticeable, however, that 
for some isotopes, namely ^Fe, “Fe and '"Cd, the F-value exceeded the critical limit at the 
95 % confidence levels. In the case of Cd the elevated F-value is mainly due to the proximity 
of the Cd levels in serum to the detection limits of die instrument. This is clearly shown in 
the discrepancy between the results for '"Cd and “Td. The precision for the latter (low 
abundance) isotope being of poorer quality than that for the former. On the other hand, the 
reason for the poor precision observed for “Fe and “Fe may be due to a fluctuation in the 
ArO interference which resides on top of these isotopes. In order to check the validity of this
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explanation, double distilled deionised water was analysed and the relative standard deviation 
of the mean of 10 readings was evaluated for both isotopes. The results, 9.35% and 8.42%, 
are very close to those obtained for digested serum, thus confirming that the observed poor 
precision is not due to the digestion procedures.
Table 4.7 Calculated and expected relative standard deviation of the mean for digested serum 
and analytical standards solution
Isotope Concentration % precision 
1 2 3
F-value
1/2 2/3
*Li 0.95 (ng.ml ') 5.23 4.95 6.92 1.11 NS 1.96 NSlOfi 134.12 (ng.ml ') 21.63 18.15 24.49 1.42 NS 1.82 NS
“B 121.96 (ng.ml') 11.46 13.41 13.19 1.37 NS 1.03 NS
"Mg 12.97 (Acg.ml *) 2.38 3.49 3.12 2.15 NS 1.25 NS
"Mg 13.60 (/tg.ml ') 2.47 4.00 3.57 2.62 NS 1.26 NS
"Al N.DSly N.D
"Cr N.D
"Fe 0.90 (jag.ml ') 4.93 11.24 11.11 5.19 1.02 NS
"Mn 3.05 (ng.ml') 7.64 8.50 8.33 1.24 NS 1.04 NS
"Fe 0.95 (jag.ml ') 2.95 10.33 9.83 12.28 1.10 NS
"Fe 1.02 (/ig.ml ') 4.50 5.66 5.13 1.59 NS 1.22 NS
"Co N.D
“ Cu 1.02 (/ig.ml ') 2.48 4.23 7.20 2.90 NS 2.89 NS
“ Cu 1.03 Og.ml ') 2.68 4.89 6.21 3.33 NS 1.61 NS
“ Zn 0.51 (/tg.ml') 2.74 3.67 5.08 1.79 NS 1.92 NS
“ Zn 0.50 (/ig.ml ') 2.88 4.12 5.15 2.05 NS 1.56 NS
"As N.D
"Se 148.26 (ng.ml') 28.95 44.51 45.33 2.36 NS 1.04 NS
"Se 164.40 (ng.ml ') 23.14 19.60 20.46 1.39 NS 1.09 NS
"Se 104.87 (ng.ml ') 14.51 18.61 16.67 1.64 NS 1.25 NS
"Br 4.05 (/ig.ml ') 2.89 5.17 8.61 3.19 NS 2.77 NS
®‘Br 4.47 (/ig.ml ') 2.87 5.31 5.57 3.41 NS 1.10 NS
"Se 102.40 (ng.ml-') 19.24 11.38 15.45 2.86 NS 1.84 NS
“Rb 98.34 (ng.ml') 2.49 2.86 1.86 1.32 NS 2.37 NS
"Mo N.D
"Mo N.D
"Mo N.D
‘“Cd N.D
“^Cd 1.54 (ng.ml ') 34.90 92.78 43.84 7.07 4.48
‘"Cd 2.80 (ng.ml ') 35.72 62.70 44.60 3.08 NS 1.98 NS
‘"Cs 1.20 (ng.ml ') 5.99 7.17 7.70 1.43 NS 1.15 NS
1 Expected precision
2 Observed precision for serum
3 Observed precision for synthetic solution
N.D Not determined
NS No significant difference at the 95 % confidence level
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Another test for the precision of the digestion technique was to compare the relative 
standard deviation of the mean for the 10 digested serum samples against that of 10 readings 
from a synthetic standard solution containing the same levels of analytes as those found in the 
serum. The results of this experiment are also listed in Table 4.7. With the exception of ”^Cd, 
no significant difference in the precision of either sets of measurements was obsei*ved.
Considering the results of both tests, it could be concluded that the wet digestion 
technique used for this study, exhibit no detrimental effects on the precision/reproducibility 
of the analysis of the blood serum matrix for the reported elements.
4.5.2.3 Accuracy
The accuracy of these analytical procedures was tested by comparing results of 
analysis for two international serum reference materials, namely, bovine serum SRM 1598 
(NIST, Gaithersburg, USA) and second generation human serum reference material (J 
Versieck, Ghent, Belgium) with certified values.
Six samples of each material were digested. However, in the case of the second 
generation serum, available in its freeze dried form, around 150 mg samples were used 
instead of 1 ml. Table 4.8 lists the results for both reference materials. It is clear that a good 
level of accuracy was obtained for Mg, Co, Cu, Zn, Se, Br, Rb and Cs. The iron levels were 
relatively high for bovine serum but not for second generation serum. This makes any attempt 
to explain such discrepancies very difficult indeed.
In the case of Mo the data were much lower than the certified values for bovine serum 
which might imply the possibility of elemental loss during digestion. This suggestion, could 
not be tested for second generation serum because the results were below the detection limits 
of the instrument. However, the certified value for Mo in bovine serum is suspiciously high 
since the true levels of Mo in serum are about one order of magnitude lower than this 
(Chapter II). Furthermore, considering the poor detection limits of ICP-MS for Mo, it is clear 
that it will be virtually impossible to determine the Mo levels in the serum samples involved 
in this study by ICP-MS.
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Table 4.8 Elemental content of serum reference materials compared to certified values
Element NIST SRM1598* SECOND GENERATION**
This work* Certified This work* Certified
Li 1.4 ± 0 .1 N.C 14.8 ± 2 .8 N.C
B 101.8 ± 9.5 N.C 228 ±16 N.C
Mg 20.6 ± 2 .0 20.6 ± 0 ,2 180 ± 10 N.C
Al N.D 3.81 ± 1.0 N.D 20.2
V N.D N.C N.D N.C
Cr N.D 0.14 ±  0.08 N.D 0.76
Mn 8.6 ± 3 .01 3.89 ± 0 .3 3 42.6 ± 6 .9 5 7.7
Fe 3.26 ± 0 .13 2.62 ± 0 .1 26.3 ±  1.71 25.9
Co 1.31 ± 0 .37 1.28 ± 0 .1 9 3.4 ± 0 .7 3.6
Cu 0.74 ± 0.05 0.74 ±  0.04 11.07 ±  1.08 11.1
Zn 0.93 ± 0 .0 2 0.92 ± 0.06 9.65 ± 0 .9 5 9.6
Se 0.04 ±0 .01 N.C 1.04 ± 0 .1 5 1.05
Br 3.6 ± 0 .5 N.C 46.5 ± 3.5 48.8
Rb 0.18 ±0 .01 0.18 ±  0.02 1.62 ± 0 .11 1.85
Mo 6.67 ± 1.15 11.83 ± 1.13 N.D 7.5
Cd N.D 0.09 ± 0 .0 2 N.D 2.0
Cs < 0.3 0.1 9.9 ± 0 .2 10.0
* ng.ml '
^ ng*g ‘* Mean ± SD of six measurements 
N.C Not certified
N.D Not determined
For Al, V, Cr and As no results could be obtained due to the string of problems 
associated with the measurement of these elements, previously discussed in this chapter. In 
the case of Cd, on the other hand, the levels were below the detection limits of the 
instrument.
Since neither reference material is certified for Li or B, the following experiment was 
devised to test the accuracy of the digestion procedures. Ten aliquots of the serum pool were 
digested, whilst another 10 were 10 fold diluted with 1% nitric acid. The two batches were 
then run under long and short scans respectively. Table 4.9 lists the results of this experiment 
together with the t-values from 2 tailed Student t-tests reflecting no significant differences 
between the two set of results at the 95% confidence level.
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Table 4.9 Comparison between digested and straight diluted serum
Elements long scan short scan t-value*
Li 0.95 ±  0.05 0.97 ± 0 .0 4 0.988
B 145.34 ±14.35 139.62 ±8.11 1.097
* Two tailed t-test (degrees of freedom = 1 8 )
4.5.2 A  Discussion
The overall conclusion from the 3 above mentioned tests is that using the described 
wet digestion technique as a mean of sample preparation, allows the determination of Li, B, 
Mg, Co, Cu, Zn, Se, Br, Rb and Cs accurately and with a precision better than 10%.
With the exception of Fe, the difficulties with the elements that could not be 
determined with a reasonable degree of accuracy and precision are inherent problems specific 
to ICP-MS and not due to the digestion technique. In the case of Fe there is a shade of doubt 
regarding the accuracy of the measurements, caused by the poor data obtained for bovine 
serum. However, with accurate results obtained for second generation serum and keeping in 
mind that the data for the serum pool agree with the levels of Fe in serum reported in the 
scientific literature, values for Fe were collected and included in this study.
4.5.3 Storage of the Samples
Because samples can not always be prepared and analysed immediately after 
collection, the stability of the solution with time must be investigated to detect possible 
variations of elemental concentrations due to evaporation or transpiration of the liquids, 
adsorption of the trace element onto the walls of the storage container, and chemical changes 
such as precipitation or colloidal formation of the element under conditions of storage.
Five freshly collected serum samples were pooled together. Four 1 ml aliquots from 
this pool were digested and analysed whilst the rest, c.a. 13 ml, were transferred equally into 
3 sterilin tubes. The three tubes were then stored at -20 °C. As recommended by Veillon 
[Veillon 1986] the tubes were packaged in sealed plastic bags containing a few cubes of ice, 
so that they were in an approximately 100% relative humidity environment within the freezer. 
This method of packaging can, according to Veillon, slow down the process of gradual 
moisture loss through the containers' walls by lyophilization.
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Fifteen days later, one of the tubes was taken from the freezer and left to thaw at 
room temperature, '20 "C, for two hours in a clean environment (glove box); four 1 ml 
aliquots were pipetted out of the tube, digested and analysed. The same procedures were then 
repeated after 1 and 3 months.
Table 4.10 Effects of long term storage on the elemental stability of serum*
Set 1 Set 3 Set 3S Set 4
Li (ng.ml') 1.40 ± 0.07 1.38 ± 0.04 1.28 ± 0.08 1.33 ± 0.13
B (ng.ml') 98.20 ± 10.44 99.15 ± 11.29 96.65 ± 11.36 99.87 ± 11.36
Mgi/ig.ml‘) 15.23 ± 0.20 15.48 ± 0.19 15.30 ± 0.19 15.24 ± 0.19
Fe Otg.ml') 1.35 ± 0.09 1.37 ± 0.06 1.37 ± 0.09 1.35 ± 0.09
Co (ng.ml ') 0.31 ± 0.07 0.23 ± 0.13 0.34 ± 0.17 0.27 ± 0.06
CuO*g.ml‘) 1.07 ± 0.06 1.17 ± 0.07 1.03 ± 0.06 1.01 ± 0.08
Zn (/tg.ml ') 0.58 ± 0.01 0.62 ± 0.03 0.54 ± 0.02 0.56 ± 0.05
Se (ng.ml ') 83.20 ± 8.20 83.40 ± 8.60 80.50 ± 12.20 80.30 ± 7.50
Br (/tg.ml ') 4.43 ± 0.30 4.45 ± 0.32 4.50 ± 0.21 4.55 ± 0.17
Rb (ng.ml ') 120.00 ± 4.18 121.50 ± 1.80 115.32 ± 5.63 116.53 ± 3.12
Cs (ng.ml ') 1.45 ± 0.21 1.55 ± 0.22 1.48 ± 0.38 1.53 ± 0.15
* Values expressed as the mean ± standard deviation of 4 readings.
set 1 = fresh serum.
set 2 =  serum stored for IS days.
set 3 = serum stored for 1 month.
set 4 =  serum stored for 3 months.
Table 4.10 lists the results obtained for the 4 sets of data. A one way analysis of 
variance (ANOVA) test showed no significant differences, at the 95% confidence limits, 
between the results with F values ranging between 0.033 for B and 2.739 for Cu. This 
experiment shows that there is no risk of material loss or sample contamination from the 
storage procedures as long as the samples are prepared and analysed within a period of three 
months from the date of collection.
4.6 Overall Summary
In accordance with the operating conditions reconunended by Gray et al [Gray 
1987b], the dwell time and the scanned mass range were optimised in order to get the best 
detection limits for lithium. Using these settings, the extent of matrix interference was 
evaluated. The results showed that as little as a three fold dilution is enough to render non­
significant any possible signal suppression or enhancement. However, the presence of high 
levels of Cl, K and C in the samples caused the formation of polyatomic interferences that
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prevented the accurate determination of V, Cr, Mn and As. Sample preparation was needed 
in order to overcome the problem of signal deterioration caused by the high levels of solids 
in the serum. The described wet digestion method has proven to be suitable for the accurate 
and precise analysis of Li, B, Mg, Co, Fe, Cu, Zn, Se, Br, Rb, and Cs. Problems were, 
however, encountered with respect to Cd and Mo, due to their very low levels in serum. 
Finally, before any large scale serum study could be undertaken, the suitability of long term 
storage (up to 3 months) of the samples at -20 “C was investigated; no problems were 
associated with this process.
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5ÉÂSs;:sss:sss;s>^ ^* "-'''' . :'. . . Trace Elements Status in Skin Disorders
5.1 Introduction
After establishing a method for routine analysis of Li in blood serum, the main 
objectives of this study were to determine die levels of Li in the serum of 'healthy' subjects 
and to test whether or not these levels are affected by disease. In addition, another aim of the 
work was to look for possible statistically significant relationship between the concentrations 
of Li and any of the other elements that were determined. It is hoped that this work will 
highlight the potentials of ICP-MS for conducting research into the elemental interactions 
within such an important and complex biological matrix as blood serum.
In a recent publication, Li succinate ointment has been reported to be beneficial for 
the treatment of sebhorreic dermatitis [Boyle 1986]. In order to determine whether this effect 
is due to a repletion of a Li deficiency caused by the diseàse, skin disorders were chosen as 
study groups. The chosen disorders were atopic eczema, seborrhoeic dermatitis, acne, 
psoriasis, polymorphic light eruption, and photosensitivity dermatitis. This choice was 
supported by the well known relationship between minerals and skin disorders. In fact, there 
are many reports in the literature relating zinc to acrodermatitis enteropathica [Nelder 1975], 
copper to eczematous dermatitis [Barranco 1972], nickel and selenium to contact dermatitis 
[Smith 1937; Amor 1945; Bear 1973; Sunderman 1975] and cobalt, titanium and vanadium 
to skin lesions [Friberg 1979].
5.2 The Human Skin
The skin is one of the largest organs of the body in terms of surface area. 
Structurally, the skin consists of two principal parts epidermis and dermis. The epidermis is 
made up of various types of cells and forms the visible top layers of the skin. The dermis, 
on the other hand, is a thick, elastic layer beneath the epidermis. The dermis is made up of 
coimective tissues (fibres) which contribute to the strength and elasticity of the skin. It 
contains blood capillaries, nerves, hair follicles, dermal papillae and corpuscules of touch 
(Meissner's). Fibers from the dermis extend down into a subcutaneous layer called the 
hypodermis and anchor the skin to the underlying tissues and organs (Figure 5.1). Healthy 
normal skin has numerous functions which may be classified as follows:-
(A) Regulation of the body temperature: when the body is too hot, loss of heat is
increased through the evaporation of sweat and by the dilation of the capillaries in the
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Figure 5.1 Structure of the skin and underlying subcutaneous layer.
skin. When the body is too cold the capillaries contract and a layer of air is trapped 
over the skin by the erected hair.
(B) Protection: the skin is essentially a covering that protects the underlying organs from 
physical abrasion, bacterial invasion, dehydration, and ultraviolet radiation.
(C) Excretion: small amounts of water, salts and organic compounds are excreted through 
the skin.
(D) Perception of stimuli: the skin contains numerous nerve endings and receptors that 
detect stimuli related to temperature, touch, pressure and pain.
Synthesis of vitamin D: cholecalciferol, a precursor of vitamin D is produced by the 
action of sunlight on 7-dehydrocholesterol, which is widely distributed in the skin. 
(F) Immunity: antigens introduced into the skin are processed by the so-called Langerhans 
cells which deliver a sensitizing signal to the immune apparatus. This signal, in turn, 
triggers the appropriate response for the elimination of the respective antigens.
The skin is susceptible to all of the types of pathological disorders that affect other 
tissues. However, since it is more exposed to external factors such as heat, radiation, 
chemicals and other irritants, the skin may develop specific disorders such as the ones 
considered in the present study i.e. acne, atopic eczema, psoriasis, seborrhoeic dermatitis, 
polymorphic light eruption, and photosensitivity dermatitis.
5.2.1 Acne
This is a chronic skin disorder in which the sebaceous gland and hair follicles are the 
target organs. The disorder is characterized by an increased production of sebum (oil) from 
sebaceous glands and the formation of skin lesions, called comedones; the main affected areas 
are the face, upper back and the chest. Predisposing causes for acne include hereditary or 
familial tendencies and disturbances in androgen-oestrogen balance affecting the activity of 
the sebaceous glands.
Acne begins at puberty. At that time the increased secretion of androgen in both males 
and females causes an increase in the size and activity of the sebaceous glands. Should this 
be accompanied by the blockage of the ducts through which the sebum reaches the skin, there 
will be an accumulation of sebum which gradually becomes infected with skin micro­
organisms. This infection leads to the formation of comedones, the characteristic feature of 
acne [Cunliffe 1985; Buxton 1988].
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5.2.2 Atopic Dermatitis (AD)
This is a pathological disorder affecting the upper dermis and epidermis. It is 
characterized by extreme itching and scratching in individuals with inherently irritable skin. 
Although there may be allergic or psychological components, in about 70% of all cases there 
is a family history of the disease [Hanifm 1983].
In most cases, atopic eczema starts in infancy at about the age 3 or 4 months. The 
condition appears first as red areas, or papules, on tlie edge of the scalp, spreading to the face 
which soon erupt and start oozing or weeping. In some cases the eruption spreads all over the 
body [Kang 1987].
N.B. Atopic dermatitis is often called atopic eczema. This is mainly due to an early confusion 
witli regard to the usage of the terms 'eczema' and 'dermatitis'. Eczema is fundamentally a 
reaction to irritants. The term, however, was used at one time to describe cases of red, 
irritable, sore and itching skin caused by internal factors. Dermatitis, on the other hand, 
means inflammation of the skin and was used to describe the same above listed symptoms 
when they are due to external sources. Nowadays, the idea of dividing skin conditions in this 
way is recognized as being too simplistic and the trend is to regard the two terms as 
synonymous.
5.2.3 Psoriasis
A recurrent, genetically determined dermatitis consisting of discrete pink or dull red 
lesions surmounted by characteristic silvery scales. Lesions may become confluent, and 
although they are not persistent, they usually are chronic. The lesions appear most often on 
the scalp, knees, elbows, chest, back and buttocks. The cause of psoriasis is unknown, but 
it is believed to be strongly influenced by genetic factors [Buxton 1987].
Psoriasis is due to an abnormally high rate of mitosis in epithermal cells that may be 
related to a substance carried in the blood, a defect in the immune system or a virus [Krueger 
1984]. The rapid growth of cells in the affected area leads to the accumulation of young cells 
on the skin surface. Since young cells are more sticky than old ones, scales are produced. 
Furthermore, the blood vessels at the infected sites become more dilated than normal and the 
blood within them flows at an unusually fast rate. This increase in the blood supply to the 
infected skin explains why patches of psoriasis are red and bleed easily.
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5.2.4 Seborrhoeic Dermatitis (SD)
A usually mild though often chronic inflammatory condition of the skin. It is 
characterized by rounded irregular, or circinate lesions covered with yellowish or brownish- 
grey greasy scales. The main affected areas are the scalp, around the eyebrows, behind the 
ears, between the shoulders and other skin folds. The underlying cause of seborrhoeic 
dermatitis is not known, and although the hair and scalp may be excessively oily, there is still 
no known relation between this and the disorder [Br^m^ 1988].
5.2.4 Polymorphic Light Eruption (PLE)
A condition of the skin caused by an abnormal reaction to sunlight. Although the 
initial response may include itching, burning or tingling, the main characteristic of 
polymorphic light eruption (PLE) is the swelling and redness of the skin caused by the 
congestion of the capillaries near the surface. In the majority of cases, the eruption is confined 
to the exposed area (hands, arms, face, neck...). However, for unknown reasons, most of 
those with PLE only react on some of the exposed sites.
Results of T lymphocyte studies using monoclonal antibody techniques [Moncada 
1984] and the demonstration that the PLE reaction may involve injury to upper dermal 
venules mediated by T cells and Langerhans cells [Muhlbau^ 1983] provide some support 
for the involvement of immune mechanisms in PLE. However, the specificity of these 
findings awaits confirmation.
5.2.5 Photosensitivity Dermatitis (PD)
This is a disease related to inflammation of the skin caused by exposure to radiant 
energy. Unlike PLE, the reaction of the skin in PD is due to exogenous factors which 
stimulate immunological and non-immunological responses [Frain-Bdl 1985]. This type of 
dermatitis affects mainly the middle-aged and elderly male. The areas of the skin particularly 
affected are those of the forehead, the nose, the cheeks, the upper end of the stemo-mastoid 
muscle, the rim of the pinnae, the balding scalp, and the back of the neck.
Several contact allergens have been reported to exacerbate PD. These include plants 
[Thune 1980] and fragrance materials [Addo 1982]. The mode of action of these allergens is 
not known. Koshevar suggested that endogenous sources may cause protein oxidisation which 
sensitises the immune system and triggers the allergic response [Koshevar 1979]. Giannelli
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et al, on the other hand, suggested that the contact allergens together with radiant energy can 
trigger free radical-lipid peroxidation reactions. Should the cells of the skin fail to prevent 
such reactions from taking place, skin inflammation (PD) will be observed [Gianndli 1983].
5.3 Sample Collection and Analysis
Blood samples were collected from 16 centres in the UK and Finland. Standard sets I
of needles, syringes and tubes were used by all centres. Whole blood was taken in a 10 ml j
Stardest syringe fitted with an 18 gauge needle. Blood was then placed in a 10 ml Stardest !
tube with coagulation beads and inverted several times. After the blood had clotted the serum 
was removed using a disposable tip-end pipette and placed in a 5 ml Stardest tube for freezing 
prior to analysis.
Seven hundred and ninety three samples were collected over a period of 12 months 
and were sent, in batches, to the university. The patients (130 acne, 154 AD, 100 SD, 170 
psoriasis, 24 PLE, 19 PD) were of either sex, aged 16 to 65, and with well defined classical 
dermatoses. Their disease was diagnosed by senior dermatologists and was in active 
inflammatory form at the time of collection. For all patients the duration of condition, overall 
severity, infected body area and medication were recorded. Control volunteers (196 subjects) 
on the other hand, were of either sex, aged 16-65, had no history of skin disease and were 
not suffering from any inflammatory disorder at the time of blood sampling. In order to 
ensure that the study was double blind, no indication about the origin of the samples was 
made available until the end of the study.
During the period of collection, a 600 ml serum pool was made up, frozen and 
lyophilized before being irradiated with a Co source (dose of " 3.6 Mrad) in order to prevent 
bacterial growth. Ten samples of this pool, together with 3 samples of second generation 
serum reference material were then wet digested and analyzed. The results of the analysis are 
listed in Table 5.1.
The collected serum samples were prepared and analyzed in batches. Each batch 
consisted of 2 samples from the serum pool, 19 serum samples and 3 deionised water 
samples. The deionised water was used as a reagent blank, whilst the serum pool samples 
were utilised for testing quality control (batch inspection). The data from each batch were 
accepted only if the two results for the serum pool samples were within ± 1.96 cr of the mean
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value reported in Table 5.1. When the data did not meet this criterion, other specimens from 
the individual samples were prepared and analyzed. This procedure was repeated until either 
the first criterion was met or insufficient material remained, in which case the samples were 
rejected.
Table 5.1 Elemental levels of pooled serum and second generation serum reference material
Element Pooled Serumf Second Generation Serumt
Li (ng.g ‘) 8.0 ±  0.5 14.6 ±  2.1
B (ng.g‘) 173 ±  35 224 ±  19
Mg (Mg.g *) 181 ±  5 183 ±  7
Co (ng.g ‘) 9.7 ±  0.6 3.6 ±  0.5
Cu Otg.g ') 11.4 ±  0.6 11.0 ±  0.6
Zn Oig.g ') 8.5 ±  0.4 9.7 ±  0.6
Se Otg.g') 1 ±  0.18 1.04 ± 0.10
Br Otg.g ') 37 ±  2 47.2 ± 2.7
Rb (jig.g') 1,46 ±  0.03 1.61 ± 0.15
Cs (ng.g ') 6.6 ±  0.5 10.2 ±  0.9
t  based on 10 determinations 
t  based on 3 determinations
Figure 5.2 shows that the accurate determination of B could not be carried out 
routinely. The results for the serum pool varied dramatically on a day to day basis. This may 
be due to the fact that the ICP-MS instrument used in this work was not dedicated solely for 
the analysis of biological materials, but was also used for the analysis of geological samples 
and matrices rich in B. This indiscriminate introduction of various matrices to the ICP-MS 
often resulted in the contamination of the internal lines of the machine with B. Thus, the 
accuracy of the B results depended mainly on the nature of the materials analyzed preceeding 
the analysis of the serum.
In the case of Co, the observed levels ranged between ^  0.2 and 0.7 ng.ml \  
However, since the results for 74% of the samples were below the detection limits, i.e. 0.2 
ng.ml ', no further statistical evaluation of the data was conducted.
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Figure 5.2 Relative concentration of B in pooled serum as determined on various working days
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5.4 Results and Discussion
5.4.1 Studio on Healthy Subjects
5 A. 1.1 Reference levels o f Lithium in serum
The results from the analysis of 196 samples, collected from 'healthy' subjects, 
showed that the Li data did not fit in a normal distribution. Hence, a more informative format 
of statistical presentation is to report the range, median and quaitiles. Table 5.2 lists the 
minimum, lower quartile, median, upper quartile and maximum concentration detected. These 
levels are in good agreement with the more recent data reported in the literature (Chapter II, 
Table 2.9).
Table 5.2 Elemental levels in the serum of 187 'healthy* individuals.
Element Mean ± SD Minimum Lower
Quartile
Median Upper
Quartile
Maximum
Li (ng.ml *) 1.2 ± 0.9 <  0.2 0.6 0.9 1.4 10.8
Mg Og.ml'*) 19.5 ±  3.7 9.9 17.6 19.3 21.2 34.6
Cu (Atg.ml ‘) 1.1 ±  0.3 0.5 0.9 1.0 1.3 2.5
Zn (/ig.ml *) 0.8 ± 0.3 0.3 0.6 0.8 0.9 2.4
Se (jxg.wl'^) 0.09 ±  0.04 < 0.04 0.06 0.08 0.11 0.22
Br (/ig.ml *) 5.0 ±  3.0 0.9 2.6 4.3 6.7 15.3
Rb (ng.ml ‘) 165 ±  54 56 127 165 192 397
Cs (ng.ml ‘) 0.7 ±  0.4 < 0.2 0.4 0.6 0.9 2.4
The spread of the Li concentrations over a wide range have also been reported by 
Moynier et al [Moynier 1987]. This might be due to nutritional factors since, as reported by 
studies on manic patients, serum Li increases directly with Li intake. Because no information 
on the nutritional habits of the subjects were available, it was hoped that the geographical 
locations from which the samples were drawn could be used as indicators of these habits. The 
samples were, therefore, classified according to the collection centre and a one-way analysis 
of variance between the various centres was undertaken. No significant differences were 
observed at the 95% confidence levels. This, together with the fact that the result of this 
study, conducted on a British and a Finish population, agree with the published results of 
studies on Soviet and French subjects (Chapter II, section 2.5), reflect no statistical 
relationship between serum Li and geographical location.
The possibilities of age and sex differences were also investigated. Figures 5.3 and
5.4 are box plots for the Li distribution by sex and age groups. Statistical analysis, one-way
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Figure 5.3 Effects of sex on the concentration of Li in serum, (A) maximum, (B) upper quartile, (C) 
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Figure 5.4 Effects of age on the concentration of Li in serum
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analysis of variance, showed no significant differences between the various groups at the 95% 
confidence limits.
5.4.1.2 Other elements
Data for the other elements determined in this study are also presented in Table 5.2. 
The results are in good agreement with the literature values surveyed in Chapter II. 
Multivariate analysis of variance (MANOVA) tests were conducted in order to determine 
possible variations (95% confidence level) with age, sex and geographical location. To 
describe the results of these tests, each element will be considered separately.
Magnesium: The levels of Mg in blood serum appear not to be affected significantly with 
variations in age, sex or geographical locations. This is clearly demonstrated in Figures 5.5 
to 5.7. The immunity of serum Mg against the above mentioned factors is not surprising since 
the element plays a major role in regulating metabolic activities e.g. protein synthesis and 
intracellular fluid regulation, and thus its levels in serum are homeostatically controlled.
Copper: Significant differences, at the 99% confidence limits, were observed in the levels of 
Cu between males and females (Figure 5.8). A large population of the female subjects had 
their serum Cu elevated above 'normal*. A reason for this elevation is the possibility that 
these subjects were using the combined oestrogen-progestogen type of oral contraceptives. It 
is well established that the oestrogen component of these contraceptives is responsible for an 
increase in the serum copper concentrations [SmiÜi 1976, Vir 1981]. Apart from this 
observation, there were no statistically significant effects that could be attributed to either age 
or geographical location. Although some authors have reported an age related increase in the 
concentration of Cu in the serum of male subjects (chapter II, section 2.4), such an effect was 
not observed in this study.
Zinc: In agreement with the reported findings in Chapter II (section 2.4), the levels of Zn did 
not vary significantly with either sex or geographical location. Furthermore, there were no 
significant differences between the various age groups. A possible reason for not observing 
the well documented decline in serum Zn after an age of ’ 60 years is the limited number of 
subjects above that age.
113-
Mg concentration (mg/l)
Females
Sex
Figure 5.5 Effect of sex on the concentration of Mg in serum
Mg concentration (mg/l)40
30
20
10
Males
Under 20 Adult 21-40 Adult 41-60
Age groups
Over 60
30
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Selenium'. Naturally, the soil and forage crops of Finland are Se depleted [Oksanen 1970, 
Koljonen 1975]. As a result, it has been known for a long time that the levels of Se in the 
blood of Finnish people were low [Westermarck 1977]. In 1979, Shamberger et al reported 
an inverse relationship between the content of Se in the blood of humans and the mortality 
rate from both cardiovascular diseases and cancer [Shamberger 1979]. Consequently, as a 
preventive measure against Se deficiency, all agricultural multi-nutrient fertilizers in Finland 
were, as from the autumn of 1984, supplemented with sodium selenate in an attempt to 
elevate the Se content of the domestic agricultural products. As reported by Eurola et al, 
these procedures were effective in elevating the average selenium intake per person from 25 
/ig per day, in 1975, to 124 per day in 1989 [Eurola 1991]. Figure 5.9 shows that the 
levels of Se in the serum of the Finnish population included in this study are significantly 
higher than their British counterparts. This is in line with the fmdings of a recent report by 
the Food and Agriculture Organisation of the United Nations where the levels of Se in 
Finnish agricultural and dairy products were significantly higher that those in Scottish 
products (whole wheat: 174 as compared to 23 /ig.kg '; potatoes 88 as compared to 6 jug.kg ^ ; 
milk 305 as compared to 115 /ig.kg'*) [Kumpulainai 1989]. These findings suggest that 
fertilizer supplementation should be monitored closely, because otherwise, the project might 
defeat its original purpose and instead of avoiding Se deficiency such addition might, in the 
long run, elevate the Se concentration to toxic levels.
In addition to differences between Finnish and British populations. Figure 5.9 shows 
that the levels of Se in subjects from Edinburgh and Durham, are relatively high compared 
to those from Cornwall. Whether this is due to variations in the Se content of the soil in the 
UK, or to a difference in the sources or nature of consumed dietary products remains to be 
discovered. Finally, no significant differences could be observed in relation to sex or age. 
This is in accordance with the findings of several published reports on this subject (Chapter 
n, section 2.4). The reported trend that the concentration of Se in serum increases with age 
up to maturity could not be tested since all the subjects were above that age.
Bromine'. Figure 5.10 shows differences in the Br levels between centres. These differences 
are statistically significant at the 95% confidence limits. This might be due to the fact that the 
levels of Br in body fluids are directly related to dietary intake which can vary widely 
especially when organic Br compounds are used as fumigants for soils or stored grains 
[Undawood 1977]. Furthermore, it has been reported that due to the use of bromine
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compounds as additives in petrol, the level of Br in city environments is very much higher 
than that in urban ones [Oe 1981]. Such a difference might in turn affect the levels of Br in 
humans. Wielopolski et al reported significant differences in the serum Br levels between 
residents of three cities on the Pacific coast (Rongelap: 12.54 ±  3.16; Majuro: 9.63 ± 2.31; 
New York: 6.39 ± 1.67 /ig.ml ‘) [Wielopolski 1986]. It was suggested, in the report, that the 
increase in the concentration of Br was related to dietary intake since it was found that for 
Marshallese people the daily intake of Br from coconuts was 3 times higher than the 
recommended intake set by the World Health Organisation (WHO).
Rubidium: Significant differences in the concentration of Rb in serum were observed between 
centres (Figure 5.11). As reported by Mervyn, "Foods vary tremendously in their content of 
rubidium and blood levels reflect the amounts taken in the diet" [Mervyn 1989]. It is possible, 
therefore, that the observed differences are due to regional dietary variability. The normal 
daily intake of Rb has been reported by the above mentioned author, to vary between 3 and 
6 mg for UK residents and around 4.2 mg for residents of Finland. Further tests showed no 
statistically significant variations in Rb levels with either sex or age.
Caesium: Statistical analysis showed that serum Cs did not vary significantly with either age
or sex. However, statistically significant differences were observed between centres. Figure 
5.12 shows that the concentration of Cs in the serum of subjects from Bristol is relatively 
high. Although this might be due to dietary habits, this is very difficult to confirm since there 
is still a lack of information on Cs especially with regard to its content in foodstuff and its 
daily intake by humans. Another possible source of variability is haemolysis. If the personnel 
in charge of sample collection were careless during serum separation, a slight haemolysis 
might result in an elevation of Cs levels. This could be particularly pertinent as the Cs content 
of packed cells is about 7 times higher than that of serum [Tjioe 1977].
5.4.1.3 Inter-element interactions
It has been known for a long time that, in biological systems, trace elements interact 
between each other [Schutte 1964]. These interactions can lead to either enhancement 
(synergism) or depression (antagonism) of their overall biological effects. The modes of action 
of these interactions are thought to be via [Da Silva 1978]:-
(A) Substitution in active sites in enzymes e.g. Hg replacing Fe in thioiate groups.
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(B) Replacement of certain groups in biological molecules e.g. arsenate or selenate 
competing with phosphate due to similar properties of dimension, charge and shape.
(C) Complexation or precipitation of the metals of metallo-enzymes or other important 
groups e.g. A1 or Ge ions which can precipitate the phosphate group, and Fe ions 
which complex adenosine tri-phosphate (ATP).
(D) Replacement of elements with electrochemical roles e.g. bromide competition with 
chloride.
Typical examples of these interactions in human systems are: (a) the depression of Zn 
toxicity effects in the presence of high Cu, because the Cu restores the activity of hepatic 
cytochrome oxidase (a copper metallo-enzyme) which was depressed by the high levels of Zn; 
and (b) the exaggeration of Zn deficiency effects with increased levels of dietary Ca which 
cause the formation of insoluble Ca-phytate-Zn complexes that are poorly absorbed in the 
intestine [Davi^ 1972].
Inter-element interactions are usually observed when the concentration of a certain 
element exceeds or falls below a given level. Therefore, in this section it was not expected 
to discern clear trends since most of the determined concentrations were within the reference 
ranges and not sufficiently extreme to trigger off interactions.
Table S.3 Bartlett's test of sphericity for healthy subjects.
Determinant =  0.36090
Bartlett test of sphericity =  143.19218 with 28 D.F.
Signihcance =  0.000
In order to test whether there are significant correlations between the determined 
elements, Bartlett's test of sphericity and principal components analysis were conducted in 
preference to Pearson's correlations. This is because in the latter case the large number of 
tests, correlating each element to all the others, increases the chances of observing statistically 
significant correlations which may not be true. The results of the Bartlett's test are listed in 
Table 5.3. Since the observed significance level is very small, the hypothesis that the elements 
are independent is rejected. Furthermore, Table 5.4 shows that each element loads highly on 
only one of the components, which suggests that none of these elements is highly correlated 
with the others. These findings i.e. that elements are dependent but not highly correlated to 
each other, were expected as explained previously.
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Table 5.4 Rotated correlations between components and dependent variables.
Variables
Components
1 2 3 4 5 6 7 8
Li 0.0516 0.0313 -0.0289 0.9900 0.0563 -0.0567 -0.0240 -0.0922
Mg 0.0540 0.0317 0.0377 0.0611 0.9652 0.1252 0.1729 0.1172
Cu 0.0041 0.0410 0.9821 -0.0305 0.0360 0.0567 0.1637 0.0388
Zn -0.0187 0.9854 0.0407 0.0321 0.0298 -0.0160 0.0523 0.1488
Se -0.0498 0.0586 0.1827 -0.0273 0.1827 0.1450 0.9473 0.0906
Br 0.0989 -0.0165 0.0586 -0.0599 0.1228 0.9724 0.1348 0.0638
Rb 0.2171 0.1732 0.0443 -0.1089 0.1272 0.0701 0.0941 0.9376
Cs 0.9717 -0.0202 0.0033 0.0556 0.0518 0.0985 -0.0467 0.1941
5.4.2 Studies on Skin Disorders
5.4.2.1 Effects o f disease on serum elemental levels
In order to test for significant variations in the concentration of the elements measured 
between the 7 groups ('healthy' and the 6 disease groups), a MANOVA test was conducted. 
The model was set up such that the previously observed elemental differences between centres 
were taken into consideration. Table 5.5 lists the results for this test. These results indicate 
that the concentration of Li in serum varies significantly in cases of skin disorders. A 
statistical summary of the Li data is presented in Table 5.6. This summary together with a 
median test revealed that subjects with PLE have significantly lower levels of serum Li than 
'controls'. The implications of this observation are difficult to interpret especially since there 
is a lack of knowledge regarding both the etiology of PLE and the mechanisms of action of 
endogenous Li. Available literature reports with regard to the relationship between Li and 
skin disorders concentrate mainly on the aggravation of psoriasis in patients undertaking Li 
treatment for mania [Gupta 1987]. Whilst this exacerbation of psoriasis could not be attributed 
to immunological reactions to Li [Sasaki 1989], Holy and Nejdekova suggested that the effect 
is caused by a Li inhibition of adenyl cyclase in the cell membrane which leads to the 
reported decrease in the activity of cyclic adenosine mono-phosphate (cAMP) during psoriasis 
[Holy 198Q. Further research with regard to the influence of Li on health is required in order 
to achieve a greater understanding of the observed effect of PLE on serum Li.
Tables 5.5 and 5.7 show clearly that the studied diseases do not affect significantly 
the levels of Mg in serum. Although low serum Mg has been reported in various disorders 
e.g. idiopathic epilepsy, congestive heart failure, and alcoholic cirrhosis [Panday 1988], the 
element has not been previously related to skin problems. However, this does not preclude
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the possible physiological role of Mg in relation to skin diseases especially since Mg^  ^ is a 
co-factor in the activation and formation of cAMP [Aikawa 1976],
Table 5.5 MANOVA test for differences in the concentration of 
some elements in serum due to skin disorders.
Variable F-value level of 
Significance
Li 1.617 0.024
Mg 1.087 0.348
Cu 2.142 0.001
Zn 1.129 0.297
Se 1.651 0.024
Br 2.932 0.000
Rb 1.121 0.306
Cs 1.578 0.030
Table 5.6 Concentration of Li in serum of patients from various disease groups (ng.ml ‘).
Disease Mean ± SD Minimum Lower
Quartile
Median Upper
Quartile
Maximum
Acne 1.4 ± 1.1 0.1 0.6 1.1 1.7 9.4
Atopic dermatitis 1.4 ±  1.3 0.1 0.5 1.1 1.8 7.2
Normal 1.2 ±  0.9 0.1 0.6 0.9 1.4 6.2
Photodermatoses 0.8 ± 0.7 0.1 0.4 0.5 1.1 2.6
Polymorphic light 0.7 ±  1.7 0.1 0.1 0.4 0.6 8.7
Psoriasis 1.2 ± 0.9 0.1 0.6 1.0 1.5 8.2
Sebherroic dermatitis 1.7 ±  1.6 0.1 0.9 1.2 2.0 8.6
Total 1.3 ±  1.2 0.1 0.6 1.0 1.6 9.4
The concentration of Cu in the serum of patients with AD or psoriasis was 
significantly higher than that of the 'controls' (Tables 5.5 and 5.8). This observation is in 
agreement with the findings of Hinks et al and Dogan et al [Hinks 1987; Dogan 1989] but 
not with those of Di Toro et al who reported no significant difference in serum Cu between 
21 children with AD and 19 'healthy* children pDi Toro 1987]. It is worth mentioning, 
however, that unlike the first two studies where the reported mean serum Cu concentration 
for 'controls' was comparable to the value obtained in this study (Table 5.2), the mean value 
reported by Di Toro and his co-workers was relatively high (1.29 ± 0.08 //g.ml ‘). Hinks et 
al attributed the serum Cu elevation to the inflammatory condition associated with the two 
above mentioned disorders. However, Dogan et al reported that an observed low activity of 
superoxide dismutase in psoriatic polymorphonuclear leucocytes deposited in the epidermis
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may increase the levels of free oxygen radicals. This in turn will cause an increase in 
ceruloplasmin levels in order to provide an increased antioxidant activity against the leakage 
of these free radicals into the extracellular space. Since Cu bound to ceruloplasmin accounts 
for 90 to 95 % of serum Cu, an increase in the enzyme's activity will cause an elevation in 
the concentration of Cu in serum.
Table 5.7 Concentration of Mg in serum of patients from various disease groups (/tg.ml ').
Disease Mean ± SD Minimum Lower
Quartile
Median Upper
Quartile
Maximum
Acne 19.6 ± 4.0 7.3 17.6 19.6 22.3 27.7
Atopic dermatitis 19.2 ± 3.6 11.2 16.8 19.2 21.3 32.9
Normal 19.5 ± 3.7 9.9 17.6 19.3 21.2 34.6
Photodermatoses 19.3 ± 3.5 14.5 16.1 18.9 22.0 28.0
Polymorphic light 19.5 ± 2.9 10.8 17.9 19.1 22.3 23.8
Psoriasis 19.4 ± 3.9 10.5 17.0 19.3 21.7 31.7
Sebherroic dermatitis 19.7 ± 3.2 11.5 17.6 19.9 21.7 29.0
Total 19.5 ± 3.7 7.3 17.5 19.4 21.7 34.6
Table 5.8 Concentration of Cu in serum of patients from various disease groups (jixg.ml ').
Disease Mean ±  SD Minimum Lower
Quartile
Median Upper
Quartile
Maximum
Acne 1.04 ± 0.34 0.37 0.82 1.01 1.19 2.77
Atopic dermatitis 1.30 ± 0,46 0.52 1.01 1,21 1.48 2.92
Normal 1.10 ± 0.34 0.49 0.87 1.03 1.25 2.49
Photodermatoses 1.09 ± 0.18 0.71 0.95 1.15 1.19 1.39
Polymorphic light 1.13 ± 0.30 0.65 0.90 1.13 1.27 1.91
Psoriasis 1.20 ± 0.44 0.47 0.92 1.13 1.36 3.57
Sebherroic dermatitis 1.07 ± 0.33 0.59 0.84 1.03 1.23 2.13
Total 1.14 ± 0.39 0.37 0.89 1.07 1.29 3.57
Tables 5.5 and 5.9 show no significant differences in serum Zn between the 7 groups. 
However, whilst inspecting the data for each centre it was observed that, for subjects from 
Dundee, patients with AD and psoriasis had significantly lower serum Zn than 'controls' 
(Table 5.10). Owing to this discrepancy it is difficult to adequately interpret the results. It has 
been known for a long time that Zn deficiency causes skin lesions e.g. erythrematosquamous 
eruption [Wiesmann 1978] and acrodermatitis enteropathica [Moynahan 1974]. However, to 
date there are still two major areas of research (a) the effects of skin disorders on the Zn 
levels in the body, and (b) the role of Zn in controlling the extent and the severity of the
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disease. With regard to the former question, several authors argue that since the epidermis 
is rich in Zn and a considerable amount of this Zn is lost as a result of skin infection, Zn 
deficiency should be expected [Michadlsson 1984]. Whilst this hypothesis is supported by 
reports on lower serum or plasma Zn in psoriasis [McMillan 1983], AD [David 1984], and 
acne [Rebdlo 1986], many authors did not observe such variations [Cimmino 1986; Dreno 
1986; Di Toro 1987; Hinks 1987; Lamg 1990]. Furthermore, should this hypothesis be true, 
a correlation between serum Zn and the severity of the disease will be expected; this study 
confirms the fmdings of David et al where no such correlation was observed [David 1984]. 
These conflicting observations may be due to the fact that serum Zn is not a valid indicator 
of tissue Zn levels and that 'normal' serum Zn does not preclude tissue Zn depletion 
[Garretts 1977; Solomons 1979]. Unfortunately, no more reliable index of body Zn status has 
yet been established. With regard to the latter question, oral Zn supplementation has been 
reported to be beneficial in reducing the symptoms of psoriasis, acne and dermatitis 
[Clemmensen 1980; Dreno 1989; Heimburger 1990]. Some of the suggested mode of actions 
of Zn are increasing the serum levels of retinol binding proteins [Midiaelsson 1977]; 
interactions with essential fatty acids where Zn appears to be required for normal conversion 
of linoleic acid to gamma-linoleic acid [Horrobin 1980]; and inhibition of the production of 
free fatty acids [Shalita 1974]. The results of fliis work clearly suggest the presence of other 
factors associated with skin disorders and which can cause serum Zn depletion. These factors 
could not be related to the severity of the disorder nor to the sex or age of the patients.
Table 5.9 Concentration of Zn in serum of patients from various disease groups (/tg.ml *).
Disease Mean ±  SD Minimum Lower
Quartile
Median Upper
Quartile
Maximum
Acne 0.87 ± 0.48 0.33 0.61 0.81 0.93 4.04
Atopic dermatitis 0.80 ± 0.27 0.31 0.58 0.76 0.90 1.75
Normal 0.80 ± 0.26 0.32 0.64 0.77 0.90 2.40
Photodermatoses 0.87 ± 0.17 0.60 0.73 0.84 1.00 1.20
Polymorphic light 0.89 ± 0.26 0.37 0.78 0.88 1.14 1.30
Psoriasis 0.87 ± 0.71 0.41 0.69 0.80 0.96 9.19
Sebherroic dermatitis 0.84 ± 0.52 0.34 0.63 0.81 0,93 5.16
Total 0.84 ± 0.46 0.31 0.64 0.80 0.93 9.19
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Table 5.10 Concentration of Zn in serum of patients from Dundee Oig.ml ').
Disease Mean ±  SD Minimum Lower
Quartile
Median Upper
Quartile
Maximum
Acne 0.68 ± 0.18 0.37 0.64 0.74 0.83 0.84
Atopic dermatitis 0.55 ± 0.16 0.31 0.42 0.56 0.67 0.80
Normal 0.92 ±  0.16 0,67 0.80 0.90 1.00 1.30
Photodermatoses 0.87 ± 0.17 0.60 0.73 0.84 1.00 1.20 ;
Polymorphic light 0.89 ± 0.26 0.37 0.78 0.88 1.14 1.30 1
Psoriasis 0.65 ± 0 .1 1 0.47 0.57 0.67 0.73 0.77 !
Sebherroic dermatitis 0.68 ±  0.19 0.37 0.55 0.70 0.81 1.00
Total 0.84 ±  0.46 0.31 0.64 0.80 0.93 9.19
Table 5.11 Concentration of Se in serum of patients from various disease groups (/ig.ml'^).
Disease Mean ±  SD Minimum Lower
Quartile
Median Upper
Quartile
Maximum
Acne 0.08 ±  0.04 0.01 0.06 0.08 0.11 0.20
Atopic dermatitis 0.08 ±  0.04 0.01 0.06 0.08 0.10 0.20
Normal 0.09 ± 0.04 0.01 0.06 0.08 0.11 0.22
Photodermatoses 0.09 ± 0.02 0.06 0.08 0.08 0.09 0.15
Polymorphic light 0.08 ±  0.02 0.06 0.07 0.07 0.10 0.14
Psoriasis 0.08 ±  0.04 0.01 0.06 0.07 0.10 0.22
Sebherroic dermatitis 0.09 ±  0.03 0.01 0.07 0.08 0.10 0.19
Total 0.09 ±  0.04 0.01 0.06 0.08 0.10 0.22
The data in Table 5.5 indicate that there is a significant difference in serum selenium 
between the various groups. This difference, however, is not clearly observed in Table 5.11, 
A possible explanation of the latter remark can be drawn from the work of Fairris et al who 
reported that Se supplementation to patients with psoriasis and AD caused the elevation of 
their blood Se up to the 'normal' levels with no subsequent effect on the severity or extent 
of the disease [Fairris 1989a, 1989b]. Since the subjects from Finland had elevated serum Se 
due the supplementation of Finnish fertilizers with Se, the inclusion of the data from the 
Finnish population in Table 5.11 may have masked potential deficiencies in other subjects. 
When the data from Finland was ignored, one way analysis of variance together with Tukey 
honestly significant tests showed a significant decrease in serum Se for the AD and psoriasis 
groups. This is in line with the findings of other authors [Hinks 1987; Corrocher 1989, 
Fairris 1989b]. The exact reason for the low Se is not clear, it may be due to a low intake, 
decreased absorption, or increased losses from the skin [Micfaaelsson 1989]. However, since 
Se is an essential constituent of the enzyme glutathione peroxidase, a low Se concentration
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may mean a reduction in the activity of the enzyme. Furthermore, because glutathione 
peroxidase play a major role in the metabolic destruction of peroxides [Shamberger 1984], 
a reduction in its activity might be the reason for the reported accumulation of lipid peroxides 
on the psoriatic skin [Zadorozhny 1973; Dogan 1989].
Significantly lower levels of Br in the serum of patients with acne can be observed 
in Table 5.12. Further investigations, e.g. analysis of other body tissues or in-depth study of 
the biochemistry of Br, are needed since there is a limited knowledge regarding the biological 
functions of Br. Furthermore, since studies on healthy subjects suggested a possible 
relationship between exposure and serum levels [Duvaldestin 1977], social and psychological 
factors which can limit the exposure of the patients to exogenous Br could be important.
Table 5.12 Concentration of Br in serum of patients from various disease groups (jag.ml ').
Disease Mean ±  SD Minimum Lower
Quartile
Median Upper
Quartile
Maximum
Acne 3.6 ±  2.7 0.9 1.9 2.8 4.4 23.2
Atopic dermatitis 4.2 ±  2.2 1.1 2.7 3.6 5.6 12.1
Normal 5,0 ±  3.0 0.9 2.6 4.3 6.7 15.3
Photodermatoses 5.8 ± 3.4 1.6 3.3 4.6 7.6 13.5
Polymorphic light 6.1 ±  2.6 2.1 4.2 6.1 7.2 11.5
Psoriasis 4.3 ±  2.7 0.8 2.5 3.6 5.7 20.9
Sebherroic dermatitis 4.3 ±  2.1 1.2 2.5 3.8 5.8 12.5
Total 4.4 ±  2.7 0.8 2.4 3.7 5.8 23.2
Data from Tables 5.5 and 5.13 show no significant variations in serum Rb. The 
element is not known to be essential and there are no indications that it might be related to 
skin problems.
Patients suffering from acne and AD were found to have significantly lower Cs levels 
than 'controls' (Tables 5.5 and 5.14). As with Br, it is very difficult to interpret this result 
since there is a lack of information regarding the physiological and biochemical roles of Cs.
-126-
Table 5.13 Concentration of Rb in serum of patients from various disease groups (ng.ml ').
Disease Mean ± SD Minimum Lower
Quartile
Median Upper
Quartile
Maximum
Acne 148 ± 49 64 113 139 179 408
Atopic dennatitis 163 ± 97 62 111 148 191 900
Normal 165 ± 54 56 127 165 192 397
Photodermatoses 191 ± 58 114 152 171 256 304
Polymorphic light 186 ± 46 94 162 186 204 292
Psoriasis 163 ± 65 46 112 158 204 357
Sebherroic dermatitis 178 ± 83 69 122 164 211 687
Total 164 ± 69 46 118 156 195 900
Table 5.14 Concentration of Cs in serum of patients from various disease groups (ng.ml ').
Disease Mean ±  SD Minimum Lower
Quartile
Median Upper
Quartile
Maximum
Acne 0.5 ± 0.3 0.1 0.3 0.4 0.6 2.2
Atopic dermatitis 0.5 ±  0.3 0.1 0.3 0.5 0.6 1.8
Normal 0.7 ±  0.4 0.1 0.4 0.6 0.9 2.4
Photodermatoses 0.8 ±  0.3 0.1 0.6 0.8 1.0 1.4
Polymorphic light 0.7 ±  0.3 0.1 0.6 0.6 0.9 1.7
Psoriasis 0.6 ±  0.4 0.1 0.4 0.6 0.8 2.3
Sebherroic dermatitis 0.7 ±  0.4 0.1 0.4 0.6 0.9 2.0
Total 0.6 ±  0.4 0.1 0.4 0.6 0.8 2.4
5.4.2 Inter-element Interactions
The results from principal components analysis for the six disease groups are listed 
in Tables 5.15 to 5.20. The data show that no significant correlations could be observed for 
acne, AD, psoriasis, PLEand SD. However, for patients with PD , Table 5.20 shows that 
some elements load on more than 1 component which suggest possible interactions between 
these elements. Pearson correlation test identified significant relationships (at the 99% 
confidence limits) between Li and Br (Figure 5.13), and between Mg and Cu (Figure 5.14). 
Such relationships have not been previously reported, and it is possible that this observation 
is due to the limited number of samples in the study group.
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Table 5.15 Rotated correlations between components and dependent variables (AD).
Variables
Components
1 2 3 4 5 6 7 8
Li 0.01894 -0.01815 -0.05562 -0.13475 -0.13268 0.13217 0.97108 -0.00102
Mg -0.00239 0.06049 0.08354 -0.06489 0.04578 0.98220 0.12782 0.04474
Cu 0.00036 0.98015 0.10789 -0.03235 0.01663 0.06064 -0.01751 0.14951
Zn 0.04285 0.01648 0.00760 -0.01755 0.98875 0.04488 -0.12548 0.04624
Se 0.13433 0.11421 0.95988 0.01538 0.00759 0.08899 -0.05779 0.18969
Br 0.01337 -0.03160 0.01523 0.98272 -0.01802 -0.06499 -0.13030 0.10644
Rb 0.96577 -0.00170 0.13085 0.01192 0.04500 -0.00367 0.01937 0.21820
Cs 0.26968 0.19026 0.22643 0.13591 0.05889 0.05567 -0.00082 0.90264
Table 5.16 Rotated correlations between components and dependent variables (Acne).
Components
Variables 1 2 3 4 5 6 7 8
Li 0.08134 0.00106 -0.02681 0.01981 -0.06856 0.99095 0.01239 0.07366
Mg 0.34041 0.00073 0.14359 0.15459 -0.12398 0.09482 0.10855 0.89636
Cu 0,93018 0.02162 0.16689 0.02921 -0.08003 0.09496 0.03341 0.29842
Zn 0.02916 0.01927 0,02123 0.99037 0.00776 0.01968 0.06000 0,11597
Se 0.15573 0.00079 0.96043 0.02294 0.12934 -0.02998 0.14262 0.12176
Br -0.07449 0.12319 0.12471 0.00797 0.97090 -0.07291 0.07440 -0.10077
Rb 0.03765 0.31304 0.16053 0.07295 0.08257 0.01524 0.92315 0.10118
Cs 0.01929 0.95012 -0.00322 0.01943 0.12928 0.00078 0.28247 -0.00159
Table 5.17 Rotated correlations between components and dependent variables (SD).
Components
Variables 1 2 3 4 5 6 7 8
Li -0.04996 -0.09216 -0.08966 0.19525 0.96470 0.00858 -0.04252 -0.10164
Mg 0.08010 -0.05303 0.11793 0.09134 0.01053 0.94743 0.25854 0.06286
Cu 0.02225 0.08017 0.13976 -0.03704 -0.04538 0.25866 0.94720 0.07760
Zn -0.00350 -0.04027 -0.06660 0.97111 0.19120 0.08404 -0.03283 0.07857
Se 0.08094 0.00030 0.97512 -0.06633 -0.08720 0.11006 0.12977 -0.04047
Br 0.06666 0.98023 0.00062 -0.04011 -0.08805 -0.04688 0.07120 0.13445
Rb 0.95021 0.06950 0.08974 -0.00697 -0.04935 0.07826 0.02111 0.27415
Cs 0.30838 0.16153 -0.05014 0.09205 -0.11514 0.06809 0.08496 0.91799
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Table 5.18 Rotated correlations between con^onents and dependent variables (Psoriasis).
Variables
Components
1 2 3 4 5 6 7 8
Li -0.00088 -0.01328 0.99292 -0.07185 0.04376 0.02418 -0.04372 -0.06603
Mg -0.00495 0.00384 0.04508 0.10346 0.98394 -0.04586 0.11912 0.05296
Cu -0.03738 -0.01957 -0.04447 0.03412 0.11767 0.06969 0.98791 0.02041
Zn -0.03875 -0.03785 0.02409 -0.03623 -0.04440 0.99425 0.06828 0.00012
Se 0.01116 0.08480 -0.07780 0.96431 0.10957 -0.03967 0.03649 0.20450
Br 0.13478 0.98163 -0.01369 0.08122 0.00385 -0.03925 -0.01991 0.09744
Rb 0.19531 0.10775 -0.07562 0.21788 0.05878 0.00090 0.02319 0.94502
Cs 0.97238 0.13830 -0.00039 0.01120 -0.00562 -0.04140 -0.03940 0.17870
Table 5.19 Rotated correlations between components and dependent variables (PLE).
Components
Variables 1 2 3 4 5 6 7 8
Li -0.06172 0.95102 0.01309 0.12408 -0.02286 -0.18561 -0.13330 -0.15310
Mg -0.05348 0.11615 0.09627 0.97338 0.12419 -0.08835 -0.05773 -0.01867
Cu -0.14049 0.01289 0.95719 0.10101 0.14010 0.01762 -0.12883 -0.13090
Zn -0.04126 -0.19763 0.02079 -0.09990 0.16335 0.92929 0.23607 0.05326
Se 0.04801 -0.02381 0.14360 0.13506 0.94857 0.15523 0.13723 0.12470
Br 0.09079 -0.14494 -0.14476 -0.06589 0.14759 0.24313 0.92174 0.12231
Rb 0.32576 -0.18434 -0.15832 -0.02144 0.14849 0.06274 0.13272 0.88926
Cs 0.94470 -0.05821 -0.14243 -0.05801 0.04413 -0.03981 0.08113 0.26530
Table 5.20 Rotated correlations between components and dependent variables (PD).
Components
Variables 1 2 3 4 5 6 7 8
Li 0.88229 -0.18717 -0.05647 0.07325 -0.06919 -0.36965 0.11192 0.15496
Mg 0.33293 0.25868 0.26763 0.04448 0.22925 0.27181 0.78880 0.00019
Cu 0.09771 0.22403 -0.14838 -0.31033 0.89114 0.03193 0.16357 -0.00628
Zn 0.00319 0.05479 0.95143 0.13906 -0.12644 0.17840 0.15687 -0.00298
Se 0.12529 -0.01004 0.13609 0.94882 -0.24467 0.06605 0.03462 0.00025
Br -0.23956 0.32229 0.26985 0.10117 0.02947 0.82988 0.25712 -0.00296
Rb 0.04202 0.93304 0.05825 -0.02007 0.20245 0.23342 0.16825 -0.00991
Cs 0.93878 0.20056 0.04761 0.09212 0.16908 0.05051 0.14866 -0.12034
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Figure 5.13 Observed relationship between the levels of Li and Br in PD
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Figure 5.14 Observed relationship between the levels of Mg and Cu in PD
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5.5 Conclusions
The analysis of endogenous levels of Li in serum was conducted successfully using 
ICP-MS. The results obtained are in good agreement with recent literature values. However, 
the method used in this work is more precise, provides better detection limits, has 
simultaneous multi-element capabilities, and is faster than the other techniques used for such 
analysis. Owing to the multi-element capability of the method, this study provided the first 
comparative work between the concentration of Se in the serum of a British and a Finnish 
population. The results of this comparison suggest a need for close monitoring of the levels 
of Se added to fertilizers in Finland since the levels of serum Se in Finnish subjects have 
risen sharply to significantly higher levels than those in their British counterparts. With 
regard to the relationship between skin disorders and elemental levels found in serum, the 
results showed good agreement with some well established trends and pinpointed other 
possible effects where fiirther research is needed to identify their significance. Finally, this 
work is the first long term study using ICP-MS for the analysis of blood serum. The 
technique has proven to be suitable for undertaking these measurements and can certainly be 
a useful tool for further studies on the physiology and biochemistry of trace elements.
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.Chapter VI.
f Conclusions ana Further Rem ark
The first aim of this work was to test the suitability of ICP-MS for routine analysis 
of endogenous levels of Li in blood serum. The instrument operating parameters were first 
optimised to provide the best detection limits (0.07 ng.ml‘ in solution). Under these 
conditions, the presence of spectroscopic and non-spectroscopic interferences was 
investigated. Such interferences were not observed. The possibility of analysing dilute serum 
was pursued. However, the high levels of proteins in the samples caused partial blockages of 
the nebuliser and the injector. These blockages resulted in a fast deterioration of the 
magnitude and the stability of the signal. Consequently, a wet digestion technique using HNO3 
followed by a 3 fold dilution was devised and tested for recovery, precision and accuracy. 
The observed recovery varied between 109.67 ±  4.78 for 5 ng.ml ‘ Li in the undigested 
solution to 137.3 ± 45.76 for 0.25 ng.ml *. The reason for the poor recovery at the lower 
levels was the large precision error on the signal as these levels approached the detection 
limits of the technique. The effect of the digestion procedures on the overall precision of the 
measurements was evaluated by comparing the observed variance from the analysis of 10 
replicates of a pooled serum sample with the estimated variance derived from the calculation 
procedures. No significant difference, at the 95% confidence limits, was observed (expected 
%RSD = 5.23, observed %RSD = 4.95). The effect of digestion on the accuracy was tested 
by comparing the mean concentration obtained from the analysis of 10 digested samples taken 
from a serum pool against that of 10 samples of the serum pool which had been diluted 10 
fold; no significant difference was observed at the 95% confidence limits (digested 0.95 ± 
0.05 ng.ml *; diluted 0.97 ± 0.04 ng.ml *). Another test of the accuracy of the results was 
conducted through taking part in an international effort aiming at the certification of a second 
generation serum reference material. The value for Li obtained in this work was 14.7 + 2.8 
ng.g *. This is in excellent agreement with the data quoted by the manufacturer during the 
preparation of this manuscript (15.1 ± 0.5 ng.g '). As a result of the above mentioned tests 
it was concluded that, with a limited sample preparation, the Li levels in serum could be 
routinely analysed down to a concentration of 0.2 ng.ml *.
In order to benefit from the multi-element capabilities of ICP-MS, the possibility of 
determining various trace elements in serum, under the optimal conditions used for Li, was 
explored. Owing to the nature of the serum matrix several spectroscopic interferences were 
observed. The magnitude of these interferences was calculated and an attempt was made to 
correct for them. Unfortunately, no satisfactory (accurate and precise) corrections could be 
undertaken for V, Cr, and As. The second generation serum and the bovine serum reference
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materials were used to verify the accuracy of the results. On this basis, it was concluded that 
Mg, Co, Cu, Zn, Se, Br, Rb, and Cs could be determined accurately. Owing to the lack of 
certified values for B, an accuracy test similar to that conducted for Li was carried out. No 
significant differences were observed between the diluted and digested samples (diluted 139.62 
± 8.11 ng.ml*; digested 145.34 ±  14.35 ng.ml '). The results for Fe were scrutinized 
carefully because of possible spectroscopic interferences on this element which are caused by 
recombinations of Ar and O, the two major elements in the plasma. The data obtained for the 
second generation serum reference material were in good agreement with the certified value 
(obtained 26.3 ± 1.71 ng.g*; certified 25.9 ng.g '). However, the results obtained for the 
bovine serum reference material were not satisfactory (observed 3.26 ±  0.13 ng.ml *; certified 
2.62 ± 0 .1  ng.ml *). Molybdenum and Cd could not be determined accurately due to (A) their 
low levels in serum, and (B) the small relative abundancy of their major isotopes. Finally, 
the analysis of Al proved to be very tedious. The precision of the signal was very poor even 
at relatively high levels (12.75 %RSD for 25 ng.ml *). The origin of this problem could not 
be identified.
Seven hundred and ninety three samples were collected from patients with skin 
disorders (acne, atopic dermatitis, seborrhoeic dermatitis, psoriasis, polymorphic light 
eruption, and photodermatoses) and age and sex matched 'controls'. These controls were used 
for establishing a reference range for the levels of Li in healthy subjects. The data varied 
between <0.2 ng.ml * and 10.8 ng.ml * with an inter quartile range of 0.6 to 1.4 ng.ml *. The 
concentration of Li in serum was found to be unrelated to factors such as age, sex or 
geographical location. Furthermore, statistical tests showed that for healthy subjects there are 
no significant interactions between the levels of Li and those of other elements. This study 
also showed that the levels of Se in the serum of 'healthy' subjects from Finland are 
significantly higher than those observed in subjects from Britain. This elevation which is due 
to the addition of Se to fertilizers in Finland suggests the need for a close monitoring of the 
supplementation process in order to avoid possible toxic Se effects.
With regard to the relationship between the levels of trace elements in serum and skin 
disorders, this study showed the following trends
(A) the levels of Li in serum are significantly higher in patients with polymorphic light 
eruption than in 'controls';
(B) serum Cu is significantly elevated in psoriasis and atopic dermatitis;
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(C) the concentration of Se in serum decreases significantly in psoriasis and atopic 
dermatitis, Se supplementation restores serum Se but with no significant effects on 
the disease;
(D) serum Br dropped significantly in acne;
(E) patients with atopic dermatitis have significantly lower serum Cs than 'controls'.
No inter-element interactions could be observed in six of the study groups. However, 
significant correlations were found between both Li and Br, and Mg and Cu in the seium of 
patients with polymorphic light eruption.
In Summary, ICP-MS can be routinely used for multi-element analysis of blood 
serum. Elements such as Li, B, Mg, Cu, Zn, Se, Br, Rb and Cs can be determined accurately 
after a sample digestion step is undertaken. Further research is needed to overcome the 
problems of spectroscopic interferences on several biologically important elements such as V, 
Cr and As. The use of different sample introduction techniques e.g. flow injection or 
electrothermal vaporisation could be a useful step in the right direction.
This work provided the first large scale study on the levels of Li in healthy subjects. 
Although the results were is close agreement with recent literature values, other studies 
suffered from the lack of accuracy check as well as relatively small number of samples 
analysed. Several trends were observed in relation to the elemental levels of blood serum in 
subjects with skin disorders. Further research on the biochemical interactions of these 
elements is needed to identify the significance of these trends. ICP-MS is in a position to 
provide a useful tool for conducting these investigations.
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A .l An Overview
As described in Chapter III, the data collected by the multi-channel scaler at the end 
of each analysis is transmitted to the personal computer and stored in a disk-file for further 
processing. Before integration, the counts for each channel are corrected for dead time 
according to the following equation:-
T r u e  c o u n t s  °  M x DD -  {M X t)
where M is the measured counts, D is the total dwell time, and t is the dead time defined in 
the configuration file. Using a preset channel to mass calibration, the channels corresponding 
to the mass range M - 0.35 to M -f 0.35 amu, where M is the mass of the isotope of interest, 
are scanned for a maximum peak. The corresponding mass for this peak (MP) is then
calculated and depending on the integration range defined in the configuration file a low and 
a high channel are identified as:-
Low channel = channel for the mass (MP - integration range/2)
High channel = channel for the mass (MP + integration range/2)
The peak integral is then calculated as the sum of the true counts in the channels between 
these two limits. Finally, the integrals for each isotope are corrected by the internal standard 
used and converted to concentrations using the calibration curves obtained from the analyses 
of standard solutions.
Owing to the problems associated with the choice of suitable internal standards (e.g. 
choices relating to mass, ionisation energy, absence from the original sample, and intensity 
of the signal), the calculation procedures provided by the VG software are rather constrictive 
and do not provide a real alternative if internal standards are not to be used (no proper drift 
correction is conducted). It was, therefore, decided to write a specific program in which 2 
different modes of signal correction can be used (linear drift of sensitivity standards, and 
internal standard correction) together with one of 3 calibration procedures, 2 quantitative 
(sensitivity standard, reference material) and one semi-quantitative (internal spike). Figures 
A .l - A.7, are flow charts for the major subroutines in this program.
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A.1.1 Linear Drift of Sensitivity Standards
Sensitivity standards are usually synthetic standard solutions which are analysed at 
specific intervals between the samples during the run. In this correction mode, it is assumed 
that any possible drift in the signal, which could be caused by partial bockages of the 
nebuliser, the injector, or the cone and skimmer apertures, is linear. Therefore, a straight line 
is drawn between two consecutive sensitivity standards and the expected value for the 
standard at a time when a sample was analysed is calculated. Subsquently, the signal for that 
sample is normalised by dividing it by the calculated value of the sensitivity standard. Similar 
normalisation of the signals for the reagent blanks is conducted before blank correction.
A.1.2 Internal Standard Correction
In this correction mode, it is assumed that the signal drift afreets all the elements to 
the same extent. Therefore, for each sample the signal for the element of interest is 
normalised by dividing it by the signal for the internal standard before any calculation can be 
undertaken.
A. 1.3 Quantitative Analysis
For this type of analysis, a calibration curve is drawn based on the instrument réponse 
for known concentrations of the element. Owing to the wide linear dynamic range of the 
instrument and the very low background signal (usually < 20 counts) for the majority of the 
elements, it is a common practice to generate the calibration curve based on the reading(s) for 
only one concentration of the element of interest. This program allows the operator to use 
either the sensitivity standard or an external standard solution (which could be a standard 
reference material) for generating the calibration curve.
A. 1.4 Semi-Quantitative Analysis
This calculation procedure is based on the Saha equation described in Chapter III 
(scetion 3.2.2). As shown in Figure 3.4 data for the percentage ionisation can be obtained for 
all the elements under specific run conditions. Should this data together with the isotopic 
abundancy be used as correction factors, it is possible to estimate the concentration of 'all the 
elements' in a sample if the concentration of one element in it (e.g. the internal standard) is 
known. This is based on the following equation:-
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where A is the element with unknown concentration, B is the element of known 
concentration, SF is the Saha factor for the element, and lA is the isotopic abundancy of the 
element.
A.2 Listing of the Newpq Program
CHARACTER*! ANS,NA,A 
CHARACTER*12 INFI ,STORE,INF 
CHARACTER*2 ELM(40,6),ELM1(20)
CHARACTER*6 ID(101),NAL6 
CHARACTERS NALI
INTEGER NE(6),DATA(100,21),MASSEL(20),IST 
REAL DF(100),SCONC(40,6),SC2(20)
INCLUDE 'F77PC 
CALL FPAGE 
877 FORMAT(14X,A3,2X,20(4X,A2,I3))
833 FORMAT(2X,A6,2X,F7.3,2X,20(2X,I7))
859 FORMAT(2X,A6,11X,20(1X,F8.3))
445 CALL RPROC(DF,ID,ELM,SCONC,INFI,NDKTR,NT,NSTD,NE,NA)
IF (NA.EQ.'N'.OR.NA.EQ.'n') THEN 
491 WRITE(*,'(1X,A28 )') 'PLEASE ENTER INPUT FILENAME: '
READ(*,'(A)') INF 
0PEN(7,FILE-INF)
READ(7,*,I0STAT=IST) NT,NEL
IF (IST.GT.O) THEN
WRITE(*,*) 'SOMETHING IS WRONG'
CLOSE(7)
GOTO 491 
ENDIF
READ(7,877,IOSTAT=IST) NALI,(ELM1(J),MASSEL(J),J= l.NEL)
IF (IST.GT.O) WRITE (*,*) 'ERROR2' ,NALI,J,ELM1(J)
DO 497 1=1,NT
497 READ(7,833,IOSTAT=IST) ID(I),DF(I),(DATA(I,J),J= 1,NEL)
IF (IST.GT.O) WRITE (*,*) 'ERR0R3',ID(I-1)
READ(7,859,IOSTAT=IST) NAL6,(SC2(I),I= 1,NEL)
IF (IST.GT.O) WRITE (*,*) 'ERROR4',NAL6 
CLOSE(7)
CALLCALC(ID,NT,NEL,NSTD,NE,ELM1,ELM,MASSEL,SC2,DATA,DF,INF)
ELSE
CALLGETDA(NEL,ELM1,DATA,NT,MASSEL,ID,SC0NC,SC2,NSTD,NE,ELM 
/ ,INF)
664 WRITE (*,'(IX,A42)') DO YOU WANT TO STORE THE RAW COUNTS(Y/N): '
READ(*,'(A)') ANS
IF(ANS.EQ.'Y'.OR.ANS.EQ.'y') THEN 
662 WRITE(*,'(1X,A28 ) ’) PLEASE ENTER STORE FILENAME: '
READ(*,'(A)') STORE 
153 OPEN(7,FILE= STORE,STATUS =  'NEW' ,I0STAT=IST1)
IF (ISTl.GT.O) THEN
WRITE (*,*) THIS FILE ALREADY EXIST'
GOTO 662
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(  Start )
Call fp a g e
Call rproc
m  = Yy
filename Call g e td a
open inf
(inf) 
NT, NEL store
error? open store
^  (inf)elmd) —> elm(nel)
masseld) —> masse! (nei)
(store) 
nt, nei
(store) 
elmd) —> elm (nei)
j  >  N T
1 = 1(inf)
id(i), df(i)
data(i,1) —> data (i.nel)
(store)
id(i), df(i)
data(i,1) -  > data (i,nel)
i=i+1
/  (infl 
nal6
sc2d) —> sc2(nei)
i=i+1
close inf
(store)
nal6
sc2(1) —> sc2(rcall calc
close infAnother set?
Figure A .l The main module of the Newpq program
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lopw Ifld
" (Inf} 
ndXtr, n ttd , n t
K=1
(inf}
elmtk.l). sconclKH
open Inf
ne. nstd
l>nstd
ndKtr
n sstd
nblK
nrbIK
eNl.D
seonclj.l)
n t= ns+ nsstd+ nsd t 
+nbik+nrblK 
1=1
- (  1=1+1 I
Mil. dfU
dl =*(
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Figure A.2 Subroutine Rproc
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(  start ')
f infile
open infile
nei
(infile)
eimc(i)j>nel
i=i+1 Mmel=1in=1
open mas.fad
eim1(in)=elmc(mel) isotop=0 
 kn=1_____
/  (mas.fad)
imasselm2(kn) |kn=kn+11
ilm2(ki^
elniïdrj).rror'{
rewind inas.fad  in=in+1
mei=mei+lW^n>nel>
in=in+1nei=nei+1elm1{ln)=eim1(in-1)
massel(in)=imassnk=1 massel(in)=imass
nk=1pj+1 ik>ne(j)> J>net /  (infile)massd)—>mass(5) 
countsd)—>counts{5)
(return)sc2(j)=
sconc(nk=1) i<5masse]
data(k,in)=counts(J)
k=k+1nk=nk+1
rewind infiie 
kn=kn+1k>nt
Figure A 3 Subroutine Getda
-142-
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Figure A 4 Subroutine Calc
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Figure A.5 Subroutine Ccalc
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( s ta r t )
^idjr
rb ink
TbIanI
d a ta (ij)<
^et_lim.
( r e tu r n )
d a ta ( ij)= -1 *d a ta ( ij)
b il= d a ta (i,j)*c o rre c t
d e t_ lim = d f(i)*d l( j)
q=df(i)-^sconc1*(bil-b1)
data(i,j)=q/(div~b3)
q = d f(i)*sco n c1 *(b il-b 2 )
data(i,j)=q /(d iv-b3)
Figure A.6 Subroutine Calcl
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foufile
oufile
( call da te (
(oufile)
oufile,inf (fa te /^
(oufile)
elmd),masseld) — > 
elm(ne1),massel(ne1)
i=sstdd,21)
l>ns
(oufile)
id(i),data1(i,1) 
— >data1(i,neji=i+1
(oufile)
did)— >dl(ne1)
close oufile
(  return )
Figure A.7 Subroutine Output
-146-
ENDIF
WRITE(7/,IOSTAT=IST) NT,NEL
IF (IST.EQ.59) THEN
CALL MESSAGEl
GOTO 153
ENDIF
WRITE(7,877,IOSTAT==IST) •DIL',(ELM1(J),MASSEL(J),J= 1,NEL)
IF (IST.EQ.59) THEN 
CALL MESSAGEl 
GOTO 153 
ENDIF
DO 818 I=1,NT
818 WRITE(7,833,I0STAT=IST) ID(I),DF(I),(DATA(I,J),J= 1,NEL)
IF aST.EQ.59) THEN 
CALL MESSAGEl 
GOTO 153 
ENDIF
WRITE(7,859,IOSTAT=IST) 'SCONC. ',(SC2a),I= 1 ,NEL)
IF aST.EQ.59) THEN 
CALL MESSAGEl 
GOTO 153 
ENDIF 
CL0SE(7)
ELSEIF(ANS.NE.'N'.OR.ANS.NE.'n') THEN 
WRITE(*,'(1X,A20)') 'PLEASE ANSWER Y OR N'
GOTO 664 
ENDIF
CALL CALCaD,NT,NEL,NSTD,NE,ELMl,ELM,MASSEL,SC2,DATA,DF,INF) 
ENDIF 
493 WRITE (*,444)
444 FORMAT(5X, 'ANOTHER SET (Y/N): ' )
READ (*.'(A)') ANS
IF (ANS.EQ. 'Y'.OR.ANS.EQ.'y') THEN
GOTO 445
ELSEIF (ANS.EQ.'N'.OR.ANS.EQ.'n') THEN
WRITE(*,*) 'THANK YOU VERY MUCH FOR USING NEWPQ*
ELSE 
GOTO 493 
ENDIF 
END
************************* SUBROUTINE MESSAGEl ************************* 
SUBROUTINE MESSAGEl 
CHARACTER* 1 ANS
WRITE (*,*) 'DISK IS FULL MY DEAR PLEASE INSERT A NEW ONE' 
WRITE (*,*) 'PRESS RETURN WHEN READY'
READ (*,*) ANS
RETURN
END
************************* SUBROUTINE FPAGE ***************************
C THIS SUBROUTINE PRODUCES THE FRONT PAGE 
C THE PROGRAM NAME AND THE NAME OF THE WRITER 
SUBROUTINE FPAGE 
CHARACTER*1 A 
CALL INITSCREEN 
CALL CLRVIDEO 
CALL SCREENUNIT (1)
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CALL TEXTWINDOW (15,8,65,16)
CALL TEXTFRAME (.TRUE.)
CALL PAPER (3)
CALL INK(O)
CALL CLRSCR 
1=13
CALL GOTOXY (1 + 1,0)
CALL PUTCHATTR (' ',0,3,22)
CALL PUTCHAR ('N',1)
CALL GOTOXY (1+2,0)
CALL PUTCHAR (’E',1)
CALL GOTOXY (1+3,0)
CALL PUTCHAR ('W',1)
CALL GOTOXY (1+4,0)
CALL PUTCHAR ('P',1)
CALL GOTOXY (1+5,0)
CALL PUTCHAR ('Q',1)
CALL GOTOXY (1+6,0)
CALL PUTCHAR (':',1)
CALL GOTOXY (1+7,0)
CALL PUTCHAR ('F',1)
CALL GOTOXY (1 + 8,0)
CALL PUTCHAR ('A',1)
CALL GOTOXY (1+9,0)
CALL PUTCHAR (’D ’,1)
CALL GOTOXY (1+10,0)
CALL PUTCHAR ('I',l)
CALL GOTOXY (1+11,0)
CALL PUTCHAR (' ',1)
CALL GOTOXY (1+12,0)
CALL PUTCHAR ('A',1)
CALL GOTOXY (1+13,0)
CALL PUTCHAR CB',1)
CALL GOTOXY (1+14,0)
CALL PUTCHAR ( 0  ,1)
CALL GOTOXY (1+15,0)
CALL PUTCHAR ('U',1)
CALL GOTOXY (1+16,0)
CALL PUTCHAR ('-',1)
CALL GOTOXY (1+17,0)
CALL PUTCHAR ('S',1)
CALL GOTOXY (1+18,0)
CALL PUTCHAR ('H',1)
CALL GOTOXY (1+19,0)
CALL PUTCHAR ('A',1)
CALL GOTOXY (1+20,0)
CALL PUTCHAR ('K',1)
CALL GOTOXY (1+21,0)
CALL PUTCHAR ( R ',l)
CALL GOTOXY (1+22,0)
CALL PUTCHAR ('A',1)
CALL GOTOXY (1+23,0)
CALL GOTOXY (1,1)
WRITE (1,93) WELCOME TO THE ICP-MS CALCULATION PROGRAM' 
93 FORMAT (4X,A43)
CALL GOTOXY (1,4)
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WRITE (1,97) ’PLEASE TYPE RETURN TO CONTINUE'
97 FORMAT (8X,A30)
READ (*,'(A)’) A 
CALL INITSCREEN 
CALL CLRSCR 
RETURN 
END
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
************************** SUBROUTINE RPROC *****************************
C THIS SUBROUTINE RPROC IS DIVIDED IN TWO PARTS 
C A. TO WRITE A RUN PROCEDURE 
C B. TO READ FROM A WRITTEN RUN PROCEDURE
SUBROUTINE RPROC (DF,ID,ELM,SCONC,INFI,NDKTR,NT,NSTD,NE,NA)
CHARACTER*1 ANS, ANSI,NA
CHARACTER*5 STP
CHARACTER*12 INFI
CHARACTER*2 ELM(40,6)
CHARACTERS ID(lOl)
INTEGER NE(6)
REAL DF(100),SCONC(40,6)
C INTRODUCTION. WHAT IS WHAT:
DO 755 1=1,30 
755 WRITE(*,*)
WRITE(*,*)
WRITE(*,'(A38)') 'PLEASE PRESS RETURN AFTER EACH ANSWER'
WRITE(*,*)
WRITE(*,*)
WRITE(*,'(A40 )') 'ARE YOUR DATA STORED AS PQ OUTPUT(Y/N): '
603 READ(*,'(A)') NA
IF(NA.EQ.'Y'.OR.NA.EQ.'y') GOTO 601 
IF(NA.EQ.'N'.OR.NA.EQ.'n') GOTO 601 
WRITE(*,'(A21 )') 'PLEASE ANSWER (Y/N):'
GO TO 603 
601 CONTINUE
WRITE(*,'(A46 )') DO YOU WISH TO USE AN OLD RUN PROCEDURE(YZN):' 
606 READ(*,'(A)') ANS
IF(ANS.EQ.'Y',OR.ANS.EQ.'y') GOTO 604 
IF(ANS.EQ.'N'.OR.ANS.EQ.'n') GOTO 605 
WRITE(*,'(A21 )') 'PLEASE ANSWER (Y/N):'
GO TO 606
C IF RUN PROCEDURE IS ALREADY WRITTEN GET ITS NAME 
C AND GO TO MAIN
604 WRITE(*,'(A33 )') PLEASE ENTER YOUR RUN PROCEDURE: '
READ(*,'(A8)') INFI
GOTO 111 
C THE START OF PART A:
C COLLECT INFORMATION ABOUT YOUR RUN
605 WRITE(*,'(A70)') PLEASE ENTER THE NAME OF THE NEW RUN PROCEDURE 
/ (MAX. 8 CHARACTERS):'
READ(*,'(A8)') INFI
OPEN(5 ,FILE= INFI, STATUS = 'NEW' ,IOSTAT=IST)
IF (IST.GT.O) THEN
WRITE (*,*) 'THIS FILE ALREADY EXIST'
GOTO 605 
ENDIF
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WRITE(*,*)
WRITE(*,*)
723 WRITE(*'(A30 )') 'HOW MANY SAMPLES DO YOU HAVE:' 
READ(*,*,IOSTAT=IST) NS
IF(IST.GT.O) THEN
WRITE(*,'(A30)') 'TAKE CARE, NUMBERS EXPECTED!!'
GOTO 723
ENDIF
WRITE(*,*)
724 WRITE(*,'(A39 )') 'HOW MANY STANDARDS DO YOU HAVE(MAX.6): ' 
READ(*,*,IOSTAT=IST) NSTD
IF(IST,GT.O) THEN
WRITE(*,'(A30)') 'TAKE CARE, NUMBERS EXPECTED!!'
GOTO 724 
ENDIF
DO 701 I=1,NSTD  
DO 707 K = l,4  
707 WRITE(*,*)
WRTTE(*,'(A20,I2)') 'INPUT FOR STANDARD ',I 
WRITE(*,*)
WRITE(*,*)
725 WRITE(*,'(A44 )') 'HOW MANY ELEMENTS IN THIS STANDARD(MAX.40):' 
READ(*,*,IOSTAT=IST) NE®
IF(IST.GT.O) THEN
WRITE(*,'(A30)') 'TAKE CARE, NUMBERS EXPECTED!!'
GOTO 725 
ENDIF
DO 702 1=1,NE®
WRITE(*,*)
WRITE(*,*)
WRITE(*,*)
WRITE(*,'(A15,I2,A2)') 'ENTER ELEMENT :'
READ(*,'(A)') ELM(J,I)
726 WRITE(*,'(A7,A2,A22 )')'ENTER ',ELM(J,I),' CONCENTRATION(NG/ML):'
READ(*,*,IOSTAT=IST) SCONC(J,I)
IF(IST.GT.O) THEN
WRITE(*,'(A30)') 'TAKE CARE, NUMBERS EXPECTED!!'
GOTO 726 
ENDIF 
702 CONTINUE
701 CONTINUE
WRITE(*,*)
WRITEC*,'»')
NDKTR=1
IF (NSTD.EQ.l) GOTO 728
727 WRITE(*,'(A40 )') 'WHICH STD. NO IS YOUR SENSITIVITY STD.:'
READ(*,*,IOSTAT=IST) NDKTR
IF(IST.GT.O) THEN
WRITE(*,'(A30)') 'TAKE CARE, NUMBERS EXPECTED!!'
GOTO 727
ENDIF
WRITE(*,*)
728 WRITE(*,'(A51 )') 'HOW MANY TIMES WILL YOU RUN YOUR SENSITIVITY S
/ TD.:'
READ(*,*,IOSTAT=1ST) NSSTD 
IF(IST.GT.O) THEN
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WRITE(*,'(A30)') TAKE CARE, NUMBERS EXPECTED!!'
GOTO 728
ENDIF
WRITE(*,*)
WRITE(*,*)
WRITE(*,'(A46 )’) 'ARE YOUR BLANK & REAGENT BLANK THE SAME(Y/N):'
609 READ(*,'(A)') ANS 
IF(ANS.EQ.'Y'.OR.ANS.EQ.'y') GOTO 607 
IF(ANS.EQ.’N'.OR.ANS.EQ.'n ') GOTO 608 
WRITE(*,'(A21 )') 'PLEASE ANSWER (Y/N):'
GO TO 609
607 WRITE(*,*)
WRITE(*,*)
730 WRITE(*,'(A40 )’) 'HOW MANY TIMES WILL YOU RUN YOUR BLANK:'
READ(*, *,IOSTAT=1ST) NBLK
IF(IST.GT.O) THEN
WRITE(*,'(A30)') 'TAKE CARE, NUMBERS EXPECTED!!'
GOTO 730 
ENDIF 
NRBLK=0 
GO TO 610
608 WRITE(*,*)
WRITE(*,*)
731 WRITE(*,'(A40 )') 'HOW MANY TIMES WILL YOU RUN YOUR BLANK: ' 
READ(*,*,IOSTAT=IST) NBLK
IF(IST.GT.O) THEN
WRITE(*,'(A30)’) 'TAKE CARE, NUMBERS EXPECTED!!'
GOTO 731
ENDIF
WRITE(*,*)
732 WRITE(*,'(A48 ) ') 'HOW MANY TIMES WILL YOU RUN YOUR REAGENT BLANK
/  :'
READ(*,*,IOSTAT=IST) NRBLK 
IF(IST.GT.O) THEN
WRITE(*,'(A30)') 'TAKE CARE, NUMBERS EXPECTED!!'
GOTO 732 
ENDIF 
GO TO 610
610 NT= NS+ NSSTD+ NSTD+ NBLK+NRBLK 
DO 705 K = l,4
705 WRITE(*,*)
WRITE(*,'(A21,I2,A20)') 'YOU HAVE A TOTAL OF ',NT,' SAMPLES IN THI 
/ S RUN'
C COLLECTING INFORMATION ABOUT EACH SAMPLE AND 
C WRITING THE RUN PROCEDURE
WRITE(5,'(5X,I1,3X,I1,4X,I2)') NDKTR,NSTD,NT 
DO 704 1=1,NT 
715 WRITE(*,'(A34)') 'MENU'
WRITE(*,'(A24)') 'l.BLANK'
WRITE(*,'(A27)') '2.STANDARD'
WRITE(*,'(A35)') '3.SENSITIVITY STD.'
WRITE(*,'(A25)') '4.SAMPLE'
720 WRITE(*,'(A26,I2,A7 )') PLEASE IDENTIFY SAMPLE NO ',1,' (1-4):'
READ(*,*,IOSTAT=IST) NK 
IF(IST.GT.O) THEN
WRITE(*,'(A30)') 'TAKE CARE, NUMBERS EXPECTED!!'
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GOTO 720 
ENDIF
IF (NK.EQ.l) GOTO 711 
IF (NK.EQ.2) GOTO 712 
IF (NK.EQ.3) GOTO 713 
IF (NK.EQ.4) GOTO 714 
GOTO 715
711 D F® =1
ID® = 'BLANK '
IF (ANS.EQ.'N'.OR.ANS.EQ.'n') GOTO 719 
WRITE (5,’(3X,A6,20X,F7.3)') ID® ,DF®
GOTO 704
719 WRITE(*,'(A38 )') 'IS IT A BLANK(B) OR REAGENT BLANK(R):'
718 READ(*'(A)') ANSI
IF (ANSl.EQ.'B'.OR.ANSl.EQ.'b*) GOTO 716 
IF (ANSl.EQ.'R'.OR.ANSl.EQ.'r') GOTO 717 
WRITE (*,'(A20 )') 'PLEASE ANSWER(BZR):’
GOTO 718
716 WRITE (5,'(3X,A6,20X,F7.3)') ID®,DF(I)
GOTO 704
717 ID(I)='RBLANK'
WRITE (5,'(3X,A6,20X,F7.3)') ID® ,DF®
GOTO 704
712 WRITE (*,»)
KSTD=1
IF (NSTD.EQ.l) GO TO 740
741 WRITE ( * '(A33,I1,A2 )') 'WHICH STANDARD NO IS THIS 0NE(1-',NSTD,
/ ’):'
READ(*,*,IOSTAT=IST) KSTD 
IF(IST.GT.O) THEN
WRITE(*,'(A30)’) 'TAKE CARE, NUMBERS EXPECTED!!'
GOTO 741 
ENDIF 
740 D F ® =1
IF (NSTD.EQ.l) THEN 
WRITE(5,'(3X,A6,21X,F7.3)') 'SSTND. ',DF(I)
ELSE
WRITE(5,'(3X,A5,I1,20X.F7.3)')PID,KSTD,DF®
ENDIF
DO 742K1 = 1,NE(KSTD)
742 WRITE(5,'(3X,I2,10X,A2,5X,F8.3,1X,A1)') K1,ELM(K1,KSTD),SC0NC(K1,K 
/ STD), A'
GOTO 704
713 D F® =1  
WRITE(5,'(3X,A6,20X,F7.3)') 'SSTND.',DF®
GOTO 704
714 WRITE(*,'(A36 )') 'GIVE SAMPLE CODE(MAX.6 CHARACTERS): '
READ(*,'(A)') ID®
744 WRITE(*'(A14,A6,A17 )')'PLEASE ENTER ' ,ID ® , ' DILUTION FACTOR: '
READ(*,*,IOSTAT=IST) DF®
IF(IST.GT.O) THEN
WRTTE(*,'(A30)') 'TAKE CARE, NUMBERS EXPECTED!!'
GOTO 744 
ENDIF
WRITE(5,'(3X,A6,20X,F7.3)') ID® ,DF®
704 CONTINUE
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CL0SE(5)
C START OF PART B.
C READ THE RUN PROCEDURE AND GO BACK TO MAIN 
111 OPEN(6,IOSTAT=IST,FILE=INFI,STATUS =  'OLD ')
IF (IST.GT.O) THEN
WRITE(*,*) THIS FILE DOES NOT EXIST'
GOTO 604 
ENDIF
READ(6,'(5X,Il,3X,Il,4X,I2)',IOSTAT=IST) NDKTR,NSTD,NT
IF (IST.NE.O) THEN
WRITE(*,*) 'SOMETHING IS WRONG'
GOTO 604 
ENDIF 
1 = 1
766 READ(6,’(3X,A6,20X,F7.3)',IOSTAT=IST) IDa),DF®
IF (IST.EQ.O) THEN
1 = 1 + 1  
GO TO 766
ELSE IF(IST.GT.O) THEN
BACKSPACE 6
IF (NSTD.EQ.l) THEN
K 55=l
ELSE
BACKSPACE 6
READ(6,'(3X,A5,I1,20X,F7.3)') STP,K55,ST1
ENDIF
K=1
768 READ(6,'(3X,I2,10X,A2,5X,F8.3)',IOSTAT=IST1) K7,ELM(K,K55),SCONC(
/ K,K55)
IF (ISTl.GT.O) GOTO 767
K=K+1
GOTO 768
767 NE(K55)=K-1 
BACKSPACE 6 
GOTO 766 
ENDIF 
CLOSE (6)
RETURN
END
********************** SUBROUTINE GETDA *********************************
C THIS SUBROUTINE IS DESIGNED TO READ THE DATA FROM 
C AN ICP-MS INTEGRA'nON FILE STORED IN ASCII CODE 
C THE SUBROUTINE WILL COLLECT THE ELEMENTS OF INTEREST 
C FROM THE SCREEN (OPERATOR) LOOK FOR THEIR ISOTOPIC 
C MASSES IN THE FILE CALLED MAS.FAD THEN COLLECT THE 
C RAW COUNTS FROM THE ICP-MS FILE
SUBROUTINE GETDA(NEL,ELMl,DATA,NT,MASSEL,ID,SCONC,SC2,NSTD, 
/ NE,ELM,INFILE)
CHARACTER*81 LINEl ,LINE(23)
CHARACTER*12 INFILE 
CHARACTER*6 ID(lOl)
CHARACTER*2ELMC(10),ELM1(20),ELM2(200),ELM(40,6)
INTEGER MASS(5),COUNTS(5),DATA(100,21),MASSEL(20),NE(6),IST 
REAL SCONC(40,6),SC2(20)
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MAX=NT
913 WRITE('\'(A52)') ‘PLEASE ENTER INPUT DATA FILENAME(MAX. 8 CHARACTE
/ RS):'
READ(*,'(A)') INFILE
OPEN(5 ,FILE= INFILE, STATUS = ' NEW ' ,IOSTAT=1ST)
IF (IST.GT.O) THEN 
CL0SE(5)
OPEN(5,FILE=INFILE)
ELSE
WRITE(*,*) ‘THIS FILE DOES NOT EXIST'
GOTO 913 
ENDIF
915 WRITE(*,'(A39 )’) HOW MANY ELEMENTS TO ANALYSE (MAX. 10): '
READ(*, '(12)' ,IOSTAT=IST) NEL 
IF (IST.GT.O) THEN
WRITE (*,*) 'CARFUL NUMBERS EXPECTED'
GOTO 915 
ENDIF
OPEN(6,FILE= 'MAS.FAD')
104 FORMAT(5X,I3,3X,A2,3X,F6.2)
DO 71 I=1,NEL
WRITE(*,'(A24,I2,A2 )') 'PLEASE ENTER ELEMENT NO',I,' :'
71 READ (*,'(A)') ELMC®
MEL=1
IN=1
121 WRITE(*,'(A24,I2)') ' LOOKING FOR ELEMENT NO:',MEL
ELM1(IN)=ELMC(MEL)
ISOTOP=0  
KN=1
120 READ(6,104,IOSTAT=IST) IMASS,ELM2(KN)
IF(IST.LT.O) GOTO 112 
IF(ELM2(KN).NE.ELM1(IN)) GOTO 111 
K=1
WRITE(*,'(A20,A2,I3,A2)')'ACQUIRING DATA FOR ',ELM1(IN),IMASS,' !'
ISOTOP= ISOTOP+1
IF (ISOTOP.GT.l) GOTO 113
MASSEL(IN)=IMASS
L=MASSEL(IN)
GOTO 115 
113 IN=IN+1
NEL=NEL+1
ELM1(IN)=ELM1(IN-1)
MASSEL(IN)=IMASS
L=MASSEL(IN)
115 READ(5,'(5(2X,I3,3X,I8))',IOSTAT=IST) (MASS(J),COUNTS(J),J= 1,5)
IF (IST.GT.O) GOTO 115
IF (MASS(1).EQ.O.OR.MASS(1).GT.L) GOTO 115 
DO 108 IM=1,5 
IF(MASS(IM).EQ.L) GOTO 100 
108 CONTINUE
GOTO 115 
100 D ATA(K,IN)=COUNTS(IM)
K=K+1
IF(K.GT.MAX) GOTO107 
GOTO 115 
107 REWIND 5
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111 KN=KN+1 
GOTO 120
112 REWIND 6 
IN=IN+1
IFaN.GT.NEL) GOTO 122 
MEL=MEL+1 
GOTO 121 
122 CONTINUE
DO 847 J=1,NEL 
DO 847 NK=1,NSTD 
DO 847 NK1 = 1,NE(NK)
IF(ELMia).EQ.ELM(NKl,NK)) THEN 
SC2(J)= SCONC(NKl ,NK)
ENDIF 
847 CONTINUE
RETURN 
END********************* SUBROUTINE CALC *******************************
SUBROUTINE CALC aD,NS,NE1,NSTD,NE2,ELMl,ELM,MASSEL,SC2,DATA,DF 
/ ,INF)
CHARACTER * 12 OUFILE,INF 
CHARACTER * 6 ID(lOl)
CHARACTER * 2 ELM(40,6),ELM1(20),SQELM,ELM4,RET,EL(96)
CHARACTER * 1 ANS,ANY
INTEGER BLK(11,20),RBLK(11,20),SSTD(11,21),NE2(6),IMA(128)
INTEGER BK(20),RBK(20),MASSEL(20),DATA(100,21),K,L,M 
REAL SD,SD1,ABUND(20),ABND,ABD(128),IO(96)
REAL C(100),DF(100),DATA1(100,20),DL(20),SC2(20),RATIO(20),RI 
DATA IMA / 7, 9, 10, 11, 23, 24, 26, 27, 28, 29, 31, 32, 35, 37,
/ 39, 42, 44, 45, 47, 49, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60,
/ 63, 65, 66, 68, 69, 71, 72, 73, 74, 75, 76, 77, 78, 79, 81, 82,
/ 83, 85, 88, 89, 90, 91, 93, 95, 96, 97, 98, 99,101,103,
/ 105,107,109,111,112,114,115,118,120,121,123,125,126,127,129,131,
/ 133,137,138,139,140,141,146,147,149,151,153,155,157,159,161,163,
/ 165,166,167,169,172,173,175,177,178,179,181,182,183,185,188,189,
/ 191,193,194,195,197, 200,202,203,205,206,207,208,209,232,235,238,
/ 4*240/
DATA ABD / 92.50,100.00, 20.00, 80.00,100.00, 79.00, 11.00,100.00,
/ 92.20, 4.70,100.00, 95.00, 75.80, 24.20, 93.30, 0.65, 2.08,
/ 100.00, 7.50, 5.50, 99.70, 83.80, 9.50, 5.80,100.00, 91.70,
/ 2.14, 67.80,100.00, 26.40, 69.10, 30.90, 27.80, 18.60, 60.00,
/ 40.00, 27.50, 7.70, 36.40,100.00, 9.00, 7.50, 23.50, 50.70,
/ 49.30, 9.00, 11.50, 72.20, 82.60,100.00, 51.20, 11.20,100.00,
/ 15.90, 16.70, 9.50, 24.40, 12.70, 17.10,100.00, 22.20, 51.80,
/ 48.20, 12.80, 24.00, 28.80, 95.70, 24.10, 32.80, 57.30, 42.70,
/ 7.00, 18.70,100.00, 26.40, 21.20,100.00, 11.20, 71.90, 99.90,
/ 88.50,100.00, 17.20, 15.00, 13.80, 47.80, 52.20, 14.90, 15.70,
/ 100.00, 18.90, 24.90,100.00, 33.40, 22.90,100.00, 21.90, 16.20,
/ 97.40, 18.50, 27.20, 13.80, 99.90, 26.30, 14.30, 37.40, 13.30,
/ 16.10, 37.40, 62.60, 32.90, 33.80,100.00, 23.10, 29.70, 29.50,
/ 70.50, 24.10, 22.10, 52.40,100.00,100.00, 0.72, 99.30,
/ 4*100.00/
DATAEL/'AG','AL','AR','AS','AU','B ','BA','BE','BI','BR','C ',
/ 'CA','CD','CE’, ’CL','CO’,'CR’,'CS',’CU*,'DY','ER',*EU',
/ 'FE','GA','GD','GE','H ','HF','HG','HO',T ',TN','IR',
/ 'K ','KR','LA','Lr,'LU','MG','MN','MO','N ','NA','NB',
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/ 'NI'/O  ','OS','P ','PB','PD'/PT','RB'/RE','RH','RU',
/ 'S •,'SB','SE’/Sr,'SM '/SN ','SR ','T A ',T B ',T C ',T B ’,
/ 'TH','Tr/TL','TM ','U \'V  ','W ','XE’,'Y ','YB’,'ZN',
/ 'ZR’,18*'ZZV
DATA 10/0.9190,0.9750,0.0001,0.5420,0.5360,0.5760,0.9990,0.7590,
/ 0.9180,0.0450,0.3670,0.9960,0.8570,0.9980,0.0090,0.9290,
/ 0.9780,0.9990,0.8860,0.9960,0.9950,0.9970,0.9510,0.9970,
/ 0.9950,0.8920,0.0040,0.9860,0.4230,0.9960,0.3390,0.9850,
/ 0.7470,0.9990,0.0020,0.9970,0.9960,0.9950,0.9730,0.9430,
/ 0.9750,0.0010,0.9970,0.9810,0.9040,0.0040,0.7700,0.3680,
/ 0.9640,0.9220,0.6560,0.9990,0.9220,0.9380,0.9520,0.1710,
/ 0.9290,0.3650,0.8480,0.9980,0.9550,0.9980,0.9440,0.9960,
/ 0.9930,0.6770,0.9940,0.9890,0.9850,0.9940,0.9940,0.9850,
/ 0.9340,0.0310,0.9610,0.9940,0.7710,0.9840,18*1.0000/
ANY='A’
165 WRITE(*,*) 'WHICH CALCULATION DO YOU PREFER'
WRITE(*,*)'1-EVALUATION BY SSTD'
WRITE(*,*)'2-EVALUATI0N BY SRM'
WRITE(*,*)'3-SEMI-QUANTITATIVE ANALYSIS'
WRITE(*,*)'4-INTERNAL STANDARD CALCULATION (SSTD)'
WRITE(*,*)'5-INTERNAL STANDARD CALCULATION (SRM)' 
WRITE(*,*)'6-INTERNAL STANDARD, SEMI-QUANT ANALYSIS'
WRITE(*,*)'7-QUIT'
WRITE(*,*)
READ(*,*,IOSTAT=IST) NEV 
IF(IST.NE.O) THEN
WRITE(*,'(A29)') 'TAKE CARE,NUMBER EXPECTED!! '
GOTO 165 
ENDIF 
65 CONTINUE
IF (NEV.EQ.7) GOTO 940 
IF (NEV.GT.2.AND.NEV.LT.7) THEN
CALL INTSTD(ELM1 ,NEl,NS,INSTD,DATA,ISOL,NEV,MASSEL,SC2)
IF (ISOL.EQ.7) GOTO 940 
ENDIF
CALL VC0R(ELM1,MASSEL,DATA,NE1,NS)
CALL SECOR(ELMl ,MASSEL,DATA,NE 1 ,NS)
CALL ELSORT(ID,BLK,RBLK,SSTD,DATA,K,L,M,NS,NEI)
CALL ASC0R(ELM1 ,MASSEL,DATA,NE1 ,NS,ID,BK,RBK,BLK,RBLK,K,L,SSTD) 
IF (NEV.EQ. 1. 0R.NEV.EQ.4) GO TO 141 
IF (NEV.EQ.2.0R.NEV.EQ.5) GOTO 881
WRITE(*,*) 'BLANK CORRECTION FOR YOUR SQ-ELEMENT IS NEEDED' 
CALL GETBLK(BLK,K,RBLK,L,BK,RBK,SD,SD 1 ,NE1)
: SEMI QUANT: STEPl 
KL=64 
IM=1
DO 119 JP=1,NE1 
991 CONTINUE
IF(ELM1(JP).NE.EL(KL)) THEN 
IF (ELMl(JP).LT.EL(KL)) THEN 
KL=KL-64/2**IM 
ELSE
KL=KL+64/2**IM 
ENDIF 
IM=IM+1 
IF (IM.GT.7) THEN
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WRITE (*,*) 'SOMETHING IS WRONG!!!'
WRITE (*,*) 'I CAN"T FIND THE ELEMENT: ’,ELM1(JP)
STOP 
ENDIF 
GOTO 991 
ELSE
RAT10(JP)=I0(KL)
KL=64 
IM = 1 
ENDIF 
119 CONTINUE
C STEP 2: THIS IS SIMILAR TO STEPl BUT FOR 
C ISOTOPIC ABUNDANCY INSTEAD OF IONISATION RATIO 
KL=64 
IM=1
DO 111 IP = 1 ,NEI 
998 CONTINUE
IF(MASSEL(JP).NE.IMA(KL)) THEN 
IF (MASSEL(JP).LT.IMA(KL)) THEN 
KL=KL-64/2**IM 
ELSE
KL=KL+64/2**IM 
ENDIF 
IM=IM + 1 
IF (IM.GT.7) THEN
WRITE (*,*) 'SOMETHING IS WRONG!!!'
WRITE (*,*) 'I CAN"T FIND THE ABUNDANCY OF ',ELM1(JP),':', 
/ MASSEL(JP)
STOP 
ENDIF 
GOTO 998 
ELSE
ABUND(JP)= ABD(KL)
KL=64 
IM=1 
ENDIF 
111 CONTINUE 
C ISEMI IS USED TO STORE THE POSITION OF 
C SQELM (WHICH COLUMN)
ISEMI=NE1 
GOTO 141
881 WRITE(*,*)'PLEASE ENTER YOUR SRM CODENAME: ' 
READ(*,'(A)') ID(lOl)
KEV=0
DO 645 1=1,NS 
IF (ID(lOl).EQ.ID®) THEN 
KEV=I 
GOTO 11 
ENDIF 
645 CONTINUE
WRITE (*,880) ID(lOl)
880 FORMATC THERE IS NO ’,A6,' IN YOUR FILE')
GOTO 881
11 WRITE (*,*) DO YOU WANT BLANK CORRECTION (Y/N): '
877 READ(*,'(A)') ANY
IF (ANY.EQ.'N'.OR.ANY.EQ.'n'.OR.ANY.EQ.'Y'.OR.ANY.EQ.'y')
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/ GOTO 141 
WRITE(*,878)
878 F0RMAT(1X,'PLEASE ANSWER Y OR N: ’)
GOTO 877
141 CONTINUE
DO 207 J=1,NE1
WRITE (*,6) ELM1(J),MASSEL(J)
6 F0RMAT(5X,'CALCULATION FOR: ’,A2,1X,I3)
WRTTEC*,*)
WRITE(*,*)
IF (NEV.EQ.2.0R.NEV.EQ.5) THEN 
IF (J.LT.1.0R.ELM1(J).NE.ELM1(J-1)) THEN 
502 WRITE(*,142) ID(lOl)
142 F0RMAT(1X,'PLEASE ENTER ',A6,' CONC(NG/ML): ')
READ(*,*,IOSTAT=IST) SDCONC
IF (IST.GT.O) GOTO 502 
ENDIF
IF (ANY.EQ.’N'.OR.ANY.EQ.'n') GOTO 129 
GOTO 906
ELSEIF (NEV.EQ.3) THEN
SCONCl= RATIO(ISEMI)*SC2(ISEMI)*ABUND(ISEMI)/
/ (RATIO(J)*ABUND(J)*(SSTD(l ,ISEMI)-BK(ISEMI)))
ELSEIF (NEV.EQ.6) THEN
SCONCl=RATIO(ISEMI)*SC2(ISEMI)*ABUND(ISEMI)/
/ RATIO(J)*ABUND(J)
ELSE
SCONCl = SC2(J)
ENDIF
906 CALLGETBLK(BLK,K,RBLK,L,BK,RBK,SD,SD1,J)
129 CALL CCALC(J,SSTD,NEV,DATA,ID,BK,RBK,DF,KEV,SDCONC,SCONCl,ANY,
/ DATA1,DL,M,NS,INSTD,SD,RATI0,ISEMI)
207 CONTINUE
CALL 0UTPUT(INF,DATA1,MASSEL,ID,ELM1,SSTD,NS,NE1,NEV,DL)
940 CONTINUE
RETURN 
END**************************** SUBROUTINE ELSORT ******************************* 
C THIS SUBROUTINE SORT BLANKS, REAGENT BLANKS, AND STANDARDS 
SUBROUTINE ELS0RT(ID,BLK,RBLK,SSTD,DATA,K,L,M,NS,NE1) 
CHARACTER+6 ID(lOl)
INTEGER BLK(11,20),RBLK(11,20),SSTD(11,21),DATA(100,21),K,L,M,NS
K =0
L =0
M =0
DO 201 1= 1,NS
IF(ID® .EQ. 'BLANK .OR.ID(I).EQ. 'BLNK') THEN 
K =K +1
DO202 JE=1,NE1
202 BLK(K,JE)=DATA(I, JE)
ELSEIF(ID® .EQ. 'RBLANK' .OR.ID(I).EQ. 'RBLNK') THEN 
L =L +1
DO203 JE=1,NE1
203 RBLK(L,JE)=DATA(I,JE)
ELSEIF(ID(I).EQ. 'SSTND. '.OR.ID(I).EQ. 'STND. ') THEN 
M=M + 1
DO 204 JE= 1,NEI
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204 SSTD(M,JE)=DATA(I,JE)
SSTD(M,21)=I 
ENDIF 
201 CONTINUE
RETURN 
END**************************** FUNCTION XCOEF **************************** 
FUNCTION XCOEF(SSTD,IE,J)
INTEGER SSTD(11,21),IE,J
XCOEF= (SSTD(IE +1 ,J)-SSTD(IE, J))*l .0/(SSTD(IE + 1 ,21)-SSTD(IE,21))
RETURN
END
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *  
***************************** f u n c t io n  c t e  ******************************
FUNCTION CTE(SSTD,IE,J,A)
INTEGER SSTD(11,21),IE,J 
REAL*4 A
CTE=SSTD(IE,J)-A*SSTD(IE,21)
RETURN
END
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
***************************** FUNCTION AVG *******************************
C COMPUTES THE AVERAGE OF AN ARRAY 
FUNCTION AVG(ARR,K,J)
INTEGER ARR(11,20),K,J 
REAL SUM 
SUM=0 
DO 230 1=1,K
230 SUM=SUM+ARR(I,I)
AVG=SUM/K
RETURN
END
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *  
******************************* f u n c t io n  s t d e v  ***************************
FUNCTION SDEV(ARR,K,XM1,J)
INTEGER ARR(11,20),K,J 
REAL XM1,VR1 
VR1=0 
DO 231 1=1,K
231 VR1=VR1+(ARR(I,J)-XM1)**2 
SDEV=SQRT(VR1/K)
RETURN
END
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
**************** d e t e r m in a t io n  o f  BLANK AND REAGENT BLANK **************** 
SUBROUTINE GETBLK(BLK,K,RBLK,L,BK,RBK,SD_RBLK,SD_BLK,J)
INTEGER BLK(11,20),RBLK(11,20),BK(20),RBK(20)
REAL SD_RBLK,SD_BLK,MEAN_BLK,MEAN_RBLK 
CHARACTER*1 ANS 
906 WRITE(*,*)
C CHECK IF THERE IS NO BLANK
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C YES : CALCULATE THE MEAN AND STANDARD DEV.
C NO : GIVE THE MEAN AND SD THE VALUES OF 0 
IF (K.NE.O) THEN 
MEAN_BLK=AVG(BLK,K, J)
SD_BLK=SDEV(BLK,K,MEAN_BLK, J)
ELSE
MEAN_BLK=0
SD_BLK=0
ENDIF
C CHECK IF THERE IS NO RBLANK 
C YES ; CALCULATE THE MEAN AND STANDARD DEV.
C NO : GIVE THE MEAN AND SD THE VALUES OF 0
IF (L.NE.O) THEN 
ME AN_RBLK=AVG(RBLK,L, J)
SD_RBLK= SDEV(RBLK,L,ME AN_RBLK, J)
ELSE
MEAN_RBLK=0
SD_RBLK=0
ENDIF
C CHECK IF THERE IS MEAN RBLANK IS 0 
C YES : RBLANK = BLANK
C NO : CHECK IS SD OF RBLANK = 0 (1 RUN OF RBLANK)
C NO: OK
C YES: EVALUATE PERCENT ERROR ON BLANK AND MAKE IT TO RBLANK
IF (in t (m e a n _r bl k ).e q .o) t h e n
MEAN_RBLK=MEAN_BLK
SD_RBLK=SD_BLK
ELSEIF (SD_RBLK.EQ.O) THEN
SD RBLK=SD BLK*MEAN RBLK/MEAN BLK
ENDIF
WRITE (*,13)
13 FORMAT(10X, 'BLK' ,7X, 'SD', 1IX, 'RBLK* ,7X, 'SD ')
WRITE (*,14) INT(MEAN_BLK),SD_BLK,INT(MEAN_RBLK),SD_RBLK
14 FORMAT(9X,I4,1X,F8.3,10X,I4,1X,F8.3)
WRITE(*,*)’DO YOU ACCEPT THESE VALUES: '
119 READ(*,'(A)') ANS
IF (ANS.EQ.'Y'.OR.ANS.EQ. 'y') THEN 
BK(J)= INT(ME AN_BLK)
RBK(J)=INT(MEAN_RBLK)
GOTO 143
ELSE IF (ANS.EQ.'N*.OR.ANS.EQ.'n') THEN 
WRITE(*,*)'PLEASE ENTER BLK: ’
READ(*,*) BK(J)
WRITE(*,*)'PLEASE ENTER YOUR BLK SD: '
READ(*,*) SD_BLK
WRITE(*,*)'PLEASE ENTER RBLK: '
READ(*,*) RBK(J)
WRITE(*,*)'PLEASE ENTER YOUR RBLK SD: '
READ(*,*) SD_RBLK 
WRITE(*,*) 'ARE YOU SURE: '
READ (*,'(A)') ANS
IF (ANS.EQ.'N'.OR.ANS.EQ.'n') GOTO 906
GO TO 143
ELSE
WRITE(*,*)'PLEASE ANSWER Y OR N: '
GO TO 119
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ENDIF 
143 CONTINUE 
RETURN 
END
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
********************** SUBROUTINE CCALC ********************************* 
SUBROUTINE CCALC(J,SSTD,NEV,DATA,ID,BK,RBK,DF,KEV,SDCONC,
/ SCONCl,ANY,DATAl,DL,M,NS,INSTD,SD,RATIO,ISEMI)
INTEGER J,BK(20),RBK(20),DATA(100,21),SSTD(11,21),DIV 
REALDATA1(100,20),DF(100),C(100),SDCONC,SCONC1,DL(20)
REAL RATIO(20)
REAL*4 A,B,CORRECT 
CHARACTER*6 ID(lOl)
CHARACTER*1 ANY 
C SET THE CONSTANTS TO THEIR MOST FREQUENTLY USED VALUES 
C SOME OF THEM WILL SUBSEQUENTLY CHANGED DEPENDING ON THE 
C MODE OF CALCULATION.
C B1 = B3 =  STANDARD BLANK 
C B2 = REAGENT BLANK
C CORRECT = CORRECTION FACTOR FOR SAMPLES (IN CASE 
C OF INTERNAL STANDARD CORRECTION THIS IS = 1)
C DIV = THE COUNTS FOR THE STANDARD USED (SSTD(1,J) FOR 
C SSTD CALC OR DATA(KEV,J) IN CASE OF SRM CALC)
B1=BK(J)
B2=RBK(J)
B3=BK(J)
CORRECT = 1 
DIV =  SSTD(1,J)
IF (NEV.EQ.l) THEN 
IE=1
IF(B1.GT.SSTD(1,J)) THEN
DL(J)=0
B3=0
ELSE
DL(J)=3 *SD »SCONC 1 /(SSTD( 1, J)-B 1 )
ENDIF
DO 33 IE=1,M-1 
C FIRST LET US GET THE PARAMETERS FOR THE LINEAR 
C DRIFT BETWEEN SSTND NO IE AND THE NEXT SSTND 
A=XCOEF(SSTD,IE,J)
B = CTE(SSTD,IE,J,A)
DO 33 I=SSTD(IE,21),SSTD(IE+1,21)
C THE CORRECTION FACTOR IS THE RATIO OF THE FIRST 
C SSTND OVER THE ESTIMATED VALUES OF THE SSTND AT THE 
C TIME THE SAMPLE WAS RUN
CORRECT= SSTD( 1 ,J)*1.0/(A*I+ B)
CALLCALC1(ID,J,DATA,DIV,C0RRECT,B1,B2,B3,DF,SC0NC1,DL,DATA1,I, 
/ NEV)
33 CONTINUE
ELSEIF (NEV.EQ.2) THEN
IF (ANY.EQ.'N'.OR.ANY.EQ.’n’) THEN
B1=0
B2=0
B3 = 0
ELSE
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B3=B2
ENDIF
SCONCl=SDCONC/DF(KEV)
DO 34 IE=1,M-1 
A=XCOEF(SSTD,IE,J)
B=CTE(SSTD,IE,J,A)
DO 34 I=SSTD(IE,21),SSTDaE + l,21)
C IN ORDER TO GET THE PROPER COUNTS FOR THE SRM 
C THE DATA MUST BE CORRECTED FIRST
DATA(I,J)=INT(D ATA(I, J)*(SSTD(1 ,J)*1.0/(A*I+B)))
34 CONTINUE
C CORRECT IS STILL 1
DIV=DATA(KEV,J)
IF(B3.GE.DIV) THEN
DL(J)=0
B 3 -0
ELSE
DL(J)= 3*SD*SDCONC/(DIV-B3)
ENDIF
DO 35 I=SSTD(1,21),NS
CALL CALC1(ID,J,DATA,DIV,CORRECT,B1,B2,B3,DF,SCONCl,DL,DATA1,I, 
/ NEV)
35 CONTINUE
ELSEIF (NEV.EQ.3) THEN 
C SINCE NO STANDARD IS AVAILABLE THEN ASSUME THE 
C CORRECTION FOR THE ELEMENT OF INTEREST IS THE SAME AS 
C THE SEMIQ ELEMENT (ISEMI)
B3=0
DIV=1
DO 36 m = l,M -l  
A=XCOEF(SSTD,IE,ISEMI)
B= CTE(SSTD,IE,ISEMI, A)
DL(J)=3*SD*SC0NC1
DO 36 I=SSTD(IE,21),SSTD(IE+1,21)
CORRECT=(SSTD(1 ,ISEMI)*LO)/(A*I 4-B)
CALLCALC1(ID,J,DATA,DIV,C0RRECT,B1,B2,B3,DF,SC0NC1,DL,DATA1,I, 
/ NEV)
36 CONTINUE
ELSEIF (NEV.EQ.4) THEN
IF(B1.GE.SSTD(1,J)) THEN
DL(J)=0
B3=0
ELSE
DL(J) = 3»SD*SCONCl/(SSTD(l ,J)-B 1)
ENDIF
DO 37 I=SSTD(1,21),NS
CALL CALC1(ID,J,DATA,DIV,CORRECT,Bl,B2,B3,DF,SCONCl,DL,DATAI,I, 
/ NEV)
37 CONTINUE
ELSEIF (NEV.EQ.5) THEN
IF (ANY.EQ. 'N'.OR.ANY.EQ. n ) THEN
B1=0
B2=0
B3=0
ELSE
B3=B2
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EN D IF
D IV »D A T A (K E V ,J)
IF(B3.G E.D IV ) TH EN
D L (J)= 0
B 3 - 0
ELSE
D L (J)= 3  *SD*SD C0N C/(D IV -B3)
EN DIF
SC O N C l =  SDSCONC/DF(KEV)
DO  38 I=S S TD (1,21),N S
CA LL C A L C iaD ,J,D A T A ,D IV ,C O R R E C T ,B 1,B 2,B 3,D F ,S C O N C l,D L ,D A T A I,I,
/ NEV)
38 CONTINUE
ELSEIF (N EV .EQ .6) TH EN
IF  (B3.GE.DA TA (1,ISEM I)) TH EN
B 3 = 0
EN D IF
D IV =D A TA (1,ISEM I)
D L(J)=3*SD *SC O N C l/(D IV -B 3)
D O  39 I=S S TD (1 ,21),N S
CALL CA LC1(ID ,J,D A TA ,D IV ,CO R RECT,B  1 ,B2,B3 ,D F ,S C O N C 1 ,D L ,D A T A I ,1,
/ NEV)
39 CONTINUE 
EN D IF 
RETURN 
END
*************************** SUBROUTINE C A L C l ********************************* 
SUBROUTINE C A L C l(ID ,J,D A T A ,D IV ,C O R R E C T ,B l,B 2,B 3,D F ,S C O N C l,
/  D L ,D A TA 1,I,N EV )
INTEG ER J,D A TA (100,21),D IV
REA L D A TA 1(100,20),D F(100),SCO N C1 ,DL(20),
REAL*4 CORRECT 
CHARACTER*6 ID (101),RET 
B IL=D A TA (I,J)*C O R R EC T
IF(ID (I).EQ .'SSTN D . '.O R .ID (I).E Q .'S T N D .'.O R .ID (I).E Q . 'R B LA N K '.
/  O R .ID (I).E Q .'R B L N K ')T H E N
D A TA 1(I,J)=D F(I)*SC 0N C 1*((BIL-B 1)/(D IV -B3))
ELSE
D A TA l(I,J)=D F(I)*SC O N C l*((B IL-B 2)/(D IV -B 3))
EN D IF
DET_LIM  =  DF(I)*D L(J)
IF  (D A TA 1(I,J).LT.D ET_LIM .A N D .D A TA 1(I,J).G T.0) TH EN  
D A TA 1(I,J)= -1*D A TA 1(I,J)
EN D IF
RETU RN
END
************************** SUBROUTINE O U TPU T ****************************
SUBROUTINE O U TPU T(IN F,D A TA l,M A SSEL,ID ,ELM  1 ,SSTD ,NS,NE1 ,N EV ,D L) 
REA L D A TA 1(100,20),D L(20)
CHARACTER*12 IN F,O U FILE  
CHARACTER*6 ID (lO l)
CHARACTER*2 ELM 1(20)
CHARACTER*80 MESSAGE 
INTEG ER M A SSEL(20),SSTD (11,21),N EV  
INTEG ER*4 Y E,M O ,D A
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199 CONTINUE
W RITE(*,*) 'PLEA SE EN TER O U TPU T FILNAM E: '
R E A D (* '(A ) ')  OU FILE 
114 OPEN  (6 ,F IL E = OUFILE,STA TU S =  'N E W  ,IO S T A T = 1ST)
IF  (IST.GT.O) TH EN
W RITE (*,*) 'TH IS F ILE  ALREADY EX IST'
CL0SE(6)
GOTO 199 
EN D IF
CALL D A TE(Y E,M O ,D A )
W R ITE(6,’(9X ,A 6,A 8,20X ,A 17,A 8)’,IO STA T=IST) 'FILE: ' , O U F IL E ,'IN PU T 
/  D A TA  F IL E :',IN F
W R IT E (* ,'(A )') ' PLEASE EN TER ANY ID EN TIFIER OR M ESSA G E:'
READ (* ,'(A ) ')  M ESSAGE 
W RITE (6 ,'(9X ,A 80)') MESSAGE 
W RITE(6,91) D A ,M O ,Y E 
91 FO RM A T (lO X ,'PRO CESSIN G  D ATE: ',12,',',12,',',14)
W R ITE(6,34,IO STA T=IST) (ELM 1(I),M A SSEL(I),I=1,N E1)
IF aST.EQ.59) THEN
W RITE (*,*) 'DISK  IS FU LL M Y  D EA R PLEASE INSERT A N EW  O N E' 
W RITE (*,*) 'PRESS RETU RN  W H EN  REA D Y '
READ (*,*) ANS 
GOTO 114 
EN DIF
34 FO RM A T (10X ,20(3X ,A 2,1X ,I3))
W R ITE(6, * ,IO STA T=IST)
IF aST.EQ.59) THEN
W RITE (*,*) 'DISK  IS FU LL M Y  D EA R PLEASE INSERT A N EW  O N E' 
W RITE (*,*) 'PRESS RETU RN  W H EN  REA D Y '
READ (*,*) ANS 
GOTO 114 
EN D IF
D O  400 I=S S T D (1 ,21),N S
WRITE(6,37,IOSTAT=IST) IDa),a)ATAia,J),J= 1,NE1)
IF aST.EQ.59) THEN
W RITE (*,*) 'D ISK  IS FU L L  M Y  D EA R PLEASE INSERT A  N EW  O N E' 
W RITE (*,*) 'PRESS RETU RN  W H EN  REA D Y '
READ (*,*) ANS 
GOTO 114 
EN D IF
400 CONTINUE
DO 401 I= N S  +  1,NS +  1
401 W R ITE(6,40)O D L(J),J=1,N E1)
40 FORM A T(3X , 'D E T .L I. ' ,  1X,200F8.2, IX ))
W RITE (6 ,42,IO STA T =IST )
IF  aS T .E Q .59) TH EN
W RITE (*,») 'D ISK  IS FU L L  M Y  D EA R PLEASE INSERT A  N EW  O N E' 
W RITE (*,*) 'PRESS RETU RN  W H EN  REA D Y '
READ (+,*) ANS 
GOTO 114 
EN D IF
42 FORM A T (3 X ,'0 .0 0 = VALUE IS BELOW  D ETECTIO N  LIM ITS ')
37 FO R M A T(3X ,A 6,2X ,200^8.2,1X ))
155 CLOSE(6)
RETURN
END
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************************ SUBROUTINE VCOR ********************************
C THIS SUBROUTINE LOOK FO R TH E PRESEN CE OF V 51,
C CR 52, AND CR 53 AND IF  ALL TH REE ARE TH ERE 
C ASKS YOU IF  YOU W A N T TO CORRECT FO R  TH E CLO 
C INTERFEREN CE AND CORRECTS IT  IF  Y O U  ANSW ER YES 
SUBROUTINE VCOR (ELM  1 ,M A SSEL,D A TA ,N E 1 ,NS)
CHARACTER *2 ELM 1(20),C 1,C 2,C 3
CHARACTER *1 ANY
INTEG ER M A SSEL(20),D A TA (100,21)
REA L D A TA 1(100,20)
K N =  100 
K M = 1 1 0  
K P = 1 2 0  
F A C = 9 .5 /8 3 .8  
DO  391 J= 1 ,N E 1
IF  (E L M 1(J).E Q .'V '.A N D .M A SS E L (J).E Q .51)T H E N  
K N = J
ELSEIF (ELM 1(J).EQ .'C R '.A N D .M A SSEL(J).EQ .52) TH EN  
K M = J
ELSEIF (ELM 1(J).EQ .'C R '.A N D .M A SSEL(J).EQ .53) TH EN  
K P = J  
EN D IF 
391 CONTINUE
K T = K N + K M + K P  
IF  (KT.GT.lOO) GOTO 981
W RITE (*,*(A45)') CORRECTION FO R VANADIUM  W ILL BE U N D ER TA K EN ' 
W RITE (* ,'(A 22)')  DO YOU W ANT IT  Y /N : '
READ (* ,'(A l) ')  ANY
IF (A N Y .E Q .’N '.O R .A N Y .E Q .'a ')  GOTO 981 
D O  9 8 2 I= 1 ,N S
D A TA 1(I,K P)= DA TA (I,K P)-D A TA (I,K M )*FA C 
IF  (D A TA l(I,K P).LT.O ) GOTO 982
D A TA (I,K N )=IN T(D A TA (I,K N )-IN T(D A TA 1(I,K P)»75.8/24.2))
IF  (DATA(I,KN).LE.O) TH EN  
W RITE (*,357) ELM 1(K N ),D A TA (I,K N )
357 FO RM A T (3X ,'ER R A TIC  D A TA  A T ',1 X ,A 2 ,1 X ,'F 0 R ',1 X ,I7 )
EN D IF 
982 CONTINUE
981 CONTINUE
RETU RN  
END
************************ SUBROUTINE SECOR ********************************
C THIS SUBROUTINE LOOKS FO R  TH E PRESEN CE OF 
C SE 76, GE 73, IF  BOTH OF TH EM  ARE TH ER E ASKS 
C Y O U  IF  YOU W A N T TO  CORRECT FO R  TH E GE INTERFERN CE 
C AND CORRECTS IT  IF  Y O U  ANSW ER YES
SUBROUTINE SECOR (ELM 1,M A SSEL,D A TA ,N E1,N S)
CHARACTER *2 ELM 1(20),C1,C 2,C 3
CHARACTER *1 ANY
INTEG ER M ASSEL(20),D A TA (100,21)
REA L D A TA 1(100,20)
K N =  100 
K M = 1 1 0  
D O  391 J= 1 ,N E 1
IF  (ELM 1(J).EQ .'SE '.A N D .M A SSEL(J).EQ .76) TH EN  
K N = J
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ELSEIF (ELM 1(J).EQ .'G E '.A N D .M A SSEL(J).EQ .73) TH EN  
K M = J 
EN D IF 
391 CONTINUE 
K T = K N + K M  
IF  (KT.GT.lOO) GOTO 981
W RITE (* ,'(A 45)')  CORRECTION FO R  SELENIUM  W ILL BE U N D ER TA K EN '
W RITE (* , '(A 22)') D O  YOU W A N T IT  Y/N: '
READ (* , '(A l) ')  ANY
IF (A N Y .E Q .'N '.O R .A N Y .E Q .'n ')  GOTO 981 
D O  982 1 = 1 ,NS
D A TA (I,K N )=D A TA (I,K N )-D A TA (I,K M )
IF (DATA(I,KN).LE.O) TH EN  
W RITE (*,357) ELM 1(K N ),D A TA (I,K N )
357 FO R M A T (3X ,'ER R A TIC  D A TA  A T ',IX ,A 2 ,IX ,'F O R ',IX ,17)
EN D IF 
982 CONTINUE
981 CONTINUE
RETU RN  
END
************************ SUBROUTINE AS COR ********************************
C THIS SUBROUTINE LOOKS FO R  TH E PRESEN CE OF 
C AS 75, SE 77, AND SE 76 AND IF A LL TH REE 
C ARE TH ERE ASKS YOU IF  YOU W A N T TO  CORRECT 
C FO R  TH E CLO INTERFEREN CE AND CORRECTS IT IF  
C YOU ANSW ER YES
SUBROUTINE A SC 0R(ELM 1,M A SSEL,D A TA ,N E1,N S,ID ,BK ,R BK ,B LK ,RB LK ,
/ K ,L ,SSTD )
CHARACTER *2 ELM 1(20),C 1,C 2,C 3 
CHARACTER *6 ID (lO l)
CHARACTER *1 ANY
INTEG ER M A SSEL(20),D A TA (100,21),BK (20),RBK (20),N S,SSTD(11,21)
INTEG ER BLN K ,BLK(11,20),RBLK (11,20)
REA L D A TA 1(100,20),SD P,SD P1 
KN =  100 '
KM =  110 I
K O = 3 0  I
K P = 3 0  i
F A C = 7 .5 /9 .0  
D O  391 J= 1 ,N E 1
IF  (EL M 1(J).E Q .’A S'.A N D .M A SSEL(J).EQ .75) TH EN  
K N = J
ELSEIF (ELM 1(J).EQ .'SE '.A N D .M A SSEL(J).EQ .77) TH EN  
K M = J
ELSEIF (ELM 1(J).EQ .'SE*.A N D .M A SSEL(J).EQ .76) TH EN  
K P = J
ELSEIF (ELM 1(J).EQ .'SE '.A N D .M A SSEL(J).EQ .78) TH EN  
K O = J 
EN D IF 
391 CONTINUE
K T = K N + K M + K P + K O  
IF  (KT.GT.lOO) GOTO 981
W RITE (* ,'(A 4S )') CORRECTION FO R  ARSENIC W ILL BE U N D ERTA K EN '
W RITE (* ,'(A 2 2 ) ')  D O  YOU W A N T IT  Y/N: '
READ (* ,'(A 1 ) ')  ANY
IF (A N Y .E Q .'N '.O R .A N Y .E Q .'n ')  GOTO 981
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W RITE (* ,'(A 45)’) D O  YOU W A N T TO  USE SE 76 OR SE 78 (76/78):'
139 READ (» ,'(I3 ) ',I0 S T A T = IS T ) NSE
IF  (N SE.EQ .78) TH EN  
K P = K O  
F A C = 7 .5 /2 3 .5  
ELSEIF (N SE.N E.76) TH EN
W RITE (*,*) ' CA RFU L, PLEASE ANSW ER 76 OR 78: '
GOTO 139
EN DIF
N M = 1
W RITE(*,14) NSE
14 FO R M A T ( IX , 'S E ',13, ' BLANK IS N EED ED  FO R CO R RECTIO N ')
CA LLG ETB LK (BLK ,K ,RBLK ,L,BK ,RBK ,SD P,SD P1,K P)
W RITE(*,14) M ASSEL(KM )
CALL GETBLK(BLK,K,RBLK,L,BK,RBK,SDP21 ,SD P2,K M )
K I= 1
DO  982 1 = 1 ,NS
IF  (ID (I).E Q .'B L A N K '.O R .ID (I).E Q .'B L N K ') GOTO 982 
IF  (ID (I).E Q .'S S T N D .'.O R .ID (I).E Q .'R B L A N K '.O R .ID (I).E Q .'S T N D .'.0  
/  R .ID (I).L T .'R B L N K ') TH EN  
BLN K =BK (K P)
BLN K 1=BK (K M )
ELSE
BLN K =RBK (K P)
BLN K 1=RBK (K M )
EN D IF
K D EV =IN T(3*D A TA (I,K M )*SD P/B LN K )
D A TA 1(I,K M )=D A TA (I,K M )-IN T((D A TA (I,K P)-B LN K )*FA C)
IF  (IN T(D A TA 1(I,K M )).LE.K D EV ) GOTO 988
D A TA 1(I,K N )=D A TA (I,K N )-((D A TA 1(I,K M )-BLN K 1)*75.8/24.2)
IF  (D A TA l(I,K N ).LE.O ) TH EN
W RITE (*,357) ID (I),D A TA (I,K N ),IN T(D A TA 1(I,K N ))
357 FO R M A T (3X ,'ER R A TIC  DATA A T ',1 X ,A 6 ,1 X ,'F 0 R ',1 X ,I7 ,2 X ,I7 )
D A TA (I,K N )=1
ELSE
D A TA (I,K N )=IN T(D A TA 1(I,K N ))
EN D IF
988 IF  (I.EQ .SSTD (N M ,21)) TH EN
SSTD (N M ,K N )=D A TA (I,K N )
N M = N M  +  1 
EN D IF
IF (ID (I).E Q .'R B L A N K ') TH EN  
RB LK (K I,K N )=D  ATA(I,KN)
K I= K I+ 1  
EN D IF 
982 CONTINUE
RBK (K N )= AVG(RBLK,K,KN)
981 CONTINUE
RETU RN  
END
*********************** IN TERN A L STANDARD CALCULATION ********************** 
SUBROUTINE INTSTD(ELM1 ,NE1 ,NS,INSTD,DATA,SOL,NEV,M ASSEL,SC2,PRECI 
/ S)
CHARACTER*^ CO M (20),ELM 1(20),ELM 2(20),IN TSTD ,RET 
IN TEG ER IN STD ,D A TA (100,21),D A TA 1(100,21),K IM (100),M A SSEL(20)
INTEG ER D A TA 2(100,21),M ASSEL2(21)
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CHARACTER * 12 INFI,N A LI,K EL1 
CHARACTER*12 FILEN A M E 
REA L SC2(20),SC3(20)
R O T = 0  
S O L = 0  
IN D K T R = 2 
859 FO R M A T(2X ,A 6,11X ,20(1X ,F8.3))
833 FO R M A T(2X ,A 6,2X ,F7.3,2X ,20(2X ,I7))
877 FO R M A T(14X ,A 3,2X ,20(4X ,A 2,I3))
555 CONTINUE
IF (N E V .E Q .3.O R .N EV .EQ .6.A N D .R O T.EQ .O ) TH EN  
N E 1= N E 1  +  1
1 CONTINUE
W RITE(*,*) 'PLEA SE EN TER TH E FILE  W H ERE YO UR SQ.ELEM . IS STO RED ' 
W R ITE(*,*) 'EN T E R  N  FO R N O N E OR S FO R  THE SAM E W ORKING FILE: ' 
R E A D (* '(A ) ')  IN FI
IF  (IN FI.EQ . 'N ' .O R .IN FI.EQ . 'n ')  TH EN  
CALL M ESSAGE(SOL)
GOTO 4
ELSEIF (IN F I.E Q .'S '.O R .IN F I.E Q .'s ')  TH EN  
W RITE(*,*)
W R ITE(*,*) H ELLO  D A RLIN G '
W RITE(*,*)
ELSE
OPEN(7 ,F IL E = IN F I, STATUS =  'O L D ' ,IO STA T=IO E)
IF  (lOE.GT.O) TH EN
W RITE(*,*) IN FI, DOES N O T EXIST ON YOUR DISK '
CLOSE (7)
CALL CM N D CD EL A :IN F I')
GOTO 1 
ELSE
C A LLREA D _D A TA (N EL2,M A SSEL2,D A TA 2,ELM 2,IN D K TR ,SC3)
CLOSE (7)
EN D IF
EN D IF
ELSE
W RITE(*,*) 'I " M  LOOKING AT IN STD .STO '
O P E N (7,F IL E =  'IN S TD .ST O ',ST  A T U S = 'N E W ',IO S T A T = IO E )
IF (lOE.GT.O) TH EN
C A LLREA D _D A TA (N EL2,M A SSEL2,D A TA 2,ELM 2,IN D K TR ,SC3)
C L0SE(7)
ELSE 
CLOSE (7)
CA LL CM N D CD EL A :IN STD .STO  )
2 IN D K T R = 2
W R ITE(*,*)'PLEA SE EN TER TH E FILE W HERE YO UR IN T.STD . IS STO R ED ’ 
W RTrE(*,*) 'EN T E R  N  FO R  N O N E OR S FO R TH E SAM E W ORKING FILE: ' 
R E A D (* ,'(A )') IN FI
IF  (IN FI.EQ . N '.O R .ÏN F I.E Q .'n ')  TH EN  
CALL M ESSAGE(SOL)
GOTO 4
ELSEIF (IN FI.EQ . S ' .O R .IN FI.E Q . 's ')  TH EN  
W RITE(*,*) H ELLO  D A RLIN G '
ELSE
O P E N (7 ,F IL E = IN F I,S T A T U S = 'O L D ',IO S T A T = IO E )
IF (lOE.GT.O) TH EN
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W RITE(*,*) IN F I,'D O E S  N O T EXIST ON YOUR DISK'
CLOSE (7)
CALL CM ND CD EL A :IN F I')
GOTO 2 
ELSE
CA LLREA D _D A TA (N EL2,M A SSEL2,D A TA 2,ELM 2,IN D K TR ,SC3)
CLOSE(7)
EN D IF 
EN DIF 
EN D IF 
EN D IF 
101 CONTINUE
IF  (N EV .E Q .3.O R .N EV .EQ .6.A N D .R O T .EQ .0) TH EN  
W R ITE(*,*) 'PLEA SE EN TER Y OUR SQ ELEM ENT: '
ELSE
W RITE (*,*) PLEASE EN TER Y O U R INTERN A L STANDARD: ' 
EN D IF
READ (* ,'(A 2 ) ',I0 S T A T = IS T ) INTSTD 
IF  (IST.GT.O) TH EN
W RITE (*,*) 'W A TCH  IT YOU M A D E A M ISTAKE'
GOTO 101 
EN D IF
IF (IN D K T R .E Q .l) TH EN  
N E M = N E L 2  
D O  8 I= 1 ,N E L 2  
C O M (I)=ELM 2(I)
8 CONTINUE 
ELSE
IF (N EV .E Q .3.O R .N EV .EQ .6.A N D .R O T .EQ .0) TH EN
N E M =N E 1-1
ELSE
N E M = N E l
EN D IF
D 0  9 I= 1 ,N E M  
C O M (I)= E L M l(I)
9 CONTINUE 
EN D IF 
IN = 1
20 CONTINUE
IF (CO M (IN ).EQ .IN TSTD ) TH EN  
IN S T D = IN
E L M l(N E l)= C O M (IN )
ELSEIF (IN .LT .N EM ) TH EN
IN = IN + 1
GOTO 20
ELSE
W RITE (*,*) 'W A TCH  IT  THIS ELEM EN T DOES N O T EX IST ' 
W RITE (*,*) ERROR'
GO TO  101 
EN D IF 
30 CONTINUE
IF  (IN D K T R .E Q .l) TH EN  
DO 10 JIM = 1 ,N S  
K IM (JIM )=D  A TA2(JIM ,INSTD)
10 CONTINUE
M A SS=M A SSEL2(IN STD )
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C 0 N -S C 3 (IN S T D )
ELSE
D O  23 JIM = 1 ,N S  
23 K IM (JIM )=D A TA (JIM ,IN STD )
M A SS=M A SSEL(IN STD )
C 0N = S C 2(IN S T D )
EN D IF
IF (N EV .E Q .3.O R .N EV .EQ .6.A N D .R O T .EQ .0) TH EN
D O  55 IL = 1 ,N S
D A TA (IL ,N E1)=K IM (IL)
55 CONTINUE
M A SSEL(N E1)=M A SS
S C 2(N E l)= C O N
IF  (NEV .EQ .6.A N D .RO T.EQ .O ) TH EN
R 0 T = 1
GOTO 555
EN D IF
ELSE
DO 50 K SA = 1,N S  
DO 50 K E L = 1,N E 1
D A TA l(K SA ,K EL)=IN T(D A TA (K SA .K EL)*((K IM (l)‘î‘1.0)/KIM (KSA)))
50 CONTINUE
D O  6 0 K S A = 1 ,N S  
DO  60 K E L = 1,N E 1 
60 D A TA (K SA ,K EL)=D A TA 1(K SA ,K EL)
EN D IF 
4 CONTINUE
RETU RN  
END
************************** SUBROUTINE MESSAGE ****************************** 
SUBROUTINE MESSAGE(SOL)
INTEG ER SOL 
CH A RA CTER*! RET
W RITE(*,*) 'Y O U R  D A TA  FO R  TH E IN T. STD. M UST BE STORED' 
W RITE(*,*) 'SO M EW H ERE BEFORE ANY CLACULATION CAN TA KE' 
W RITE(*,*) 'PLA C E, E .G . IN  A FILE CALLED INSTD.STO"
W RITE(*,*)
W RITE(*,*) 'Y O U  W ILL SOON BE PROM PTED W ITH  TH E Q U ESTIO N ' 
W RITE(*,*) AN OTH ER SET?, ANSW ER YES AND IN PU T TH E IN T .' 
W RITE(*,*) STD. ELEM EN TS'
W RITE(*,*)
W RITE(*,*) 'PLEA SE EN TER RETU RN  TO CO N TIN U E'
R E A D (* ,'(A )') RET
S 0 L = 7
RETU RN
END
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *  
************************** SUBROUTINE READ D A TA  ************************** 
SUBROUTINE REA D _D A TA (N EL2,M A SSEL2,D A TA 2,ELM 2,IN D K TR,SC3) 
CHARACTER*6 K EL1,N AL6 
IN TEG ER M A SSEL2(21),D A TA 2(100,21)
CHARACTER*2 ELM 2(21)
REA L SC3(21)
859 FO R M A T(2X ,A 6,11X ,20(1X ,F8.3))
833 FO R M A T(2X ,A 6,2X ,F7.3,2X ,20(2X ,I7))
877 FO R M A T(14X ,A 3,2X ,20(4X ,A 2,I3))
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IN D K T R =1
R E A D (7 ,* ,I0S T A T = IS T ) N T2,N EL2 
IF  (IST.GT.O) W RITE(*,*) 'E R R O R l ' ,N T2,N EL2 
R EA D (7,877,IO STA T=IST) N A LI,(ELM 2(J),M A SSEL2(J),J=  1,NEL2)
IF  (IST.GT.O) W RITE (*,*) 'E R R 0 R 2 ' ,N A LI,J,ELM 2(J)
D O  497 1 = 1 ,N T2
R EA D (7,833,IO STA T=IST) K E L 1,PU M ,(D A T A 2(I,J),J=  1,NEL2)
497 CONTINUE
R EA D (7,859,IO STA T=IST) N A L 6,(SC 3(I),I=  1,NEL2)
IF  (IST.GT.O) W RITE (*,*) ER R O R 4',N A L6
RETU RN
EN D
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
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